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Introduction 
La période prénatale ainsi que les premières années de vie sont considérées comme des périodes de 
sensibilité importante aux expositions à de nombreux facteurs environnementaux. Des modifications 
survenues durant cette période pourraient entrainer des effets à court mais aussi à long terme sur la 
santé, ainsi que formulé dans le contexte de l'hypothèse DOHaD ("Developmental Origins of Health 
and Diseases", (Hanson and Gluckman 2008)). Cette hypothèse considère que les effets chez l'adulte 
associés à des expositions survenues pendant la vie fœtale pourraient s'expliquer par une adaptation du 
développement en réponse à un environnement intra-utérin défavorable. Cette adaptation 
développementale est favorable pendant la période intra-utérine mais, à cause de modification 
physiologiques et/ou métaboliques, pourrait entrainer des conséquences ultérieures néfastes (Barker 
2004, 2007; Gluckman and Hanson 2004). C'est une des raisons pour lesquelles il est important de 
caractériser les événements et expositions survenant durant la grossesse et leur impact potentiel sur le 
développement du fœtus et de l'enfant dans les premières années de vie.  
L'événement de santé étudié dans le cadre de ce travail de thèse est la croissance durant la vie fœtale et 
les premières années de vie. Une altération de la croissance fœtale est considérée comme un marqueur 
non spécifique des agressions subies pendant la vie fœtale. Un faible poids de naissance a été associé à 
un risque plus élevé de mortalité infantile, ainsi qu'à un risque plus élevé de développer des 
pathologies de type obésité, diabète, troubles cardiovasculaire à l'âge adulte (Barker 2007). Le poids à 
la naissance est un paramètre facilement mesurable et est couramment utilisé comme estimateur de la 
croissance fœtale dans les études épidémiologiques. Néanmoins, le poids est une mesure globale ne 
permettant pas d'identifier un effet sur une partie spécifique du corps et des mesures complémentaires 
telles que la taille et le périmètre crânien à la naissance sont souvent utilisées de concert. Une 
limitation à l'utilisation des mesures à la naissance est qu'elles ne fournissent pas d'information directe 
concernant des périodes spécifiques du développement du fœtus. L'utilisation de mesures 
échographique répétées pendant la grossesse permet de mettre en évidence des périodes de sensibilité 
au cours la vie fœtale. De telles mesures ont déjà été utilisées en épidémiologie environnementale pour 
évaluer les effets des polluants atmosphériques sur le développement fœtal (Aguilera et al. 2010; 
Hansen et al. 2008; Iniguez et al. 2012b; Slama et al. 2009; van den Hooven et al. 2012), mais encore 
très peu en relation avec des perturbateurs endocriniens à courte demi-vie (Snijder et al. 2013).  
La croissance post-natale précoce a été identifiée comme un facteur de risque d'obésité infantile 
(Botton et al. 2008; Giles et al. 2013). L'obésité infantile est un problème de santé publique important. 
Cette pathologie, dont la prévalence augmente dans le monde, est associée à d'autres problèmes de 
santé graves dans la jeunesse, mais aussi plus tard dans la vie adulte, comme le diabète, l'hypertension 
artérielle et les maladies coronariennes (Barker 2007; Bibbins-Domingo et al. 2007). En plus des 
déterminants connus de la croissance pré- et post-natal (génétique, alimentation...), l'exposition à des 
polluants chimiques est de plus en plus suspectée d'affecter les trajectoires de croissance.  
Les contaminants environnementaux étudiés dans ce travail appartiennent aux familles des phénols et 
des phtalates. Ils font partie des composés chimiques dont le niveau de production est très élevé (de 
l'ordre de 4 millions de tonnes dans le monde pour le Bisphénol A en 2006) et sont présents dans un 
vaste éventail de produits de consommation courante. Les phtalates de poids moléculaire inférieur à < 
250 g / mol sont utilisés dans les produits de soins personnels (parfums, cosmétiques) et dans les 
industries pharmaceutiques (enrobage de certain médicaments) tandis que les phtalates de haut poids 
moléculaire (> 250 g / mol) sont plutôt retrouvés dans les revêtements de sols et de murs, les 
emballages alimentaires et des dispositifs médicaux (A. M. Calafat et al. 2006; Hauser and Calafat 
2005). 
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Pour ce qui est des phénols, le bisphénol A est utilisé dans la fabrication des résines époxy couvrant 
l'intérieur des boîtes de conserve et dans certains plastiques de type polycarbonate. D'autres phénols 
sont utilisés pour leurs propriétés antibactériennes et de conservateurs dans les cosmétiques 
(parabènes) et les savons (triclosan). La benzophénone-3 est utilisée comme filtre anti rayons ultra-
violets dans les crèmes solaires (Calafat et al. 2008). Ainsi l'exposition à ces composés est ubiquitaire.  
Ces substances et / ou leurs métabolites ont été mis en évidence dans la quasi totalité des urines testées 
en population générale, incluant des femmes enceintes (Casas et al. 2012; Woodruff et al. 2011). Le 
fœtus est lui aussi exposé et certains métabolites ont été détectés dans le sang du cordon ombilical, le 
liquide amniotique ou le méconium des nouveau-nés (Latini et al. 2003; Zhang et al. 2009). 
Les phénols et les phtalates ont été identifiés comme étant des perturbateurs endocriniens. Ils peuvent 
interagir avec les récepteurs hormonaux, mais aussi la synthèse, la sécrétion, le transport, la fixation et 
l'élimination des hormones naturelles qui jouent un rôle important dans de nombreuses fonctions telles 
que le métabolisme, le comportement, la fertilité ou la croissance.  
Une étude réalisée au sein d'une population de femmes enceintes new-yorkaise avait suggéré un effet 
de ces composés sur la croissance fœtale estimée à l'aide de mesures à la naissance; l'effet de certains 
phénols sur le poids de naissance était différent suivant le sexe de l'enfant (Wolff et al. 2008). Une 
seule étude s'était intéressée aux effets des expositions prénatales aux phénols sur la croissance 
postnatale (Harley et al. 2013), les autres études étant transversales (Teitelbaum et al. 2012; Trasande 
et al. 2012). Dans l'étude publiée par Harley et al (2013) une association négative entre les 
concentrations maternelles de bisphénol A et le risque d'être en surpoids à 9 ans a été mis en évidence 
chez les filles.  
Les objectifs de ce doctorat étaient: 
 
1) d'étudier les associations entre les concentrations urinaires maternelles de phenols et de phtalates et 
la croissance pré et post-natale de l'enfant (chapitre II); 
2) de comparer les concentrations de phénols dosées dans l'urine maternelle à celle dosées dans le 
liquide amniotique, recueillis le même jour (Chapitre III); 
3) d'étudier la variabilité des concentrations urinaires de polluants environnementaux non persistants 
(phénols) durant la grossesse (Chapitre III);  
4) de caractériser le biais associé à l'utilisation d'un seul échantillon urinaire pour estimer l'exposition 
durant la grossesse, qui est l'approche utilisée dans la plupart des études épidémiolgiques publiées à 
cette date (Chapitre III).  
   
Introduction 
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I. Pre- and post-natal growth in humans  
1. Pre and post-natal growth as markers of well being 
a) Prenatal growth  
 Fetal growth is the reflect of healthy development and is considered to be a non-
specific marker of exposures and mechanisms taking place during fetal life (Gluckman and 
Hanson 2004; Hanson and Gluckman 2008). Birth weight is easy to collect and is often used 
as a surrogate measure for fetal growth in epidemiological studies. Term low birth weight (< 
2500 g) has been linked with a higher risk of baby's mortality (Wilcox 2001), but also with 
occurrence of several chronic conditions including cardiovascular diseases, type 2 diabetes, 
obesity and hypertension (Barker 1995, 2004; Godfrey and Barker 2001). These results are in 
line with the Developmental Origins of Health and Diseases (DOHaD) hypothesis, which 
suggests that exposures during fetal life can result in long term effects on health. These long 
term effects may result from fetal developmental adaptations, which are beneficial during the 
intrauterine period, but may lead to permanent changes in body’s structure, physiology and 
metabolism and thus may promote development of diseases later in life (Barker 2004, 2007; 
Gluckman and Hanson 2004). 
 Historically birth weight was analyzed independently of gestational duration, making 
it difficult to distinguish low birth weight due to restricted fetal growth from low birth weight 
due to preterm birth (Adams et al. 2010; Savitz et al. 2002). In studies on the effects of 
environmental factors on fetal growth, birth weight is now usually corrected for gestational 
age. In addition to low birth weight, metrics including reduction in birth weight (continuous 
variable), very low birth weight (< 1500 g) and small for gestational age (birth weight lower 
than the 10th percentile of a suitable sex- and gestational age-specific weight reference 
distribution) are commonly used in epidemiological studies. Weight at birth does not allow to 
identify an effect on a specific body part or organ and additional measurements of neonatal 
anthropometry at birth such as length and head circumference provide additional information.  
 A limitation to the use of birth outcomes in epidemiological studies is that they are 
measured at the end of intrauterine life. They therefore do not provide direct information on 
specific periods of fetal development (Hemachandra and Klebanoff 2006) and effects 
occurring at specific times of pregnancy could be missed. In addition, developmental 
Introduction 
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programming may occur independently of birth weight. Animal experiments have indeed 
shown that fetuses from mothers with nutrition restriction during early pregnancy may have 
normal weight at birth, but exhibited increased body weight and fat deposition later in life 
(Ford et al. 2007; Reynolds and Caton 2012). Repeated measurements of fetal anthropometry 
during pregnancy by ultrasound examinations may allow to highlight windows of heightened 
sensitivity to environmental contaminants during fetal life. Such measurements have already 
been used in environmental epidemiology to assess the effects of air pollutants on fetal 
development (Aguilera et al. 2010; Hansen et al. 2008; Iniguez et al. 2012b; Slama et al. 
2009; van den Hooven et al. 2012) and very recently to characterize the effect of short half-
life endocrine disruptors (Snijder et al. 2013). 
b) Early postnatal growth and link with childhood obesity 
 The definition of overweight and obesity given by the World Health Organization 
(WHO) is an abnormal or excessive fat accumulation that presents a risk to health. A crude 
measure of overweight and obesity is given by the body mass index (BMI): an adult with a 
BMI above 25 kg/m2 is defined as overweight; a BMI above 30 kg/m2 is defined as obesity. 
During childhood, body composition strongly varies with age and sex. Child's weight status is 
therefore usually determined using an age- and sex-specific references rather than the BMI 
categories used for adults. Several definitions of child's obesity and overweight exist; the most 
common used are those from the WHO, the Centers for Disease Control and Prevention 
(CDC) and the International Obesity Task Force (IOTF) (Flegal and Ogden 2011). 
Table 1: Definitions of overweight and obesity commonly used in study of weight and 
adiposity in children.  
Organization Definition of Childhood Obesity and overweight   
World Health Organization Between birth to age 5: 
Obese: BMI > 3 standard deviations above the WHO growth standard 
median  
Overweight: BMI > 2 standard deviations above the WHO growth standard 
median 
 
Centers for Disease Control and 
Prevention 
Between 2 to 19 years:  
Obese: BMI ≥ 95th percentile. 
Overweight: BMI between the 85th and the 95th percentiles 
 
International Obesity Task 
Force 
Age 2 to 18: 
Provides international BMI cut points by age and sex for overweight and 
obesity, the cut points correspond to an adult BMI of 25 (overweight) or 30 
(obesity) 
Abbreviations: BMI: Body Mass Index, WHO: World Health Organization 
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 The prevalence of childhood overweight and obesity has strongly increased in 
developed countries. Surveys during the 1990s show that in Europe an additional 1 % of the 
entire child population became overweight each year and 15 % of the European school-aged 
children are estimated to be carrying excess body fat; among them a quarter are obese (IOTF 
definition (Lobstein et al. 2004)). Obesity is associated with other health troubles during 
youth and obese children and adolescents are likely to suffer from related comorbidities 
(Figure 1). These children are also more likely to be obese as adults (Bibbins-Domingo et al. 
2007; Haslam and James 2005; Lakshman et al. 2012; Reilly et al. 2003; Singh et al. 2008). 
Figure 1: Summary of the complications related to childhood obesity (Lakshman et al. 2012). 
 
Comorbidities of childhood obesity are depicted in the outer ring with their intermediate processes in the inner 
ring.  
  Several epidemiological studies have shown an association between rapid growth 
during the first years of life and the development of obesity later in the childhood (Botton et 
al. 2008; Giles et al. 2013; Ong et al. 2000; Taveras et al. 2009), suggesting that early post-
natal growth is a risk factor for childhood obesity (Figure 2). Two periods in particular (up to 
6 months and from 2 years onward) have been associated with a later risk of overweight 
(Botton et al. 2008). Such results highlight the importance of studying determinants of 
overweight in early life. 
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Figure 2: Odds ratios (ORs) and 95% CIs of being overweight (IOTF) in 325 adolescent boys 
and girls for a 1-SD increase in weight growth velocity at different ages between 3 and 36 
months (logistic model adjusted for sex, (Botton et al. 2008)). 
 
 
 
 Early post-natal growth can be studied by collecting repeated measures of weight and 
height during childhood. Such measurements are easy to collect, especially in countries where 
they are regularly reported by the family pediatrician in the personal child health booklet 
(such as France). Skin fold thickness and abdominal circumference are not routinely 
measured. They can provide complementary information on the body fat composition and are 
also interesting to study early post-natal growth (Hauspie et al. 2004). 
2. Determinants of pre- and early post-natal growth  
a) Fetal growth  
 Fetal growth results from a complex interplay among factors including genetic, 
maternal, placental, hormonal and environmental factors (Kramer 1987; Sacks 2004; 
Williams 2005). A non-exhaustive overview of these determinants is given in this chapter. 
Genetic influences 
 A study has reported that around 50% of the variation in weight, length and head 
circumference at birth may be explained by genetic factors (n = 101,748 parent-offspring 
pairs, data from Medical Birth Registry of Norway from 1967 to 2004). Among this share of 
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50%, the fetal genome might explain about 30% of the normal variation in birth weight while 
the maternal genome would explain the other 20% (Lunde et al. 2007). Infant sex is 
associated with fetal growth and at birth boys are on average 150 g heavier than girls (Valero 
De Bernabé et al. 2004). Several fetal chromosomal anomalies including trisomy 21, 18 and 
Turner’s syndrome usually result in fetal growth retardation. Conversely, other genetic 
disorders can lead to pre- and/or post-natal over-growth. This is the case of the Beckwith-
Wiedemann syndrom, caused by the disruption of imprinting of the short arm of chromosome 
11, leading to over activity of the Insuline like Growth Factor-2 (IGF-2) gene (Gicquel and Le 
Bouc 2006).  
Placental influences  
 The placenta is the main interface between mother and fetus during pregnancy and 
fetal growth is related to its capacity to transfer oxygen and nutrients to the fetus (Jansson and 
Powell 2007; Reece and Hobbons 2007). The placenta also produces a wide spectrum of 
hormones involved in fetal growth regulation (e.g., IGF-I, IGF-II, placental growth hormone, 
(Murphy et al. 2006; Newbern and Freemark 2011)) and modifications in placental functions 
are likely to lead to fetal growth alterations.  
Endocrine regulation of fetal growth 
 A wide range of hormones influence growth and maturation, beginning in-utero and 
continuing throughout childhood. Hormones, such as IGFs, insuline, thyroid hormones and 
oestrogens control the rate of cell proliferation, apoptosis and differentiation in many tissues, 
they could either stimulate or inhibit growth in-utero.  
Maternal (non genetic) influences 
 Maternal behavioral factors affecting fetal growth include alcohol consumption and 
active smoking during pregnancy, which has been associated with decrease in offspring birth 
weight (Mills et al. 1984; Rahmalia et al. 2012; Suzuki et al. 2008). Good maternal health is 
essential for normal fetal development. Pathologies limiting nutrients and oxygen transfer to 
the fetus, including preeclampsia and anemia, negatively affect fetal growth. Conversely 
infants born to mothers with gestational diabetes are more likely to be large for gestational 
age (Gillman et al. 2003). Other maternal factors associated with size at birth include maternal 
pre-pregnancy weight, maternal age and parity; the first child weights on average less than the 
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second and third children (Reece and Hobbons 2007; Thame et al. 2004; Valero De Bernabé 
et al. 2004) 
Environmental factors  
 Environmental factors suspected to influence fetal growth include biological factors, 
microorganisms can cross the placenta and several agents including toxoplasma, rubella, 
cytomegalovirus and herpes simplex have been associated with fetal growth disorders, and 
chemical factors. We will focus here on the chemical environment. 
 There is growing concern that environmental contaminants might interact with 
developmental processes and fetal growth (Hanson and Gluckman 2008; Woodruff et al. 
2010). Research in Humans is at a somewhat advanced stage for air pollutants, metals and 
persistent endocrine disrupters (DDT, PCBs)). Among them, lead (Bellinger 2005), PCBs 
(Govarts et al. 2012) and air pollutants, notably the fine particulate matter of diameter             
≤ 2.5 µm (Dadvand et al. 2013; Shah and Balkhair 2011; Slama and Cordier In Press) have 
been identified as possibly inhibiting fetal growth. Exposure to environmental tobacco smoke 
has also been associated with an increased risk of having a baby with low birth weight 
(Salmasi et al. 2010). Data in Human are much more limited for the so-called "emerging 
chemicals", including brominated flame retardants, perfluorinated compounds, phthalates and 
phenols and do not allow to conclude yet about their potential effects on fetal growth (Slama 
and Cordier In Press). Specific review of the effects of phthalates and phenols, two families of 
non persistent endocrine disruptors, on fetal growth is available section III of this chapter 
(definition of endocrine disruptors is detailed page 18). 
b) Post-natal growth, childhood obesity  
Influences of prenatal growth on postnatal growth  
 Early postnatal growth is related to fetal growth. Smaller babies at birth are more 
likely to show an increased growth rates during early infancy compared to normal size 
newborns, what is commonly called catch up growth (Eleftheriades et al. 2006; Hindmarsh et 
al. 2008; Mook-Kanamori et al. 2011).  
Factors influencing prenatal growth also suspected to influence postnatal growth  
 As for prenatal growth, postnatal growth is controlled by hormonal (e.g., growth 
hormone) and genetic factors (Hauspie et al. 2004; K Ong et al. 2002). Infant sex is associated 
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with postnatal growth (Regnault et al. 2010). Regarding childhood obesity it has been 
suggested that inheritance may account for around 25 to 40% of the BMI inter-individual 
variability (Maffeis 2000). Several other factors affecting fetal growth are suspected to affect 
postnatal growth. This is in particular the case for maternal smoking, maternal and paternal 
height and parity. As an example, a lower weight at 3 months (Regnault et al. 2010), but not 
later in childhood (Hindmarsh et al. 2008; Ong et al. 2000) has been reported for infants 
prenatally exposed to tobacco smoke. Regarding parity, infants of primiparous pregnancies, 
which are generally smaller and thinner at birth, exhibit an important postnatal catch-up in 
weight and length, which results in larger size during childhood (Ong et al. 2000). It is not 
well known in which extent these effects are mediated by effects on prenatal growth. 
Postnatal factors  
 Postnatal factors, especially nutrition, play an important role in early post-natal 
growth. Marked differences in growth rates have been reported as early as at the age of 2-3 
months between infants who were breast- or bottle-fed. Breastfeed infants usually have lower 
weight growth velocity than formula-fed infants do. The difference in weights between these 
two groups is still observed at 31 months of age (KK Ong et al. 2002; Regnault et al. 2010).  
Environmental chemicals  
 Exposure to industrial chemicals during critical periods of development has been 
recently mentioned as a potential risk factor for obesity development; this particularly 
concerns endocrine disruptors (Casals-Casas and Desvergne 2011; DiVall 2013; Newbold 
2010; Newbold et al. 2008).  
 Endocrine disruptors have been defined as exogenous substances that alter function(s) 
of the endocrine system and consequently cause adverse health effects in an intact organism, 
or its progeny, or (sub)populations (definition from the International Program on Chemicals 
(IPCS 2002)). Endocrine disruptors interfere with the normal functioning of the endocrine 
system by affecting the synthesis, secretion, transport, metabolism and elimination of the 
natural hormones; mimicking their action and / or interfering with their receptors. Both 
natural (e.g., phytoestrogens) and man-made substances have been identified to be endocrine 
disruptors.  
 Some endocrine disruptor chemicals are in particular able to interact with receptors 
implied in adipogenenesis, lipid accumulation and metabolism (e.g., Peroxisome Proliferator-
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Activated Receptors (PPARs), Estrogen Receptors, Figure 3) and may induce epigenetic 
modifications in obesity-related genes (Casals-Casas and Desvergne 2011; DiVall 2013). For 
these reasons, they are considered potential obesogens. Endocrine disruptor chemicals can be 
categorized according to their intended use, their structural properties and / or their 
persistence in the environment and organism. Persistent endocrine disruptors suspected to act 
as metabolic disruptors include dioxins, PCBs, organochlorine pesticides (Casals-Casas and 
Desvergne 2011). We will focus here on two families of short-lived endocrine disruptors: 
phthalates and phenols. 
Figure 3: Nuclear receptors implied in the control of growth and adipogenesis, and endocrine 
disruptors likely to interact with them (Casals-Casas and Desvergne 2011). 
 
PPAR: Peroxisome Proliferator–Activated Receptors; ER: estrogen receptors, TR: Thyroid hormone receptor, 
GR: Glucocorticoid receptor, PXR: xenosensors Pregnane X Receptor, CAR: Constitutive Androstane Receptor, 
AhR: Aryl hydrocarbon receptor, ARNT: Aryl hydrocarbon receptor nuclear translocator; RXR: Retinoid X 
receptor. 
II. Phenols and phthalates  
1.  Exposure in the general population 
 Esters of phthalic acid, commonly named phthalates, are a group of chemicals with a 
wide spectrum of industrial applications (Table 2). Low molecular weight (MW) phthalates 
(MW < 250 g / mol) are primarily used in personal care products (perfumes, cosmetics) and as 
coating for pharmaceutical products while high MW phthalates (MW > 250 g / mol) are 
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mostly used in polyvinylchloride floor and wall covering, food packaging and medical 
devices (A. M. Calafat et al. 2006; Hauser and Calafat 2005). Bisphenol A, benzophenone-3, 
triclosan, dichlorophenols and parabens are phenolic compounds used in lot of common 
products: food packaging and polycarbonate plastics (bisphenol A), cosmetics (parabens), 
soap (triclosan) and sunscreen (benzophenone-3, (Calafat et al. 2008)). Precursors of 
dichlorophenols are used as intermediates in the production of several herbicides and 
insecticides (Agency for Toxic Substances and Disease 2006).  
 Exposure to these chemicals is prevalent in the general population, including pregnant 
women (Adibi et al. 2008a; Braun et al. 2011b; Cantonwine et al. 2010; Wolff et al. 2008; Ye 
et al. 2009; Ye et al. 2008). 
Table 2: Non exhaustive list of sources of exposure to the phthalates and phenols studied in 
this thesis. 
Chemicals Sources of exposure, French and EU regulation 
PHTHALATES    
Di-ethyl phthalate  Personal care products (fragrances, cosmetics), coatings (pharmaceutical 
products), dyes  
Di-butyl phthalate  Personal care products, lacquers, vanishes, coating (pharmaceutical products), 
banned from toys and childcare products (2005/12/14)a 
Di-isobutyl phthalate  Polish, lacquers 
Di-n-octyl phthalate  Medical devices, cosmetics, food packaging 
Butyl-benzyl phthalate  Vinyl flooring, adhesives and sealants, personal care products, food packaging, 
industrial solvents, banned from toys and childcare products (2005/12/14)a 
Di(2-ethylhexyl) phthalate  PVC plastics used in household products (floor tiles, furniture), food packaging, 
medical devices, banned in toys and childcare products (2005/12/14)a 
Di-isodecyl phthalate  Anticorrosive paints 
Di-isononyl phthalate  Sealants, lacquers, paints  
PHENOLS   
2,4-dichlorophenol   Metabolite of 1,3 dichlorobenzene: herbicides, pesticides, minor contaminant of 
1,4-dichlorobenzène 
2,5-dichlorophenol  Metabolite of 1,4 dichlorobenzene: pesticides, toilet-deodorizer blocks, banned 
from mothballs (2009/08/21)b  
Bisphenol A  Polycarbonate plastics and epoxy resins: food packaging, toys, medical tubing, 
dental fillings, banned from baby bottles (2010/07/01)c and food containers for 
children below 3 years  
Benzophenone-3 Sun cream, food packaging   
Triclosan Antibacterial and antifungal agent: soap, deodorant, toothpaste 
Parabens 
Methyl paraben  
Ethyl paraben  
Propyl paraben  
Butyl paraben 
 
 
Antibacterial agents, food and cosmetic preservatives 
 
Phthalates were ranged in order of increasing molecular weight. Abbreviations: PVC : polyvinyl chloride  
a Directive 2005/84/CE 
b Directive 2007/565/CE 
c French Law 2010-729 and 2012-1442 
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2. Fetal exposure  
 Human studies have shown fetal exposure to phenols and phthalates. Metabolites of 
these chemicals have been detected in amniotic fluid (Engel et al. 2006; Huang et al. 2009; 
Jensen et al. 2012; Silva et al. 2004a; Yamada et al. 2002), cord blood (Latini et al. 2003) and 
meconium (Zhang et al. 2009). This was corroborated by experimental data showing that 
several phthalates and phenols are able to cross the placenta (Balakrishnan et al. 2010; Mose 
et al. 2007; Takahashi and Oishi 2000). In an ex-vivo experimental system, where 7 human 
placentas were in contact with a perfusate enriched in bisphenol A (10 µg/L), authors 
observed rapid transfer of this phenol across the placenta (Figure 4). 
 
Figure 4: Bisphenol A concentration in 
maternal and fetal compartments during 
three hours of perfusion in an ex-vivo 
human placental perfusion system 
(Balakrishnan et al. 2010).  
 
 
3. Metabolism  
 Phenols and phthalates have short half-lives in Human, generally estimated to be less 
than 24 hours (Janjua et al. 2008; Koch et al. 2004; Sandborgh-Englund et al. 2006; Volkel et 
al. 2002). To our knowledge none of these studies have specifically explored half-lives in 
pregnant women, which may differ from those observed in men and non-pregnant women 
because of the metabolic and physiologic changes occurring during pregnancy. The short 
half-life reported in Human is a priori a desirable feature in terms of reducing exposure levels, 
but creates strong challenges when it comes to assessing exposure levels, since these will vary 
very quickly throughout the day. 
 After exposure, phthalates and phenols are rapidly metabolized and mostly excreted in 
urine. Phenols are usually excreted unchanged or conjugated (conjugation increases water 
solubility and therefore increases urinary excretion). Phthalate biotransformation is related to 
their molecular weight: low molecular weight phthalates are changed into their hydrolytic 
monoesters, which can be excreted in urine or undergo conjugation. The metabolism of the 
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higher molecular weight phthalates is more complex and results in more metabolites (Figure 
5). High molecular weight phthalates are also metabolized to hydrolytic monoesters, but then 
undergo enzymatic oxidation of the alkyl chain, to produce oxidative metabolites (Hauser and 
Calafat 2005).  
Figure 5: Metabolism of di(2-ethylhexyl) phthalate (DEHP) in Human (major metabolites 
are highlighted, (Koch et al. 2005)) 
 
4. Suspected effects of prenatal exposure to phthalates and phenols on health  
 Phthalates and phenols are known to be endocrine disruptors. They interact, among 
others with sex hormone receptors and therefore research first focused on their potential 
effects on reproductive development and sex differentiation. Experimental studies have 
suggested that phthalates may induce developmental abnormalities of the male genital tract 
(Foster 2006; Swan 2008). One study in 106 boys (Swan 2008) has suggested male 
reproductive toxicity (decreased anogenital distance) while another did not (cases-control 
study: n = 21 cases of hypospadias and 50 cases of undescended testis (Chevrier et al. 2012)). 
 The endocrine system is related to a wide range of organism functions and it has been 
recently shown that phenols and phthalates may impact other facets of health than 
reproduction. Experimental studies have reported effects on brain organization and behavior 
(Wolstenholme et al. 2011; Wolstenholme et al. 2012), respiratory health (Nakajima et al. 
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2012) and growth (Rubin and Soto 2009). In Human, epidemiological studies have reported 
associations between exposures to phthalates and phenols during perinatal periods and child 
neurodevelopment. For example, low molecular weight phthalates, measured in maternal 
urine collected during pregnancy, have been associated with a higher risk of developing 
behavioral, attention and depressive problems in children between 4 and 9 years (n = 137, 
(Engel et al. 2010; Miodovnik et al. 2011)). Prenatal exposure to bisphenol A has been 
associated with more anxious and depressed behaviors at 3 years (Braun et al. 2011a). 
Bisphenol A and phthalates have also been associated with respiratory health (Jaakkola and 
Knight 2008; Kwak et al. 2009; Spanier et al. 2012) and prenatal growth (Wolff et al. 2008). 
This thesis focuses on the effects of these chemicals on pre- and early post-natal growth.  
III. Effects of prenatal exposures to phthalates and phenols on pre- and post-
natal growth 
1. In vitro studies suggesting that phthalates and phenols interact with mechanisms 
implied in growth  
 In vitro, phthalates have shown to be weak agonists of the estrogenic receptors ER∝ 
and ERβ implied among others in growth and maintenance of a diverse range of tissues 
(mammary gland, uterus, bone, cardiovascular system...). These chemicals shown antagonist 
activities on androgen (National Institute of Health and Medical Research 2011) and thyroid 
receptors (Shen et al. 2009); they also interact with the triiodothyronine (T3) transportation 
(Boas et al. 2010; Ishihara et al. 2003). Fetal growth is regulated among other by thyroid 
hormones (Blazer et al. 2003; Shields et al. 2011). Phthalates are partial agonists of 
peroxisome proliferator-activated receptors (PPAR∝ and PPARγ) involved in lipid 
metabolism, adipocyte differentiation and energy homoeostasis. PPAR∝ activation has been 
associated with the induction of fatty acid hydroxylase (CYP4A family) involved in several 
metabolic pathways (Desvergne et al. 2009; Hurst and Waxman 2003)). 
 Regarding phenols, affinity with estrogen receptors have been reported for 
benzophenone-3, triclosan and parabens (Kunz and Fent 2006; Witorsch and Thomas 2010); 
the estrogenic activity of parabens depends on the length of the alkyl group (ER affinity: 
butylparaben > propylparaben > ethylparaben > methylparaben (Routledge et al. 1998; 
Witorsch and Thomas 2010)). A recent in vitro study has reported that parabens promote 
adipocyte differentiation in mice cells by an activation of glucocorticoid receptors and / or 
Introduction 
26 
 
PPARγ (Hu et al. 2012; Taxvig et al. 2012). Bisphenol A is one of the most studied phenols. 
Additionally to its effects on estrogen receptors, it can inhibit androgen (Sohoni and Sumpter 
1998) and thyroid receptors (Moriyama et al. 2002; Pearce and Braverman 2009). For this 
phenol, in vitro studies have also suggested an agonist effect on glucocorticoid receptors, 
notably implied in adipocyte differentiation (Sargis et al. 2010). 
 Recent studies have suggested that effects of phthalates and phenols on obesity might 
be mediated by epigenetic modifications (DiVall 2013; Fleisch et al. 2012; Manikkam et al. 
2013; Singh and Li 2012). As an example, prenatal exposure to bisphenol A has induced 
hypomethylation leading to an increased expression of the Agouti gene, inducing obesity and 
diabetes in mice (Dolinoy 2008).   
2. Effects of prenatal exposures to phenols and phthalates on growth; evidence from 
animal studies  
 Originally, animal studies aiming at assessing phthalate effects on health did not 
specifically focus on growth. However authors usually reported pup's weight as secondary 
outcome. 
a) Phthalates  
 In rodents, exposure to several phthalates (di-iso-butyl phthalate, di-n-butyl phthalate 
and benzylbutyl phthalate) during the prenatal period has been inversely associated with fetal 
weight (Ema and Miyawaki 2002; Saillenfait et al. 2003, 2006, 2008). In another study, 
exposure to low dose of mono-(2-ethylhexyl) phthalate (MEHP, dose: 0.05 mg/kg of body 
weight/day), a metabolite of DEHP, has been associated with birth weight and fat mass 
increases in male offspring; no effect was observed with higher doses of MEHP (0.25 or 0.5 
mg/kg of body weight/day, (Hao et al. 2013)). Two other studies, using high dose of DEHP 
(pregnant rats and mice were exposed to 50 mg/kg/day and 750 mg/kg/day) did not observe 
effect on weight at birth nor later in life (Gray et al. 2000; Tanaka 2005). 
b) Phenols  
 Exposure to bisphenol A (0.1 and 1.2 mg/kg of body weight/day) during perinatal 
period (day 6 of pregnancy through the period of lactation) has been positively associated 
with weight at birth (Rubin and Soto 2009; Rubin et al. 2001). This association remained later 
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in life and tended to be non-monotonic, especially in female newborns: the effect of bisphenol 
A was more marked in the group exposed to 0.1 mg compared to the group exposed to 1.2 
mg/kg of body weight/day (Figure 6). Birth and postnatal weight increase in association with 
exposure to bisphenol A during pregnancy has also been reported with lower doses of 
exposure (around 0.25 µg/kg of body weight/day, (Ryan et al. 2010) and 70 µg/kg/day (Somm 
et al. 2009)). Reports of body weight reduction at birth existed, however at high doses (300 
and 1000 mg/kg) and the authors did not see any effect with the dose of 100 mg/kg (Kim et al. 
2001). Data were sparse regarding effects of the other phenols. In rodents, weight at birth and 
in early life (postnatal day 7) decreased after perinatal (gestational and lactational periods) 
exposure to 2,4-dichlorophenol (Aoyama et al. 2005). 1,4-dichlorobenzene, a precursor of 
2,5-dichlorophenol has been associated with birth weight decrease (Agency for Toxic 
Substances and Disease 2006). 
Figure 6: Body weights of female (A, B) and male (C, D) offspring of Sprague-Dawley 
female rats exposed to 0.1 mg/kg of body weight/day ("low dose"), 1.2 mg/kg of body 
weight/day ("high dose ") of bisphenol A or to vehicle only (controls) during gestation and 
lactation (Rubin et al. 2001).  
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3. Effects of prenatal exposures to phenols and phthalates on growth, epidemiological 
studies  
a) Phthalates  
 Findings of the studies aiming at studying the associations between prenatal exposure 
to phthalates and birth outcomes in the general population are summarized in Table 3. Several 
studies have reported positive associations between phthalates and birth outcomes (Brucker-
Davis et al. 2010; Huang et al. 2009; Wolff et al. 2008). In an American cohort study of 404 
mother–infant pairs, authors have reported a positive association between monobenzyl 
phthalate (MBzP), measured in maternal urine and birth length and between monoethyl 
phthalate (MEP) and head circumference at birth (Wolff et al. 2008). In another study with a 
small sample size (n = 32 female and 33 male newborns), a significant birth weight and birth 
length increase has been observed in female newborns with the highest concentrations of 
mono-butyl phthalate (MBP) in amniotic fluid (concentration > median level); similar but not 
significant associations have been observed in male newborns (Huang et al. 2009). The 
concentration of MBP, measured in cord blood, has been positively correlated to weight, 
length and head circumference at birth in a study restricted to male newborns (n = 86, 
(Brucker-Davis et al. 2010)). Reports of inverse association also exist for the precursor of 
MBP measured in cord blood, which has been associated with an increase risk of low birth 
weight (< 2500 g) (Zhang et al. 2009). Suzuki et al. (2010) have studied the association 
between the molecular sum of phthalate metabolites measured in maternal urine and birth 
weight, and suggested a negative association (n = 149 boys and girls). 
 Comparisons across these studies are difficult because different matrices, including 
maternal urine, cord blood and amniotic fluid, have been used to measure biomarkers of 
exposure (Table 3). Sometimes the parent phthalate rather than its metabolites has been 
measured. This could lead to exposure misclassification. In the case of external contamination 
of the biological samples, levels of parent chemicals will be impacted but not those of their 
metabolites. 
 Associations between phthalate exposure and early postnatal growth have only been 
explored in a cross-sectional study. No data regarding exposure during fetal life was available 
(Teitelbaum et al. 2012). No clear association has been observed between any of the nine 
assessed phthalate metabolites (measured once in the child's urine collected between 6 and 8 
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years) and body mass index, waist circumference and height between 6 and 8 years (n = 361, 
(Teitelbaum et al. 2012)).  
b) Phenols   
 The findings of the studies aiming at studying the association between prenatal 
exposure to phenols and pre- and post-natal growth in human are summarized in Table 4. 
Most of the studies used birth measurements as proxies of fetal growth and focused on 
bisphenol A. Only two studies had fetal biometry measured during pregnancy (Lee et al. 
2010; Snijder et al. 2013).  
 The two studies with ultrasound measurements reported a negative association 
between prenatal exposure to bisphenol A and fetal head circumference (Lee et al. 2010; 
Snijder et al. 2013). Snijder et al. (2013) further reported a negative association with fetal 
weight. A negative association with fetal abdominal circumference has been observed in the 
study by Lee et al (2010). The negative associations with weight and head circumference 
reported in the study by Snijder et al. (2013) were only observed in the 80 subjects in whom 
three measurements of bisphenol A concentrations during pregnancy were used to assess 
exposure and no association was observed when only one (n = 219) or two (n = 120) samples 
were used. Inversely, in a study among 339 pregnant women from New-York city, maternal 
urinary concentrations of bisphenol A tended to be positively associated with birth weight     
(p < 0.2, (Wolff et al. 2008)). Dichlorophenols, benzophenone-3 and triclosan have been 
measured in this cohort. An inverse association between 2,5-dichlorophenol and birth weight, 
and a positive association between benzophenone-3 and birth weight in male, but not in 
female newborns, have been observed. 
 Only one study explored the potential effects of prenatal exposures to phenols on post-
natal growth. Bisphenol A concentrations measured in maternal urine collected during 
pregnancy have been associated with a decrease risk of being overweight at 9 years. This 
association was observed in girls but not in boys (Harley et al. 2013). Bisphenol A 
concentrations were also measured in the urine of the children collected at 9 years. A positive 
association with overweight at age 9 have been reported in boys and girls. This positive 
associations as well as those observed in a cross-sectional study (Trasande et al. 2012) have to 
be interpreted cautiously because of reverse causality. Overweight children may consume 
more canned drink or processed foods, which are important sources of bisphenol A, than non-
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overweight children. In addition, obesity and associated health disorders might affect 
bisphenol A metabolism, storage and elimination. 
 To summarize, only few human studies have explored the effects of prenatal 
exposures to phenols and phthalates on pre- and early post-natal growth, and most of them 
had a limited sample size (Tables 3, 4). Some of the reported associations might be due to 
false positive discovery induced by the high number of comparisons performed (high number 
of biomarkers assessed and high number of outcomes, especially for studies using repeated 
measurements of fetal biometry during pregnancy). Another limitation of these studies is the 
exposure assessment, usually based on a small numbers of maternal urine samples collected 
during pregnancy.  
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Table 3: Studies of associations between prenatal exposures to phthalates and fetal growth in the general population  
Reference, area  Phthalates 
considered  
Matrices for 
phthalate assay  
Outcomes  Population Main results  
Brucker-Davis et 
al.  
2010 
France 
MBP Cord blood Birth length  
Birth weight 
Head circumference at 
birth 
Case-control study 
regarding 
cryptorchidism 
n = 86 controls (boys 
only) 
Positive correlations with  
Weight: 0.27 (p = 0.09) 
Height: 0.29 (p = 0.007) 
Head circumference: 0.43 (p = 0.005) 
Huang et al. 2009  
Taiwan 
MBP, MEHP, 
MEP, MBzP, 
MMP 
 
Amniotic fluid  
Urine (1st 
trimester) 
Birth length  
Birth weight 
 
Cohort of women 
with planned 
amniocentesis  
n=65 (girls and boys) 
Girls: weight and height increase in the group heavily 
exposed to MBP  
Boys: no significant difference 
Latini et al. 2003 
Italy  
DEHP, MEHP Cord blood Birth weight Cohort 
n=84 (girls and boys) 
No association with birth weight 
Suzuki et al. 2010 
Tokyo 
MMP, MEP, 
MnBP, MBzP, 
MEHP, MEHHP 
MEOHP, MINP, 
MnOP 
Urines (collected 
between 9 and 40 
GW) 
Birth length  
Birth weight 
Head circumference at 
birth 
 
Cohort  
n = 149 (girls and 
boys) 
No significant association but the molecular sum of the all 
phthalate metabolites tended to be negatively associated with 
birth weight (β= - 0.12, p = 0.1) 
Wolf at al. 2008 
New York 
MEHP, 
MEHHP, 
MEOHP, 
MECPP, MBzP, 
MCPP, MiBP, 
MEP, MBP 
Urine (collected 
between 25 and 40 
GW)  
Birth length  
Birth weight 
Head circumference at 
birth 
 
Cohort 
n = 382 (girls and 
boys) 
β (95% CI) for a 1 increase in ln-transformed concentration: 
MBzP / length : β = 0.20 (0.00; 0.40) 
MEP / head circumference: β = 0.12 (0.01; 0.23) 
Low-MWP / head circumference: β = 0.13 (0.01; 0.24) 
Low-MWP / gestational age: 0.14 (0.01; 0.27) 
Zhang et al. 2009 
China 
DEP, DBP, 
DEHP MBP, 
MEHP 
Cord blood  
Meconium 
Low birth weight 
 
Case-control  
n = 88 cases of low 
birth weight and 113 
controls 
(girls and boys) 
OR (95% CI) in the 4th exposure quartile compared to the 1st: 
MBP: 4,68 (2.1; 6.9) 
MEHP: 3,23 (1,3; 5.9) 
Abbreviations : OR : odds ratio, GW: gestational week, MBP: mono-n-butyl phthalate, MBzP: monobenzyl phthalate, MCNP: monocarboxyisononyl phthalate, MCOP: monocarboxy-isooctyl 
phthalate, MCPP: mono(3-carboxypropyl) phthalate, MECPP: mono(2-ethyl-5-carboxypentyl) phthalate, MEHP: mono(2-ethylhexyl) phthalate, MEHHP: mono(2-ethyl-5-hydroxyhexyl) phthalate, 
MEOHP: mono(2-ethyl-5-oxohexyl) phthalate, MEP: monoethyl phthalate, MiBP: mono-isobutyl phthalate, ∑LMW: molecular sum of low molecular weight phthalates ∑HMW: molecular sum of 
high molecular weight phthalates 
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Table 4: Studies regarding the effects of prenatal exposures to phenols on pre- and post-natal growth in the general population  
Reference, area  
Phenols 
considered 
Matrices for 
phenol assay 
Outcomes  Population Main results  
Chou et al. 2011 
Taiwan 
BPA 
Maternal and cord 
blood collected at 
birth 
Birth weight 
Small for gestational 
age   
Birth cohort 
n = 97 (girls and 
boys) 
BPA in maternal blood was negatively correlated with weight 
U-shaped association between BPA (quartile) and the risk to be 
small for gestational age in males.  
Harley et al. 2013 
United States 
BPA 
Maternal and child 
urine 
BMI, waist 
circumference, body 
fat, obesity 
n = 311, 9 year-old 
children (boys and 
girls) 
Prenatal exposure: negative association with BMI- Z-score, waist 
circumference and with the risk of being obese in girl but not in 
boys.   
Postnatal exposure (at age 9): positive association with BMI 
 Z-score and waist circumference (not modified by sex).   
Lee et al. 2010 
Korea  
Abstract only  
BPA  
Maternal blood 
and urine  
Biparietal and 
abdominal diameter, 
femur length 
measurements at 19 
and 36 GW 
n = 125 (girls and 
boys) 
Negative association with: 
Head circumference in late pregnancy: β = - 0.06, p = 0.02 
Abdominal circumference in late pregnancy: β = - 0.32, p = 0.02) 
Femur length in middle pregnancy: β = - 0.04, p = 0.04 
Padmanabhan et 
al. 2008 
Michigan (USA) 
BPA 
Maternal blood 
collected at birth 
Birth weight  
 
General population  
n = 40 (girls and 
boys)   
No correlation between BPA concentrations and birth weight. 
Wolff et al. 2008 
New York 
2,4-, 2,5-
DCP  
BPA BP3  
TCS 
Maternal urines 
collected between 
25 and 40 GW.  
Birth length  
Birth weight 
Head circumference at 
birth 
Cohort 
n = 339 (girls and 
boys) 
Boys : weight and length decreased with exposure to 2,5-DCP, 
weight increased with exposure to BP3 
Girls: weight decreased with exposure to BP3  
Snijder et al. 2013 
Netherlands 
BPA 
Maternal urines (1 
to 3 samples). 
Ultrasounds (T2 and 
T3) and birth 
measurements of 
weight and head 
circumference  
n = 80, 120 or 219 
depending of the 
analysis 
When analyses were restricted to the 80 fetuses with 3 exposure 
assessments: Negative association with weight and HC (p <0.1), 
which disappeared if using only 1 or 2 of the 3 samples were used. 
Abbreviations: GW: gestational week, BPA: bisphenol A, BP3: benzophenone-3, DCP: dichlorophenol, TCS: Triclosan, T2: second trimester of pregnancy, T3: third trimester 
of pregnancy,  
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IV. Assessment of prenatal exposure to phenols and phthalates in 
Epidemiological studies   
1. Exposure assessment to chemicals in epidemiological studies  
 Exposure assessment is a central issue in epidemiological studies aiming at exploring 
the effects of environmental contaminants on human health; exposure misclassification may 
indeed lead to bias in the health risk estimates and impacts statistical power (de Klerk et al. 
1989; White et al. 2008). There are several methods to assess exposure to environmental 
contaminants and the choice of a particular one will depend on the characteristics, sources and 
routes of exposure to the studied chemical(s) (Figure 7). Studies focusing on atmospheric 
pollutants usually estimate chemical concentrations to which the participants may have been 
exposed (external dose) using environmental and/or personal measurements. This approach is 
not well adapted to chemicals with multiple sources and routes of exposure, such as phenols 
and phthalates. However, phthalate measurements in indoor air have been used in few 
previous studies exploring their effects on respiratory health (Bornehag et al. 2004; Kolarik et 
al. 2008). Other methods, such as questionnaires, could be used to estimate environmental 
exposure to pollutants. For chemicals with multiple sources of exposure, exposure assessment 
through questionnaires is not easy and is likely to suffer of important lack of precision. Job-
exposure matrices are usually used in studies aiming at assessing professional exposure and 
allow to infer exposure on the basis of the job title, the industry and / or calendar times of 
employment (Nieuwenhuijsen 2003; Snijder et al. 2012).  
 Human biomonitoring consists in the assessment of the levels of chemicals or their 
metabolites in human biological samples such as blood or urine and provides an estimate of 
the dose that actually enters the body (internal dose) from all sources and routes of exposures. 
For these reasons, it is the most relevant option to assess exposure to phenols and phthalates 
(A.M. Calafat et al. 2006). Biomonitoring was primarily used in occupational medicine. 
Improvements in analytical techniques have allowed detection of relatively low chemical 
concentrations in human fluid and biomarkers of exposure are now widely used in 
epidemiological studies in the general population (Angerer et al. 2007; A. M Calafat et al. 
2006; Schisterman and Albert 2012). The use of biomarkers does not guarantee an absence of 
exposure misclassification. Biomonitoring indeed only provides a snapshot in time of a 
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person’s exposure and because of the short half-life of phenols and phthalates and of the 
episodic nature of the exposures, concentrations are likely to vary over time.  
Figure 7: Schematic view of the different tools allowing to quantify exposure to the 
environmental chemicals in Environmental Epidemiology. 
 
2. Specific issues related to the use of biomarkers to assess prenatal exposure to phenols 
and phthalates 
 Phthalates and phenols have been detected in indoor air and dust and biological 
sample contamination may occur during collection and processing specimens. Sampling 
materials might also contain these chemicals. In order to minimize the risk of exposure over-
estimation due to external contamination of the biological samples, it is more desirable to 
measure metabolites, produced by transformation of the parent chemical in the organism, 
rather than the parent chemicals (Calafat and Needham 2009; A. M Calafat et al. 2006). The 
metabolism of high molecular weight phthalates leads to more than one metabolite and in 
addition to separately study each metabolite, their molecular sum is commonly considered 
(Hauser and Calafat 2005; Koch et al. 2005). This may be seen as an attempt to provide an 
estimate closer to the internal dose in the absence of toxicokinetic model.  
a) Relevant biological matrices to measure biomarkers of exposure to phthalates and 
phenols  
 Urine and blood are the most commonly used matrices for biomonitoring. Phenols and 
phthalates have already been assessed in blood in epidemiological studies (Zhang et al. 2009). 
However, blood contains enzymes able to degrade phthalates and their metabolites; which 
could lead to exposure misclassification (Koch et al. 2004). In addition, collecting blood is 
invasive. Phthalates and phenols are mostly excreted in urine, which is easier and safer to 
collect than blood. Thus urine is the preferred matrix to assess exposure to these chemicals. 
Introduction 
35 
 
Many studies aiming at assessing exposure during fetal life used maternal urine samples 
collected during pregnancy (Braun et al. 2011a; Chevrier et al. 2012; Engel et al. 2010; Wolff 
et al. 2008). However it is unclear to which extent maternal urine reflects fetal exposure. 
Alternative matrices such as amniotic fluid and meconium have been proposed (Barr et al. 
2005; A. M Calafat et al. 2006). During pregnancy, the fetus swallows amniotic fluid and 
fetal urine is one of the main source of amniotic fluid in the second half of pregnancy 
(Modena and Fieni 2004; Underwood et al. 2005). Thus, concentrations measured in this 
matrix might be a relevant dosimeter of fetal exposure. In humans, bisphenol A (Edlow et al. 
2012; Engel et al. 2006; Ikezuki et al. 2002; Yamada et al. 2002) and 2,5-dichlorophenol 
(Bradman et al. 2003) have been detected in amniotic fluid collected from pregnant women 
receiving amniocentesis as part of their routine prenatal care. However, to our knowledge, no 
published study has evaluated human amniotic fluid concentration of other prevalent 
environmental phenols, nor has compared phenol biomarker concentrations in amniotic fluid 
with their concentrations in maternal urine.  
 Several studies have assessed phthalate metabolites in amniotic fluid and maternal 
urine sample from same woman and authors reported lower rates of detection in amniotic 
fluid compared to maternal urine (Huang et al. 2009; Wittassek et al. 2009). Huang et al. 
(2009) found a correlation of 0.16 (p = 0.002, n = 64) between urine and amniotic fluid 
concentration of monobutyl phthalate (MBP). A higher correlation coefficient has been 
reported in another study for mono-isobutyl phthalate (MiBP) (ρ = 0.93, p < 0.001, n = 11 
(Wittassek et al. 2009)). Because of the difficulty encountered in the collection of amniotic 
fluid specimen, which requires an invasive procedure that can be harmful to the fetus and 
mother, this fluid is not commonly used in epidemiological studies.  
 Meconium corresponds to the earliest stools of the newborn. It starts accumulating in 
the fetal bowel at the beginning of the second trimester of pregnancy and has already been 
used to estimate fetal exposure to non persistent chemicals (Zhang et al. 2009), however 
collection standardization has to be improved to allow its routine use in epidemiological 
studies (Calafat and Needham 2009): contamination with the newborn urine is hardly 
avoidable; timing of collection after birth is also important because meconium composition 
changes rapidly. 
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 Cord blood, collected at birth, has also been used to assess phthalate exposures (Zhang 
et al. 2009). However due to the non persistence of the studied chemicals, concentrations of 
phenols and phthalates measured in this fluid may reflect exposure occurred at the hospital / 
maternity before and during delivery, which is likely to differ from exposure during the rest of 
the pregnancy. This is particularly true for di(2-ethylhexyl)phthalate and bisphenol A, which 
are found in medical tubing and medical devices potentially used during delivery (Calafat and 
Needham 2009). Such an issue has been highlighted in a study in which exposure biomarkers 
have been assayed in maternal urine collected at delivery (Vandentorren et al. 2011). 
b) Temporal variability in phenol and phthalate urinary concentrations during 
pregnancy 
 Variability in phthalate and phenol urine concentrations has been studied in adults 
(Adibi et al. 2008a; Fromme et al. 2007; Hauser et al. 2004; Hoppin et al. 2002a; Peck et al. 
2010; Preau et al. 2010; Ye et al. 2011a). Considerable within- and between-day variability in 
the bisphenol A concentrations measured in spot urine samples collected from the same 
participant (Ye et al. 2011a) has been reported. Similar variations have been observed for 
phthalates ((Preau et al. 2010) Figure 8). Data concerning pregnant women are limited (Adibi 
et al. 2008a; Braun et al. 2012; Braun et al. 2011b; Smith et al. 2012). Regarding phenols, 
reproducibility of the urinary concentrations of bisphenol A (Braun et al. 2012; Braun et al. 
2011b) and parabens (Smith et al. 2012) in pregnant women has been evaluated. However, to 
date, no study has assessed temporal variability in urinary concentration of other phenols 
during pregnancy2.  
  
                                                 
2 Mecker et al have very recently published ICCs for benzophenone-3, tricosan and dichlorophenols among 105 
pregnant women from Northern Puerto Rico (Meeker et al, 2013). This paper will be discussed in Chapter III of 
the thesis. 
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Figure 8: Concentrations of bisphenol A and monoethyl phthalate (µg/g creatinine) for all of 
the spot urine samples collected from one participant over one week (Preau et al. 2010; Ye et 
al. 2011a) 
  
 A source of variability in phenol biomarker concentrations is heterogeneity in 
collection conditions. Based on the concentration variations shown in Figure 8, one can 
hypothesize that for two women with the same real exposure, variations in sampling 
conditions (e.g. hour and day of sampling) between these women could lead to high 
difference in the exposure estimates. Because it is rarely feasible to make collection 
conditions identical for all subjects in large-scale observational studies, a statistical method 
has been developed to standardize concentrations for collection conditions (this has been 
detailed in Chapter II, page 50, (Mortamais et al. 2012)). The aim of this approach was to 
increase the between-subjects comparability of biomarkers’ levels estimated from urinary 
samples collected in varying conditions. While it has been used in epidemiological studies 
relating urinary biomarkers to health endpoints (Chevrier et al. 2012; Philippat et al. 2012), 
the impact of standardizing biomarker concentrations for collection conditions on 
reproducibility of urinary measures has never been studied. 
c)  Biomarker concentrations and urine dilution  
 Water contents usually differs across spot samples (e.g., urine tends to be more 
concentrated in the first morning-void compared to the void collected later in day) and this 
has to be taken into account when studying associations between biomarker concentrations 
and health outcomes. Adjustment for creatinine and specific gravity have been both proposed 
to solve this issue. Creatinine comes from creatine and creatine phosphate decomposition and 
is primarily cleared from the body through the kidney by glomerular filtration (Alessio et al. 
1985). Specific gravity is the ratio of urine density to water density. These measurements 
have both limitations. Creatinine adjustment might be not appropriate for chemicals excreted 
by tubular secretion (active transport); specific gravity will be affected by medical conditions 
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leading to the presence of sugar and proteins in urine. There is no clear consensus about the 
superiority of one of them to account for urine dilution in epidemiological studies related to 
exposure biomarkers. 
V. Objectives of the thesis 
The objectives of this thesis were: 
1) to study the effects of prenatal exposures to phenols and phthalates on pre- and 
early post-natal growth (Chapter II); 
2) to assess the relationship between phenol concentrations measured in maternal urine 
and amniotic fluid collected on the same day (Chapter III); 
3) to study the temporal variability in urinary phenol concentrations over the course of 
pregnancy (Chapter III) and to characterize the bias associated with the use of one 
urine sample to estimate exposure to non persistent chemicals (Chapter III). 
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Effets de l'exposition prénatale aux phtalates et aux phénols sur la croissance 
 
Introduction  
Chez les rongeurs, l'exposition périnatale (gestation et / ou lactation) à certains phénols (notamment le 
bisphénol A) et phtalates, a été associée à une modification du poids à la naissance et durant les 
premiers jours de vie. Une étude chez l'homme a suggéré un effet du bisphénol A, mais aussi des 
dichlorophénols et de la benzophénone-3 sur le poids de naissance des garçons (Wolff et al. 2008). 
Plusieurs études s'étaient aussi intéressées aux effets des expositions prénatales aux phtalates sur le 
poids de naissance chez l'homme, néanmoins leurs résultats ne permettaient pas de conclure. Une seule 
de ces études avait utilisé des mesures échographiques pendant la grossesse pour estimer la croissance 
fœtale, les autres études étant basées sur des mesures à la naissance (poids, taille, périmètre crânien). 
Les effets des expositions prénatales aux phénols et phtalates sur la croissance postnatale ont été peu 
étudiés. L'unique étude pour laquelle les expositions pendant la grossesse ont été estimées concernait 
le bisphénol A et suggérait une association négative avec l'indice de masse corporelle et la 
circonférence abdominale des filles à 9 ans (Harley et al. 2013).   
Objectif: L'objectif de ce chapitre était d'étudier les associations entre l'exposition aux phénols et aux 
phtalates pendant la grossesse et la croissance durant la vie fœtale et les trois premières années de vie.  
Expositions prénatales aux phtalates et aux phénols et poids, taille et périmètre crânien à la naissance. 
Méthodes: La population d'étude était issue d'une étude cas-témoins, concernant les malformations 
congénitales des organes génitaux masculins, nichée dans deux cohortes mère-enfant françaises, 
EDEN et PELAGIE, dont le recrutement a eu lieu entre 2002 et 2006 (n = 287). Pour évaluer les 
expositions prénatales, nous avons dosé 11 métabolites de phtalates (n = 287) et 9 phénols (n = 191) 
dans les urines maternelles prélevées entre 6 et 30 semaines de gestation. Le poids, la taille et le 
périmètre crânien des enfants à la naissance ont été recueillis à partir des dossiers de maternité. Les 
associations entre les concentrations urinaires des métabolites de phtalates et des phénols et les 
mesures à la naissance ont été étudiées à l'aide de modèles de régressions linéaires multiples, corrigées 
pour la surreprésentation des cas de malformation congénitales relative au design cas-témoins de 
l'étude. 
Résultats : Le poids à la naissance ajusté diminuait de 77 g (intervalle de confiance 95 % (IC), -129 ; -
25) et de 49 g (IC 95%, -86 ; -13) pour chaque augmentation unitaire de la concentration ln-
transformée de 2,4- et 2,5-dichlorophénol, respectivement. La concentration de benzophénone-3 était 
positivement associée avec le poids (β = 26 g, IC 95%, -2 ; 54) et la circonférence crânienne à la 
naissance (β = 0,1 cm, IC 95%, 0,0 ; 0,2). Le périmètre crânien augmentait en moyenne de 0,3 cm    
(IC 95%, 0,0 ; 0,7) pour chaque augmentation unitaire de la concentration ln-transformée de bisphénol 
A. Aucun phtalate n'était associé de façon monotone au poids de naissance (p-valeur pour le test de 
monotonie > 0.14) mais des relations non monotones ont été observées entre le                               
mono-(3-carboxypropyl) phthalate (MCPP), le mono(2-ethyl-5-carboxypentyl) phtalate (MECPP) et le 
poids de naissance. 
Conclusion : Les résultats concernant les associations entre le 2,5-dichlorophénol et la benzophénone-
3 et le poids à la naissance des garçons étaient cohérents avec ceux d'une étude antérieure menée aux 
États-Unis (Wolff et al. 2008). Des associations non-monotones avec le poids et la taille à la naissance 
ont été également suggérées dans notre analyse pour certains métabolites de phtalates.  
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Ces associations n'avaient, à notre connaissance, jamais été signalées auparavant chez les rongeurs ou 
chez l'homme, et ont donc été considérées avec prudence. 
Effets des expositions prénatales aux phénols sur la croissance fœtale, estimée à l'aide de mesures 
échographiques pendant la grossesse, et sur la croissance post-natale précoce. 
Les dosages urinaires de phénols et de métabolites de phtalates ont été étendus à d'autres femmes de la 
cohorte EDEN ayant accouchés d'un garçon (n = 410), dans le but 1) de répliquer les résultats obtenus 
précédemment, 2) d'étudier les associations avec l'anthropométrie fœtale mesurée à plusieurs reprises 
pendant la grossesse et la croissance de l'enfant durant les trois premières années de vie3. 
Méthodes : La croissance fœtale à été évaluée à l'aide de données échographiques, réalisées en cours 
de grossesse ainsi que le poids, la taille et le périmètre crânien à la naissance. Les trajectoires 
individuelles de croissance postnatale ont été prédites en utilisant les mesures de poids et de taille 
réalisées de façon régulièrement durant les trois premières années de vie. La circonférence abdominale 
ainsi que l'épaisseur des plis cutanés et le périmètre crânien ont été mesurés à 3 ans.  
Résultats: La concentration urinaire de triclosan était négativement associée à tous les paramètres de 
croissance mesurés à la 3ème échographie (p-valeurs comprises entre 0,01 pour la circonférence 
abdominale et 0,16 pour le périmètre crânien). Ce phénol était aussi associé de façon négative au 
périmètre crânien à la naissance (β = - 1,4 mm, IC 95%; -2,8 ; 0,0) et à 36 mois (β = - 1,0 mm,          
IC 95%; -2,8 ; 0,8). Les parabènes étaient positivement associés avec le poids de naissance               
(p-valeurs < 0,05). Le méthyle- et propyle-parabènes étaient aussi positivement associés avec le poids 
à 6, 12, 24 et 36 mois et avec la circonférence abdominale à 36 mois (p-valeurs comprises entre 0,02 et 
0,14). Nous n'avons pas observé d'associations entre les dichlorophénols et le poids de naissance.  
Conclusion : Nous disposions seulement d'un échantillon d'urine pour évaluer les expositions aux 
phénols et aux phtalates dans la cohorte EDEN. En raison de la courte demi-vie des composés étudiés 
et de la nature épisodique des expositions, nos résultats étaient probablement affectés par des erreurs 
de mesures concernant les expositions. Néanmoins, notre étude suggérait un effet potentiel de 
l'exposition prénatale à certains phénols sur la croissance pré- et post-natale. Les associations entre les 
dichlorophénols et le poids de naissance, suggérées dans notre 1ère analyse, réalisée au sein d'un 
échantillon de 191 sujets de la cohorte EDEN, n'ont pas été confirmées dans un échantillon plus large 
de cette population (n = 520 sujets). 
 
                                                 
3 Les associations entre l'exposition aux phtalates et la croissance pré- et post-natale ont été étudiées par J. Botton (Inserm 
U1018, Université Paris-Sud) et ne sont pas présentées ici.  
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I. Effects of prenatal exposures to phthalates and phenols on birth 
outcomes  
1. Aims of the chapter  
 Our aim was to study the relationships between prenatal exposures to phthalates and 
phenols and weight, length and head circumference at birth among male newborns4. 
2. Population and Methods  
a) Study population  
 The study population is a case-control population study of male malformations of the 
genitalia nested in the EDEN and PELAGIE mother-child cohorts. These cohorts aim to study 
the effects of the events happened during fetal life on development and health at birth and in 
childhood (Drouillet et al. 2009; Garlantezec et al. 2009). Briefly, the EDEN cohort consists 
of 2002 pregnant women recruited before the end of the 28th gestational week from April 
2003 to March 2006 in the obstetrical departments of the University Hospitals of Nancy and 
Poitiers, France (Coordinator, M.A Charles, INSERM U1018). The PELAGIE cohort consists 
of 3421 pregnant women enrolled before 19 weeks of gestation from April 2002 to February 
2006 in three districts of Brittany: Ille et Vilaine, Finistère and Côtes d’Armor, France 
(Coordinator: S. Cordier, Inserm U625). The present study includes all of the male newborns 
with undescended testis or hypospadias (identified at birth by pediatricians, n=48 in EDEN 
and 24 in PELAGIE, Figure 9). In addition, three male newborns without congenital 
malformation of the genitalia (controls) were matched to each case by recruitment center, date 
of recruitment (+ / - 6 months), day of week (week-end yes/no) and gestational week when 
the maternal urine sample was collected, for a total of 288 mother–newborn pairs (72 cases 
and 216 controls, Figure 9). 
 
 
 
                                                 
4 Our choice to focus on male newborns was that sex-specific associations have been reported, in particular 
between some phenols and birth weight. 
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Figure 9: Design of the study population for the birth outcome analyses (Gona_PE study, 
EDEN and PELAGIE cohorts, n = 287a)   
 
a the vial of one control broke before assessments 
Cases and controls were matched for center, date of recruitment and for gestational duration at the time of 
collection of the biological sample. 
 Participants provided informed consent for data and biological sample collection for 
themselves and their offspring. These cohorts received the approvals of the appropriate ethical 
committees. The involvement of the Centers for Disease Control and Prevention (CDC) 
laboratory was limited and determined not to constitute engagement in human subjects 
research 
b) Outcomes  
 We extracted from hospital maternity records weight, length and head circumference 
assessed at birth.  
c) Exposure assessment  
 Urine was collected between 6 and 19 gestational weeks in the PELAGIE cohort and 
between 24 and 30 gestational weeks in the EDEN cohort. Women were asked to provide a 
first morning urine void sample. Women from EDEN collected the urine at home before the 
hospital study visit. When forgotten, the urine sample was collected at the hospital during the 
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study visit. Urine samples were then stored at -80°C. For the PELAGIE cohort, each woman 
collected a urine sample at home and mailed it by standard 2-day mail to the research 
laboratory where, upon arrival, the samples were stored at -20°C. 
 Assessment of biomarker and creatinine concentrations in maternal urine was done by 
the National Center for Environmental Health laboratory at the Centers for Disease Control 
and Prevention (CDC) in Atlanta, Georgia, USA (Silva et al. 2007; Ye et al. 2005). We 
measured the urinary concentrations of eleven phthalate metabolites in samples from all 
mothers (n = 287, 72 cases and 215 controls because the vial of one control broke during the 
transport to the CDC laboratory). Nine phenols were measured in urine samples collected 
from mothers in the EDEN cohort only (n = 191, 48 cases and 143 controls). Phenols could 
not be measured in the PELAGIE cohort because a preservative added to the samples 
interferes with the assay used. 
Table 5: Name of the metabolites (and of their parent compounds) assessed in urine of the 
pregnant women from the EDEN and PELAGIE (phthalates only) cohorts. 
Phenols Phtalates 
 Metabolites Parents compounds 
 
2,4-dichlorophenol (2,4-DCP) 
2.5-dichlorophenol (2,5-DCP) 
Bisphenol A (BPA) 
Benzophenone-3 (BP3)  
Triclosan (TCS)    
 
Parabens:                         
Methyl Paraben (MPB)     
Ethyl Paraben (EPB)       
Propyl Paraben (PPB)       
Butyl Paraben (BPB) 
 
Mono(3-carboxypropyl) phthalate (MCPP) 
Di-n-octyl phthalate (DOP) et 
Di-n-butyl phthalate (DBP) 
Mono-n-butyl phthalate (MBP/MnBP) Di-n-butyl phthalate 
(DBP/DnBP) 
Mono-isobutyl phthalate (MiBP) Di-iso-butyl phthalate (DiBP) 
Monobenzyl phthalate (MBzP) Benzylbutyl phthalate (BBzP) 
Monoethyl phthalate (MEP) Diethyl phthalate (DEP) 
Monocarboxy-isononyl phthalate (MCNP) Di-isodecyl phthalate (DiDP) 
Monocarboxy-isooctyl phthalate (MCOP) Di-isononyl phthalate (DiNP) 
Mono(2-ethyl-5oxohexyl)phthalate  
(MEOHP)                                          
Mono(2-ethyl-5-carboxypentyl) phthalate  
(MECPP)  
Mono(2-ethylhexyl) phthalate (MEHP) 
Mono(2-ethyl-5-hydroxyhexyl) phthalate  
(MEHHP) 
 
Di (2-ethylhexyl) phthalate 
(DEHP) 
 
 
 Molar concentrations of four metabolites of DEHP (mono(2-ethylhexyl) phthalate 
(MEHP), mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono(2-ethyl-5-oxohexyl) 
phthalate (MEOHP), mono(2-ethyl-5-carboxypentyl) phthalate (MECPP)) were summed as 
total DEHP; concentrations of phthalate metabolites of MW > 250 g/mol and of molecular 
weight < 250 g/mol were summed as total of high molecular weight phthalates (∑HMW) and 
of low molecular weight phthalates (∑LMW), respectively. Total paraben concentration 
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(∑PB) was calculated by summing methyl paraben, ethyl paraben, propyl paraben and butyl 
paraben molar concentrations. 
 MEP and MBzP concentrations have been corrected using following factors: 0.66 for 
MEP and 0.72 for MBzP. These factors were provided by the CDC. MEP and MBZP 
concentrations have to be corrected because the analytical standards used by the CDC were of 
inadequate purity (Antonia Calafat, personal communication). 
d) Statistical analyses  
 We replaced concentrations below the limit of detection (LOD) by LOD/√2. We 
corrected the over-representation of congenital abnormalities, induced by the case-control 
design, using a reweighting approach; we used center-specific weights corresponding to the 
inverse of the inclusion probability of controls, so as to give cases and controls the same 
relative weight as in the original cohorts (Richardson et al. 2007). Including cases and 
controls allows to maximize sample size and statistical power. Whereas excluding cases 
would possibly induce a selection bias and limits generalization as well as comparability 
(cases were not excluded from the previous studies). Reweighing approach is not common yet 
in environmental epidemiology and we also presented the analyses restricted to controls.  
 Phthalates and phenols are non persistent compounds in humans with a half life in 
non-pregnant subjects generally estimated to below 24 hours (Janjua et al. 2008; Koch et al. 
2004; Volkel et al. 2002). A high day-to-day variability in their urinary concentrations has 
been documented among non pregnant (Hoppin et al. 2002b) and pregnant (Adibi et al. 
2008b) women, as well as within-day variations for some phthalates metabolites (Preau et al. 
2010; Silva et al. 2004b) and bisphenol A (Ye et al. 2011a). Another potential sources of 
variability in biomarkers levels may be variations in sampling conditions which constitute a 
possibly controllable source of exposure misclassification. To limit the impact of between-
subject variations in urine sampling conditions, we standardized biomarker concentrations 
using a 2-step standardization method based on regression residuals (see Box 1 for more 
details). First, we estimated associations between ln-transformed biomarker concentrations 
and sampling conditions [hour of sampling (for EDEN only), gestational age at collection, 
duration of storage at room temperature before freezing, season and day of sampling] using 
separate linear regression models for each biomarker adjusted for maternal age, body mass 
index before pregnancy, parity, year of sampling, education, current occupation, active 
smoking and center. Using estimated parameters, we predicted the concentrations that would 
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have been observed if all samples had been collected under the same standard conditions. 
These standard conditions corresponded to the median values of sampling conditions 
observed in our population; for example, it corresponded to 7:30 AM for sampling hour, the 
sampling condition that had the largest influence on measured biomarkers levels and to 5 
hours for the delay between urine sampling collection and freezing. Unless otherwise 
specified, all concentrations are the standardized values; we also report associations with 
biomarker concentrations not standardized for sampling conditions.  
 Associations between each standardized maternal urinary biomarker concentration and 
either birth weight, birth length or head circumference were estimated using separate 
weighted linear regressions. Biomarker concentrations (micrograms per liter) were ln-
transformed or coded in tertiles. We performed tests of heterogeneity in outcome value across 
exposure tertiles; p-values of trend tests were estimated using categorical variables whose 
values corresponded to the tertile-specific median biomarker levels. Situations in which 
biomarkers exhibited heterogeneity in outcome across tertiles (low p-value, heterogeneity 
test) but with little support for a trend (high p-value, trend test) were considered as suggestive 
of a non-monotonic association (A monotonic trend does not reverse direction but may have 
flat segment (Rothman et al. 2008)). We also estimated adjusted relationships between 
standardized biomarker concentrations and birth weight using restricted cubic splines (Harrell 
2001).  
 Adjustment factors were all variables possibly related to birth outcomes (based on a 
priori knowledge), including maternal pre-pregnancy weight (broken stick model with a knot 
at 60 kg, (Slama and Werwatz 2005)), maternal height (continuous), maternal smoking 
(never, 1-5, 6 cigarettes per day and more), parity (0, 1, ≥ 2), education level (high school or 
less, up to 2 years after high school, ≥ 3 years after high school), gestational duration (linear 
and quadratic terms) and recruitment center. In addition, we adjusted for urinary creatinine 
concentration (continuous, non-transformed), as a marker of urine dilution. Gestational 
duration was estimated using the date of last menstrual period (LMP, (Slama et al. 2008)) or 
gestational duration assessed by the obstetrician if it differed from the LMP-based estimate by 
more than two weeks. Adjustment for the obstetrician-estimated gestational age instead of the 
LMP-based gestational age did not modify results (not shown). Models for head 
circumference at birth were also adjusted for the mode of delivery (because passage through 
the birth canal may influence head circumference at birth). 
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 We performed sensitivity analyses excluding women with pregnancy-induced 
hypertension (n=17) or gestational diabetes (n=15).  
 All analyses were performed using STATA/SE version 11 (College station, TX 
77845). 
 In the result interpretation, we gave more weight to results in agreement with our a 
priori hypotheses, namely an effect of benzophenone-3 and 2,5-dichlorophenol on male birth 
weight (Wolff et al. 2008). Other associations (highlighted on the basis of their p-values, 
without relying on threshold p-value to define statistical significance) were considered as 
hypothesis-generating. 
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Box 1: Standardization of urinary concentration for sampling conditions 
This method was developed by Marion Mortamais (Mortamais et al. 2012). 
 
For each biomarker, we first fit  a linear regression model of log-transformed concentration 
ln([Conc]) = Y, including as covariates all sampling conditions and potential confounders for 
the relation between sampling conditions and biomarkers concentration: 
 
(Y
i
)
measured
 = α + Σj[βsamp cond j x X
i
j ] + Σk[γk x Z
i
k ] + ε
i
                 (A1) 
 
(Yi)measured : measured concentration in each subject i, 
βsamp cond j : regression parameter quantifying the effect of sampling condition Xj on the biomarker’s 
concentration,  
Zk correspond to the potential confounders (age, socio-economic status, smoking, etc.), 
ε
i : variability in Yi not explained by sampling characteristics and potential confounders. 
 
In a second step, the standardized concentration (Yi)standardized is estimated as: 
 
(Y
i
)
standardized
 = (Y
i
)
measured
 – Σj[βsamp cond j x (X
i
j-Xj
std
)]               (A2) 
 
Xj
std : standard value for sampling condition j (e.g., 7:30 AM, in the case of sampling hour).  
 
Formula (A2) can be justified the following way: We start by writing that the expected log-
transformed biomarker concentration for subject i if sampling conditions correspond to the 
standard ones (and if potential confounders Z have the values corresponding to those observed 
for each subject i) is:  
 
(Y
i
)
standardized
 =  Σj[βsamp cond j x Xj
std] + Σk[γk x Z
i
k ] + ε
i                    
(A3) 
 
Equivalently to (A1), one can write: 
 
ε
i
 = (Y
i
)
measured
 – Σj[βsamp cond j x X
i
j ] - Σk[γk x Z
i
k ]                (A4) 
 
We now assume that the residuals ε of formulas (A1) and (A3) are identical. This will be the 
case if this residual is uncorrelated to the covariates X and potential confounders Z, and if the 
effect measure of X on Y is not modified by Z. With these assumptions, we now replace εi in 
(A3) by its expression (A4), which gives: 
 
(Y
i
)
standardized
 = Σj[βsamp cond j x Xj
std
] + Σk[γk x Z
i
k ] + (Y
i
)
measured
 – Σj[βsamp cond j x Xj
i
 ] - Σk[γk x Z
i
k ]   
= (Y
i
)
measured
 – Σj[βsamp cond j x (Xj
i
 – Xj
std
)] 
 
which corresponds to formula (A2).  
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3. Results 
a) Study population  
 The 287 women with available phthalate urinary concentrations were 29 years old on 
average; 17 % smoked during the first trimester of pregnancy (Table 1). Average gestational 
age at delivery was 39.8 weeks, average birth weight was 3393 g (5th-95th percentiles,         
2640 - 4130) and 7 newborns (2 %) weighed less than 2500 g. Average birth length was 50 
cm (5th - 95th percentiles, 47 - 54) and average head circumference at birth was 35 cm           
(5th - 95th percentiles, 32 - 37, Table 6).  
Table 6: Characteristics of French pregnant women and of their offspring (Gona_PE study,   
n = 287 mother-child pairs from EDEN and PELAGIE cohorts, 2002-2006). 
Characteristic n or 
mean a
(%) 
Percentiles 
5th 50th 95th
 
Maternal age (years) (mean) 
Duration of gestationb(mean) 
Birth weight (g) (mean) 
Birth length (cm) (mean) 
Head circumference at birth (cm) (mean) 
Gestational age at samplingb (weeks) (mean) 
Creatinine concentration (g/L) (mean) 
 
 
29.3  
39.7 
3393 
50 
34.7 
21.7 
1.2 
  
22 
37 
2640 
47 
32 
9 
0.4 
 
29 
40 
3390 
50 
35 
26 
1.1 
 
38 
42 
4130 
54 
37 
28 
2.2 
Parity  
0 
1 previous child 
≥ 2 previous children 
Maternal Education  
≤ high school 
high school + 2 years 
≥ high school + 3 years 
missing value 
Active smoking 
0 
1-5 cigarettes/day  
≥ 6 cigarettes/day  
missing value 
Pre-pregnancy BMI (kg/m2) 
< 18.5 
18.5 to 25.0 
> 25.0 
missing value 
Hour of urinary sampling  
before 8 AM 
8 to 10 AM  
after 10 AM  
missing value  
 
115 
114 
58 
 
133 
62 
86 
6 
 
238 
30 
17 
2 
 
29 
181 
73 
4 
 
108 
40 
18 
121 
 
(40) 
(40) 
(20) 
 
(47) 
(22) 
(31) 
 
 
(83) 
(11) 
(6) 
 
 
(10) 
(64) 
(26) 
 
 
(65) 
(24) 
(11) 
 
 
 
 
 
 
 
 
 
 
a Sample size, unless otherwise specified. 
b Weeks of amenorrhea assessed by the date of the last menstrual period. 
BMI: Body Mass Index 
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b) Exposure 
 We detected 8 of the 11 phthalate metabolites and 5 of the 9 phenols in at least 95 % 
of the samples. Among phthalates, the highest medians were observed for the low MW 
phthalates: MEP, MiBP, MBP (Table 7).  
Table 7: Urinary phenol (n = 191) and phthalate (n = 287) biomarker concentrations after 
correction for case-control sampling (Gona_PE study, n = 287 mother-child pairs from EDEN 
and PELAGIE cohorts, 2002-2006). 
Analytes 
LOD 
(µg/L) 
%>LOD 
Standardized concentrationsa 
Percentiles (µg/L) 
 Measured concentrations 
Percentiles (µg/L) 
5th 50th 95th  5th 50th 95th 
Phenols 
2,4-DCP 
2,5-DCP 
BPA 
BP3 
TCS 
MP 
EP 
PP 
BP 
 
0.2 
0.2 
0.4 
0.4 
<LOD 
1.0 
1.0 
0.2 
0.2 
 
95.9 
99.5 
98.5 
80.5 
84.1 
100.0 
67.7 
96.9 
79.5 
 
LOD 
1.4 
0.8 
<LOD 
1.0 
9.0 
<LOD 
0.3 
<LOD 
 
0.8 
6.4 
3.1 
1.3 
17.5 
104.3 
1.5 
10.4 
2.2 
 
8.6 
316.0 
10.1 
74.5 
464.6 
2689.7 
38.2 
267.7 
63.6 
  
LOD 
1.8 
0.6 
<LOD 
<LOD 
9.1 
<LOD 
0.5 
<LOD 
 
0.9 
10.2 
2.7 
1.7 
24.1 
97.8 
4.1 
12.5 
1.7 
 
10.2 
442.0 
9.8 
143.0 
634.0 
3520 
62.3 
402.0 
53.8 
Phthalates  
MEP 
MBP 
MiBP 
MBzP 
MCPP 
MEHP 
MEHHP 
MEOHP 
MECPP 
MCOP 
MCNP 
 
0.5 
0.6 
0.3 
0.2 
0.2 
1.2 
0.7 
0.7 
0.6 
0.7 
0.6 
 
100.0 
100.0 
100.0 
100.0 
98.3 
91.8 
100 
99.7 
100.0 
92.1 
91.8 
 
28.1 
10.2 
15.6 
2.7 
0.6 
1.8 
8.0 
6.3 
18.9 
0.9 
0.9 
 
105.3 
58.1 
64.7 
21.7 
3.2 
10.5 
48.3 
36.0 
67.2 
3.9 
3.1 
 
727.0 
487.5 
365.3 
209.2 
13.8 
62.3 
246.2 
169.6 
303.0 
25.8 
22.8 
  
24.9 
7.6 
10.9 
2.0 
0.4 
<LOD 
4.6 
3.6 
11.6 
<LOD 
LOD 
 
110.22 
48.1 
45.9 
17.7 
2.2 
7.1 
32.3 
25.0 
43.8 
2.7 
1.7 
 
983.4 
398.0 
219.0 
116.6 
10.0 
40.7 
147.0 
112.0 
183.0 
17.2 
11.7 
Abréviations : BBzP : benzylbutyl phthalate , DBP : di-n-butyl phthalate, DCP: dichlorophenol, DEP : diethyl 
phthalate, DiBP : di-iso-butyl phthalate, DiDP : di-isodecyl phthalate, DiNP : di-isononyl phthalate, DOP: n-
octyl phthalate, LOD : limite de détection, MBP: mono-n-butyl phthalate, MBzP: monobenzyl phthalate, MCNP: 
monocarboxy-isononyl phthalate, MCOP: monocarboxy-isooctyl phthalate, MCPP: mono(3-carboxypropyl) 
phthalate, MECPP: mono(2-ethyl-5-carboxypentyl) phthalate, MEHHP: mono(2-ethyl-5-hydroxyhexyl) 
phthalate, MEHP: mono(2-ethylhexyl) phthalate, MEOHP: mono(2-ethyl-5-oxohexyl) phthalate, MEP: 
monoethyl phthalate, MiBP: mono-isobutyl phthalate, MP: methyl paraben, PP: propyl paraben, TCS: Triclosan.  
a Concentrations were standardized for conditions of sampling such as hour of sampling (EDEN only), time 
elapsed between sample collections and freezing, season and day of sampling and gestational age at collection. 
c) Association between phthalate concentrations and birth outcomes 
 For phthalate metabolite concentrations and birth weight, all p for trend were above 
0.14 (Table 8). There was some evidence of heterogeneity in mean birth weight across 
concentration tertiles for some phthalate metabolites: the lowest p-values for heterogeneity 
Phenols, phthalates and birth outcomes: Results 
53 
 
were observed for MCPP (p-values = 0.03) and MECPP (p-values = 0.08), given the high 
values of p for trend (0.73 and 0.59 for MCPP and MECPP, respectively), results were 
suggestive of non-monotonic associations (Table 8). For MECPP, but less so for MCPP, this 
non-monotonic association was also to some extent supported by the restricted cubic spline 
analysis (Figure 10). 
Figure 10: Birth weight as a function of MCPP (A) and MECPP concentrations (B) 
standardized for sampling conditions and coded as restricted cubic splines (log scale) 
(Gona_PE study, n = 287 mother-child pairs from EDEN and PELAGIE cohorts, 2002-2006). 
  
The predicted curves are adjusted for gestational duration, maternal pre-pregnancy weight and height, maternal 
smoking, maternal education level, parity, recruitment center and creatinine concentration.  
Shading indicates 95% confidence interval. 
Abbreviations: MCPP: mono(3-carboxypropyl) phthalate, MECPP: mono(2-ethyl-5-carboxypentyl) phthalate 
 Regarding other birth outcomes, the lowest p-values for heterogeneity were observed 
with MCPP, MCOP, MCNP, MEHP and the sum of the high MW phthalates for birth length 
and with the sum of the low MW phthalates for head circumference at birth (Table 8). 
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Table 8: Adjusted associations between maternal urinary concentrations of phthalate biomarkers standardized for sampling conditions and birth 
outcomes (Gona_PE study, n = 287 mother-child pairs from EDEN and PELAGIE cohorts, 2002-2006). 
Analytes 
(µg/L)a 
Changea in birth weight  
n = 287 
 Changea in birth length  
n = 286  
 Changea in head circumference  
n = 285 
β (g) 95% CI phetb ptrend
c  β (cm) 95% CI phetb ptrend
c  β (cm) 95% CI pheb ptrend
c 
MEP 
< 113.8 
113.8 – 275.7 
≥ 275.7 
   Ln(MEP) 
MBP 
< 45.6 
45.6 – 85.5 
≥ 85.5 
   Ln(MBP) 
MiBP 
< 48.2 
48.2 – 97.9 
≥ 97.9 
   Ln(MiBP) 
MCPP 
< 2.1 
2.1 – 4.4 
≥ 4.4 
   Ln(MCPP) 
MBzP 
< 17.6 
17.6 – 57.2 
≥ 57.2 
   Ln(MBzP) 
MEHP 
< 6.8 
6.8 – 17.1 
≥ 17.1 
   Ln(MEHP) 
 
0 
46 
-14 
3 
 
0 
52 
-30 
-13 
 
0 
61 
-31 
-44 
 
0 
-198 
-95 
-34 
 
0 
14 
-50 
-23 
 
0 
-122 
-37 
1 
 
0 
[-102; 194] 
[-162; 133] 
[-51; 57] 
 
0 
[-101; 206]  
[-174; 114] 
[-61; 35] 
 
0 
[-77; 200] 
[-190; 129] 
[-110; 23]  
 
0 
[-343; -52] 
[-243; 52] 
[-91; 22]  
 
0 
[-141; 170]  
[-223; 123] 
[-71; 24] 
 
0 
[-261; 17]  
[-184; 110] 
[-60; 62] 
 
0.61 
 
 
 
 
0.44 
 
 
 
 
0.41 
 
 
 
 
0.03 
 
 
 
 
0.67 
 
 
 
 
0.20 
 
 
 
 
0.60 
 
 
 
 
0.42 
 
 
 
 
0.48 
 
 
 
 
0.73 
 
 
 
 
0.43 
 
 
 
 
0.93 
 
 
 
  
0 
0.5 
0.0 
0.0 
 
0 
0.3 
0.1 
0.1 
 
0 
0.4 
0.3 
0.0 
 
0 
-0.7 
-0.1 
0.1 
 
0 
0.0 
0.1 
0.1 
 
0 
-0.6 
-0.3 
0.0 
 
0 
[-0.2; 0.1] 
[-0.6; 0.7] 
[-0.3; 0.2] 
 
0 
[-0.4; 0.9]  
[-0.6; 0.7] 
[-0.2; 0.3] 
 
0 
[-0.3; 1.1] 
[-0.4; 1] 
[-0.3; 0.3] 
 
0 
[-1.4; -0.1] 
[-0.8; 0.7] 
[-0.2; 0.4] 
 
0 
[-0.7; 0.7]  
[-0.9; 0.7] 
[-0.3; 0.2] 
 
0 
[-1.2; 0.0]  
[-0.9; 0.3] 
[-0.3; 0.2] 
 
0.22 
 
 
 
 
0.69 
 
 
 
 
0.46 
 
 
 
 
0.03 
 
 
 
 
0.99 
 
 
 
 
0.12 
 
 
 
 
0.58 
 
 
 
 
0.91 
 
 
 
 
0.54 
 
 
 
 
0.55 
 
 
 
 
0.88 
 
 
 
 
0.69 
 
 
  
0 
0.2 
0.4 
0.1 
 
0 
0.1 
0.1 
0.0 
 
0 
-0.1 
0.2 
-0.1 
 
0 
-0.5 
-0.3 
-0.2 
 
0 
-0.2 
-0.3 
0.0 
 
0 
0.2 
0.1 
0.0 
 
0 
[-0.3; 0.7] 
[-0.1; 1.0] 
[-0.2; 0.3] 
 
0 
[-0.5; 0.6]  
[-0.4; 0.7] 
[-0.2; 0.2] 
 
0 
[-0.6; 0.4] 
[-0.5; 0.9] 
[-0.4; 0.1] 
 
0 
[-0.1; 0.1] 
[-0.9; 0.4] 
[-0.4; 0.1] 
 
0 
[-0.8; 0.4]  
[-0.9; 0.3] 
[-0.2; 0.2] 
 
0 
[-0.7; 0.3]  
[-0.5; 0.6] 
[-0.2; 0.2] 
 
0.32 
 
 
 
 
0.89 
 
 
 
 
0.50 
 
 
 
 
0.20 
 
 
 
 
0.55 
 
 
 
 
0.55 
 
 
 
 
0.14 
 
 
 
 
0.63 
 
 
 
 
0.40 
 
 
 
 
0.77 
 
 
 
 
0.32 
 
 
 
 
0.56 
 
 
 
MEOHP 
< 25.2 
25.2 – 56.8 
≥ 56.8 
   Ln(MEOHP) 
MEHHP 
< 32.2 
32.2 – 77.9 
≥ 77.9 
   Ln(MEHHP) 
 
0 
-37 
60 
5 
 
0 
-60 
7 
4 
 
0 
[-179; 105] 
[-89; 209] 
[-56; 66] 
 
0 
[-202; 81]  
[-139; 154] 
[-54; 62] 
 
0.42 
 
 
 
 
0.58 
 
 
 
 
0.28 
 
 
 
 
0.65 
 
 
 
  
0 
-0.2 
0.3 
0.1 
 
0 
-0.3 
0.0 
0.1 
 
0 
[-0.8; 0.4] 
[-0.4; 1.0] 
[-0.2; 0.3] 
 
0 
[-0.9; 0.4]  
[-0.7; 0.7] 
[-0.2; 0.3] 
 
0.33 
 
 
 
 
0.61 
 
 
 
 
0.27 
 
 
 
 
0.80 
 
 
 
  
0 
0.0 
-0.1 
0.0 
 
0 
-1.0 
-0.1 
0.0 
 
0 
[-0.5; 0.6] 
[-0.6; 0.5] 
[-0.3; 0.2] 
 
0 
[-0.6; 0.4]  
[-0.7; 0.4] 
[-0.2; 0.2] 
 
0.94 
 
 
 
 
0.88 
 
 
 
 
0.75 
 
 
 
 
0.76 
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Table 8: Continued, Adjusted associations between maternal urinary concentrations of phthalate biomarkers standardized for sampling 
conditions and birth outcomes (Gona_PE study, n = 287 mother-child pairs from EDEN and PELAGIE cohorts, 2002-2006). 
Analytes 
(µg/L)a 
Changea in birth weight  
n=287 
 Changea in birth length  
n=286  
 Changea in head circumference  
n=285 
ß (g) 95% CI phetb ptrend
c  ß (cm) 95% CI phetb ptrend
c  ß (cm) 95% CI phetb ptrend
c 
MECPP 
< 45.8 
45.8 – 105.4 
≥ 105.4 
   Ln(MECPP) 
MCOP 
< 2.4 
2.4 – 5.9 
≥ 5.9 
   Ln(MCOP) 
MCNP 
< 2.3 
2.3 – 4.6 
≥ 4.6 
   Ln(MCNP) 
DEHP (µmol/L) 
< 0.4 
0.4 – 0.9 
≥ 0.9 
   Ln(DEHP) 
∑LMW (µmol/L) 
< 1.2 
1.2 – 2.7 
≥ 2.7 
   Ln(∑LMW) 
∑HMW (µmol/L) 
< 0.5 
0.5 – 1.3 
≥ 1.3 
   Ln(∑HMW) 
 
0 
-141  
-20 
5 
 
0 
-40 
-27 
-8 
 
0 
-40 
-15 
-3 
 
0 
-54 
36 
5 
 
0 
-3 
-100 
-38 
 
0 
-99 
19 
-2 
 
0 
[-277; -5] 
[-162; 121] 
[-64; 73] 
 
0 
[-192; 110]  
[-200; 147] 
[-72; 55] 
 
0 
[-186; 107] 
[-189; 158] 
[-67; 61] 
 
0 
[-197; 88] 
[-112; 186] 
[-60; 70] 
 
0 
[-141; 135] 
[-248; 47] 
[-109; 34] 
 
0 
[-243; 44]  
[-161; 198] 
[-70; 65] 
 
0.08 
 
 
 
 
0.87 
 
 
 
 
0.85 
 
 
 
 
0.43 
 
 
 
 
0.32 
 
 
 
 
0.17 
 
 
0.59 
 
 
 
 
0.87 
 
 
 
 
0.99 
 
 
 
 
0.29 
 
 
 
 
0.14 
 
 
 
 
0.37 
  
0 
-0.3  
0.2 
0.1 
 
0 
-0.2  
0.4 
0.1 
 
0 
0.5 
0.9 
0.3 
 
0 
-0.4 
0.1 
0.1 
 
0 
0.4 
0.0 
-0.1 
 
0 
-0.5 
0.2 
0.1 
 
0 
[-1.0; 0.4] 
[-0.6; 0.9] 
[-0.2; 0.4] 
 
0 
[-0.9; 0.4]  
[-0.5; 1.2] 
[-0.2; 0.4] 
 
0 
[-0.1; 1.2] 
[0.0; 1.7] 
[-0.1; 0.6] 
 
0 
[-1.0; 0.2] 
[-0.6; 0.9] 
[-0.2; 0.4] 
 
0 
[-0.2; 1.1] 
[-0.7; 0.7] 
[-0.4; 0.2] 
 
0 
[-1.2; 0.1]  
[-0.6; 1.0] 
[-0.2; 0.4] 
 
0.40 
 
 
 
 
0.11 
 
 
 
 
0.11 
 
 
 
 
0.18 
 
 
 
 
0.29 
 
 
 
 
0.06 
 
 
0.43 
 
 
 
 
0.19 
 
 
 
 
0.08 
 
 
 
 
0.39 
 
 
 
 
0.53 
 
 
 
 
0.26 
  
0 
0.0 
0.1 
0.0 
 
0 
-0.1 
0.0 
0.0 
 
0 
-0.1 
-0.1 
-0.1 
 
0 
0.1  
0.2 
0.0 
 
0 
0.5 
0.4 
-0.1 
 
0 
0.0 
0.2 
0.0 
 
0 
[-0.5; 0.6] 
[-0.4; 0.6] 
[-0.2; 0.3] 
 
0 
[-0.7; 0.4]  
[-0.6; 0.6] 
[-0.2; 0.3] 
 
0 
[-0.7; 0.4] 
[-0.8; 0.5] 
[-0.3; 0.1]  
 
0 
[-0.3; 0.6] 
[-0.4; 0.7] 
[-0.2; 0.2] 
 
0 
[0.0; 0.9] 
[-0.3; 1.0] 
[-0.4; 0.2] 
 
0 
[-0.5; 0.5]  
[-0.5; 0.8]  
[-0.2; 0.2] 
 
0.90 
 
 
 
 
0.77 
 
 
 
 
0.89 
 
 
 
 
0.80 
 
 
 
 
0.12 
 
 
 
 
0.82 
 
 
 
0.65 
 
 
 
 
0.79 
 
 
 
 
0.72 
 
 
 
 
0.68 
 
 
 
 
0.52 
 
 
 
 
0.54 
Regression models were corrected for the over-representation of cases of malformations of the genitalia by a weighting approach, Abbreviations: MBP: mono-n-butyl phthalate, MBzP: monobenzyl phthalate, MCNP: 
monocarboxyisononyl phthalate, MCOP: monocarboxy-isooctyl phthalate, MCPP: mono(3-carboxypropyl) phthalate, MECPP: mono(2-ethyl-5-carboxypentyl) phthalate, MEHP: mono(2-ethylhexyl) phthalate, 
MEHHP: mono(2-ethyl-5-hydroxyhexyl) phthalate, MEOHP: mono(2-ethyl-5-oxohexyl) phthalate, MEP: monoethyl phthalate, MiBP: mono-isobutyl phthalate. DEHP: molecular sum of 4 metabolites of di(2-
ethylhexyl) phthalate (MEHP, MEHHP, MEOHP,MECPP), ∑LMW: molecular sum of low molecular weight phthalates (MEP, MBP, and MiBP), ∑HMW: molecular sum of high molecular weight phthalates (MBzP, 
MCPP, MEHP, MECPP, MEHHP, MEOHP, MCOP and MCNP). 
a Adjusted for gestational duration, maternal pre-pregnancy weight and height, maternal smoking, maternal education level, parity, recruitment center and creatinine level. Models for head circumference were also 
adjusted for mode of delivery (cesarean section yes/no). 
b p-values of heterogeneity test. 
c p-values of monotonic trend test. 
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d) Association between phenol concentrations and birth outcomes 
 Birth weight decreased by 49 g (95% Confidence Interval (CI), -86 ; -13) in 
association with a 1-unit increase in ln-transformed 2,5-dichlorophenol concentration; after 
categorizing exposures in tertiles, boys in the highest exposure tertile were 152 g lighter on 
average, compared with boys in the lowest tertile (95% CI, -299 ; -5) (Figure 11). We 
observed a similar association between 2,4- dichlorophenol and birth weight (Figure 11, Table 
9), consistent with the high correlation between 2,4- dichlorophenol and 2,5- dichlorophenol 
(r = 0.95). 2,5- dichlorophenol ln-transformed concentration was also inversely associated 
with head circumference at birth (-0.1 cm, 95% CI, -0.2 ; 0.0).  
 Each 1-unit increase in ln-transformed benzophenone-3 concentration was associated 
with an increase of 26 g in birth weight (95% CI, -2; 54) and of 0.1 cm in head circumference 
at birth (95% CI, 0.0; 0.2). 
Figure 11: Adjusteda associations between 2,5-DCP (A), 2,4-DCP (B) and BP3 (C) maternal 
urinary concentrations (tertiles) standardized for sampling conditions and birth weight 
(Gona_PE study, n = 191 mother-child pairs from EDEN cohort, 2003-2006). 
  
Abbreviations: 2,4-DCP: 2,4-dichlorophenol, 2,5-DCP: 2,5-dichlorophenol, BP3: benzophenone-3. 
a Adjusted for gestational duration, maternal pre-pregnancy weight and height, maternal smoking, maternal 
education level, parity, recruitment center and urine dilution (creatinine level).  
Vertical bars indicate 95% confidence intervals.  
 For bisphenol A, estimates suggested an inverse U-shape association: birth weight 
increased by 169 g (95% CI, 14 ; 324) in the second bisphenol A concentration tertile and by 
85 g (95% CI, -62 ; 233) in the third concentration tertile, compared to the first (Figure 12). 
BPA concentrations were positively associated with head circumference, which increased by 
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0.8 cm in the highest bisphenol A concentration tertile, compared to the lowest tertile        
(95% CI 0.2 ; 1.3).  
Figure 12: Birth weight as a function of bisphenol A concentrations standardized for 
sampling conditions, categorized in tertile (A) and coded as restricted cubic splines (log scale, 
B) (Gona_PE study, n = 191 mother-child pairs from EDEN cohort, 2003-2006). 
  
Abbreviations: BPA : bisphenol A. 
Shading indicates 95% confidence interval. 
 For all other phenols, there was no evidence of associations with offspring measures at 
birth [all p for heterogeneity were above 0.24 (Table 9) and curves obtained using restricted 
cubic splines did not clearly support an association (data not shown). 
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Table 9: Adjusted associations between maternal urinary concentrations of phenol biomarkers standardized for sampling conditions and birth 
outcomes (Gona_PE study, n = 191 mother-child pairs from EDEN cohort, 2003-2006). 
 
Analytes 
(µg/L)a 
Changea in birth weight  
n = 191 
 Changea  in birth length  
n = 190 
 Changea in head circumference  
n = 189 
ß (g) 95% CI phet
b ptrend
c  ß (cm) 95% CI phet
b ptrend
c  ß (cm) 95% CI phet
b ptrend
c 
2,4-DCP 
< 0.6 
0.6 - 1.3 
≥ 1.3 
   Ln(2,4-DCP) 
2,5- DCP 
< 3.9 
3.9 – 13.9 
≥ 13.9 
   Ln (2,5-DCP) 
BPA 
< 2.2 
2.2 - 4.7 
≥ 4.7 
   Ln(BPA) 
BP3 
< 0.7 
0.7 - 2.7 
≥ 2.7 
   Ln(BP3) 
TCS 
< 4.5 
4.5 - 51.3 
≥ 51.3 
   Ln(TCS) 
MPB 
< 62.8 
62.8 – 213.0 
≥ 213.0 
   Ln(MPB) 
EPB 
< 0.6 
0.6 - 3.7 
≥ 3.7 
   Ln(EPB) 
 
0 
24 
-181 
-77 
 
0 
-49 
-152 
-49 
 
0 
169 
85 
-9 
 
0 
-15 
105 
26 
 
0 
-58 
-40 
-6 
 
0 
-32 
24 
-2 
 
0 
10 
17 
-1 
 
0 
[-129; 177]  
[-323; -40] 
[-129; -25]  
 
0 
[-206; 108]  
[-299; -5] 
[-86; -13] 
 
0 
[14; 324] 
[-62; 233] 
[-98; 80] 
 
0 
[-155; 124] 
[-40; 250] 
[-2; 54] 
 
0 
[-194; 78] 
[-171; 90] 
[-31; 19] 
 
0 
[-168; 105]  
[-121; 168] 
[-37; 34] 
 
0 
[-129; 148] 
[-145; 178] 
[-43; 41] 
 
<0.0
1 
 
 
 
 
0.10 
 
 
 
 
0.10 
 
 
 
 
0.20 
 
 
 
 
0.68 
 
 
 
 
0.75 
 
 
 
0.98 
 
 
<0.01 
 
 
 
 
0.03 
 
 
 
 
0.70 
 
 
 
 
0.09 
 
 
 
 
0.79 
 
 
 
 
0.58 
 
 
 
 
0.86 
 
  
0 
0.7 
0.2 
-0.1 
 
0 
0.4  
0.3 
0.0 
 
0 
0.0 
0.1 
0.0 
 
0 
-0.3 
0.4 
0.1 
 
0 
-0.2 
0.1 
0.0 
 
0 
0.2 
0.4 
0.1 
 
0 
0.6 
0.3 
0.1 
 
0 
[0.1; 1.3]  
[-0.5; 0.9] 
[-0.4; 0.2] 
 
0 
[-0.3; 1.0]  
[-0.4; 1.0] 
[-0.2; 0.2] 
 
0 
[-0.7; 0.8] 
[-0.7; 0.9]  
[-0.4; 0.4] 
 
0 
[-0.1; 0.3] 
[-0.3; 1.0] 
[-0.1; 0.2] 
 
0 
[-0.9; 0.4] 
[-0.6; 0.7]  
[-0.1; 0.1] 
 
0 
[-0.5; 0.8]  
[-0.3; 1.2] 
[-0.1; 0.3] 
 
0 
[-0.1; 1.3] 
[-0.4; 0.9] 
[-0.1; 0.3] 
 
0.09 
 
 
 
 
0.53 
 
 
 
 
0.98 
 
 
 
 
0.17 
 
 
 
 
0.68 
 
 
 
 
0.47 
 
 
 
 
0.24 
 
 
0.77 
 
 
 
 
0.70 
 
 
 
 
0.83 
 
 
 
 
0.14 
 
 
 
 
0.59 
 
 
 
 
0.23 
 
 
 
 
0.97 
 
  
0 
0.8 
-0.3 
-0.1 
 
0 
-0.3 
-0.5 
-0.1 
 
0 
0.3 
0.8 
0.3 
 
0 
0.2 
0.5 
0.1 
 
0 
0.2 
-0.2 
-0.1 
 
0 
0.2 
0.2 
0.0 
 
0 
0.4 
0.2 
0.1 
 
0 
[0.2; 1.4] 
[-0.8; 0.3] 
[-0.3; 0.1] 
 
0 
[-0.8; 0.3]  
[-1.1; 0.0] 
[-0.2; 0.0] 
 
0 
[-0.3;0.9] 
[0.2; 1.3] 
[0.0; 0.7] 
 
0 
[-0.5; 0.8] 
[-0.0; 1.0] 
[0.0; 0.2] 
 
0 
[-0.3; 0.7] 
[-0.7; 0.3] 
[-0.2; 0.0] 
 
0 
[-0.4; 0.7]  
[-0.4; 0.8] 
[-0.1, 0.2] 
 
0 
[-0.2; 1.0] 
[-0.4; 0.8] 
[-0.1; 0.3]  
 
<0.01 
 
 
 
 
0.14 
 
 
 
 
0.04 
 
 
 
 
0.12 
 
 
 
 
0.31 
 
 
 
 
0.79 
 
 
 
 
0.47 
 
 
0.01 
 
 
 
 
0.10 
 
 
 
 
0.01 
 
 
 
 
0.04 
 
 
 
 
0.18 
 
 
 
 
0.58 
 
 
 
 
0.94 
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Table 9: Continued, Adjusted associations between maternal urinary concentrations of phenol biomarkers standardized for sampling 
conditions and birth outcomes (Gona_PE study, n = 191 mother-child pairs from EDEN cohort, 2003-2006). 
 
Analytes 
(µg/L)a 
Changea in birth weight 
n = 191 
 Changea  in birth length 
n = 190 
 Changea in head circumference 
n = 189 
  ß (g) 95% CI phet
b ptrend
c  ß (g) 95% CI phet
b ptrend
c  ß (g) 95% CI phet
b ptrend
c 
PPB 
< 4.7 
4.7 – 24.8 
≥ 24.8 
   Ln(PPB) 
BPB 
< 0.6 
0.6 – 6.8 
≥ 6.8 
   Ln(BPB) 
∑PB (µmol/L) 
< 0.5 
0.5 – 1.6 
≥ 1.6 
   Ln(∑PB) 
 
0 
-2  
-5 
-10 
 
0 
-15 
-2 
-1 
 
0 
-16  
6 
-3 
 
0 
[-137; 132]  
[-151; 140] 
[-40; 19] 
 
0 
[-156; 126]  
[-155; 150] 
[-32; 29] 
 
0 
[-150; 118]  
[-143; 156]  
[-39; 33] 
 
1.00 
 
 
 
 
0.97 
 
 
 
 
0.95 
 
 
 
0.95 
 
 
 
 
0.95 
 
 
 
 
0.86 
  
0 
-0.1 
0.2 
0.0 
 
0 
0.2 
0.1 
0.0 
 
0 
0.2 
0.4 
0.1 
 
0 
[-0.7; 0.6]  
[-0.8; 0.7] 
[-0.2; 0.2] 
 
0 
[-0.5; 1.0]  
[-0.9; 0.7] 
[-0.2, 0.2] 
 
0 
[-0.4; 0.9]  
[-0.4; 0.1]  
[-0.1; 0.3] 
 
0.98 
 
 
 
 
0.58 
 
 
 
 
0.61 
 
 
 
0.93 
 
 
 
 
0.49 
 
 
 
 
0.38 
  
0 
-0.3 
-0.2 
-0.1 
 
0 
0.2 
0.3 
0.1 
 
0 
0.2 
0.2 
0.0 
 
0 
[-0.8; 0.2]  
[-0.8; 0.3] 
[-0.2; 0.1] 
 
0 
[-0.3; 0.7]  
[-0.3; 0.8] 
[-0.1; 0.2] 
 
0 
[-0.4; 0.7]  
[-0.4; 0.7] 
[-0.2; 0.1] 
 
0.52 
 
 
 
 
0.61 
 
 
 
 
0.80 
 
 
 
0.62 
 
 
 
 
0.45 
 
 
 
 
0.66 
 
Abbreviations: BP: butyl paraben BPA: bisphenol A, BP3: benzophenone-3, DCP: 2,5-dichlorophenol, MP: methyl paraben, EP: ethyl paraben, PP: propyl paraben, TCS: Triclosan, ∑PB: 
molecular sum of parabens. 
Regression models were corrected for the over-representation of cases of malformations of the genitalia by a weighting approach. 
a Adjusted for gestational duration, maternal pre-pregnancy weight and height, maternal smoking, maternal education level, parity, recruitment center and creatinine level. Models for head 
circumference at birth were also adjusted for mode of delivery (cesarean section yes/no). 
b p-values of heterogeneity test.  
c p-values of monotonic trend test. 
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e) Sensitivity analyses  
 For phenols, associations with birth outcomes remained similar after exclusion of 48 
cases of male malformations of the genitalia (not shown) Using biomarker concentrations not 
standardized for sampling conditions instead of concentrations standardized for sampling 
conditions did not markedly change associations between either 2,4-, 2,5-dichlorophenol, 
benzophenone-3 or bisphenol A and birth weight. Similarly, associations between either 
benzophenone-3 or bisphenol A and head circumference at birth remained similar (not 
shown).  
 In analyses restricted to controls only or using concentrations not standardized for 
sampling conditions, findings concerning phthalates were consistent with those obtained in 
the main analysis, excepted for MECPP: The birth weight change observed in the second 
MECPP concentration tertile was -141 g (95% CI, -277; -5) in the whole study population,     
- 79 g (95% CI, -220; 61) after exclusion of cases and -51 g (95% CI, -187; 84) using non-
standardized biomarker concentrations. These sensitivity analyses are difficult to interpret 
because the restriction to controls decreased population size, and because standardization 
sometimes induced strong variations in the distribution of biomarker concentrations and 
hence in the cut-off values of tertiles. 
 
 Excluding women with pregnancy-induced hypertension or gestational diabetes did 
not modify our main results (data not shown).  
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4. Discussion 
 Within our study population of 191 male newborns, maternal urinary concentrations of 
2,4- and 2,5-dichlorophenol were associated with a birth weight decrease, while urinary 
concentrations of benzophenone-3 were positively associated with weight and head 
circumference at birth. Bisphenol A urinary concentrations were positively associated with 
head circumference; there was no evidence of monotonic associations between phthalate 
metabolite concentrations and birth weight.  
a) Phenols and birth outcomes 
 In our study population, birth weight decreased by 152 g in the highest                     
2,5-dichlorophenol concentration tertile compared to the lowest tertile (95% CI, -299 ; -5); the 
only other human study addressing this issue reported a decrease by 210 g in the third                    
2,5-dichlorophenol concentration tertile compared to the first (95% CI, -348, -71, ((Wolff et 
al. 2008)). Concentrations of 2,5-dichlorophenol (and hence tertiles) were much higher in the 
study by Wolff et al. (median: 53 µg/L) than in ours (median standardized concentration:      
6.4 µg/L). Wolff et al. also reported that boys were 0.3 cm shorter at birth per increase by one 
in ln(2,5-DCP) (95% CI, -0.6; -0.4); our results did not clearly support such an association 
(0.0 cm per increase by one in ln(2,5-DCP), 95% CI; -0.2; 0.2), but birth length is not very 
accurately assessed, implying potentially strong measurement error. 2,5-dichlorophenol is a 
metabolite of 1,4-dichlorobenzene, which is used as chemical intermediate in the production 
of dyes and organic chemicals and which is found in mothballs and toilet-deodorizer blocks 
(Agency for Toxic Substances and Disease 2006; Yoshida et al. 2002). Dichlorophenols may 
also be released from water treatments (Abrahamsson and Xie 1983). 
 2,4-dichlorophenol was also associated with a birth weight decrease. It is a metabolite 
of 1,3-dicholorobenzene, a minor contaminant of 1,4-dichlorobenzene (Agency for Toxic 
Substances and Disease 2006; Yoshida et al. 2002), which may explain the high correlation 
reported between concentrations of both dichlorophenols. 2,4-dichlorophenol is also an 
environmental transformation intermediate of the antiseptic agent triclosan and of some 
herbicides such as 2,4-dichlorophenoxyacetic acid and 2-(2,4-dichlorophenoxy) propionic 
acid (Yang et al. 2010; Zona et al. 2002). Our results concerning 2,4-dichlorophenol are 
difficult to compare with those of Wolff et al (2008), who studied male and female newborns 
altogether for this compound.  
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Taken together, these studies suggest an effect of dichlorophenols, or one of their precursors, 
on birth weight.  
 Benzophenone-3 urinary concentrations were positively associated with weight and 
head circumference at birth. Boys were 105 g heavier (95% CI, -40 ; 250) in the highest 
benzophenone-3 concentration tertile compared with the lowest. Similarly, Wolff et al (2008) 
noted a birth weight increase in male infants in the highest benzophenone-3 concentration 
tertile compared to the lowest (betas not reported); they did not report effect estimates for 
benzophenone-3 and head circumference in males. Exposure to benzophenone-3 likely results 
from use of consumer products as sunscreens or cosmetics (Calafat et al. 2008).  
 Bisphenol A urinary concentrations were positively associated with head 
circumference at birth. After categorizing exposures in tertiles, we observed an inverse           
U-shape association between bisphenol A concentrations and birth weight. Such non-
monotonic dose-response curves between perinatal exposures to bisphenol A and weight in 
early life have been reported in rodents (Rubin and Soto 2009; Rubin et al. 2001). However, 
urinary bisphenol A concentrations were relatively low in our study population, enhancing the 
analytical uncertainties and hence the potential for exposure misclassification, which may 
limit our ability to distinguish monotonic from non-monotonic associations. 
b) Phthalates and birth outcomes 
 There was no strong evidence of monotonic association between phthalate metabolite 
concentrations and birth outcomes, excepted for the possible positive association between 
MCNP and birth length. Our analyses suggested non-monotonic associations with birth 
weight and birth length for some phthalate metabolites. Such associations between phthalate 
metabolites and birth weight have, to our knowledge, never been reported previously in 
rodents or in humans and therefore should be considered cautiously.  
c) Study population  
 To correct the over-representation of cases induced by our case-control design, we 
weighted the observations in regression models (Richardson et al. 2007). We also performed 
non-weighted analyses, restricted to controls, and our main results regarding birth weight 
remained similar to those based on the whole weighted study population.  
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d) Exposure assessment  
 Sampling conditions, such as hour of urine sampling or storage duration before 
freezing, may influence the concentrations of several biomarkers (Mahalingaiah et al. 2008; 
Samandar et al. 2009). We used a 2-step standardization method based on regression residuals 
to reduce undesirable variability in biomarker urinary concentrations due to sampling 
conditions (Mortamais et al. 2012). To our knowledge it is the first time that such an approach 
has been applied to study associations between phthalate or phenol prenatal exposures and 
birth outcomes. We repeated our analyses using concentrations not standardized for sampling 
conditions and associations between dichlorophenols or benzophenone-3 and birth weight or 
between benzophenone-3 and bisphenol A and head circumference were similar.  
e) Limitations 
 The assayed phenols and phthalates and their metabolites have relatively short half-
lives in humans (typically, one day or less), but accurate information on half-lives in pregnant 
women, in whom metabolism may differ compared to non-pregnant women, is not available. 
We assessed exposures from the urinary concentrations at a single point during pregnancy; 
increasing the number of urine samples collected would have provided a more accurate 
estimate of the average exposure during the whole gestation. Adibi et al. reported that for 
phthalates, the probability of correctly classifying a woman into a low exposure group based 
on a single urine sample, if she truly had low exposure based on multiple measurements, was 
between 0.43 for monoethyl phthalate (MEP) and 0.95 for mono-isobutyl phthalate (MiBP) 
(Adibi et al. 2008a). Concerning phenols, bisphenol A concentrations also vary during 
pregnancy (Braun et al. 2011b). Therefore, there clearly is exposure misclassification, whose 
amplitude differs according to the biologically relevant exposure window (if any) and to the 
chemical considered.  
 We adjusted for many potential confounders, but residual confounding cannot be 
discarded. For example, specific metabolic disorders associated with both fetal growth and 
xenobiotic metabolism would constitute potential confounders; in our study, excluding 
women with pregnancy-induced hypertension or gestational diabetes did not alter associations 
with bisphenol A and benzophenone-3 (not shown). Multiple comparisons are generally an 
issue in studies relying on several biomarkers; although we did not formally correct for 
multiple comparisons, our choice to focus our conclusions on previously reported associations 
limits the risk of chance being a likely explanation for our main findings.   
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5. Conclusion  
 In our study, there was no strong evidence of monotonic association between phthalate 
metabolite concentrations and birth outcomes. Urinary concentrations of 2,4- and                
2,5-dichlorophenols were negatively associated with birth weight while benzophenone-3 
concentrations were associated with a birth weight increase. Results concerning                    
2,5-dichlorophenol and benzophenone-3 were in agreement with another publication 
concerning male newborns from New-York (Wolff et al. 2008) and we aimed at replicating 
our findings in a larger sub-population of pregnant women from the EDEN cohort. 
 
Phenols and pre-and early post-natal growth: Methods  
65 
 
II. Effects of prenatal exposures to phenols on fetal growth, estimated using 
repeated ultrasound measurements and early postnatal growth 
1. Aims of the chapter 
 The objectives of this study were 1) to expand phenol measurements to 410 other 
women from the EDEN mother child-cohort delivering boys, in order to replicate results on 
birth outcomes published in 2012 (Philippat et al. 2012) and reported above (see I of this 
chapter); 2) to explore the associations between phenol exposures during pregnancy and 
repeated ultrasound measurements; 3) to study the associations between phenol exposures 
during pregnancy and growth during the first three years of life. 
2. Population and methods  
a) Population and exposure assessments  
 The study population relies on a subgroup of the EDEN mother–child cohort. 
Inclusion criteria for the present study was delivering boy with complete data on prenatal 
(three ultrasound measurements and biometry at birth) and postnatal growth (≥ 4 
measurements of weight and height within the first three years of life), corresponding to a 
total of 520 mother-child pairs. Among those, 110 were included in the Gona_PE analysis 
aiming at studying associations between prenatal exposure to phthalates and phenols on birth 
outcomes described previously in this Chapter (See II, page 44) and had their urine samples 
analyzed for phenols in 2008 (Chevrier et al. 2012; Philippat et al. 2012). We extended these 
measurements to all women matching the inclusion criteria and 410 other urine samples were 
analyzed in 2011 (Figure 13).  
 Urine samples were collected between 22 and 29 gestational weeks. Women were 
asked to collect the first morning urine void at home before the hospital study visit. If 
forgotten, the urine sample was collected at the hospital. Urine samples were aliquoted and 
stored at -80°C. Measurements of nine phenol biomarkers5 and creatinine were done by the 
National Center for Environmental Health laboratory at the Centers for Disease Control and 
Prevention (CDC) in Atlanta, Georgia, USA (Ye et al. 2005). Total paraben concentration 
                                                 
5 Phthalates metabolites were also measured. J. Botton (Inserm U1018, Université Paris-Sud), in collaboration with our team, 
is in charge of the analyses regarding the associations between phthalates and pre- and post-natal growth, which are not 
presented in this manuscript.  
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(∑PB) was calculated by summing molar concentrations of methyl-, ethyl-, propyl- and butyl-
parabens.  
Figure 13: Study population for fetal and postnatal growth analyses (PEnDevE study, n = 520 
mother-child pairs from the EDEN cohort). 
 
Abbreviations: EDEN: Etude sur les Déterminants pré- et post-nataux précoces du développement psychomoteur 
et de la santé de l’ENfant, Gona_PE: Gonades et Perturbateurs Endocriniens, PEnDevE: Perturbateurs 
Endocriniens et Développement de l’Enfant 
 
 
b) Growth assessment 
 We assessed biparietal diameter (BPD) by ultrasound (US) at three occasions during 
pregnancy (around 12.6, 22.5 and 32.6 gestational weeks (GW)) while the other measures of 
fetal size (head circumference (HC), abdominal circumference (AC) and femur length (FL)) 
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were assessed only during the two last ultrasound examinations (Albouy-Llaty et al. 2011). 
We estimated fetal weight (EFW) using the formula by (Hadlock et al. 1985):  
log (EFW) = 1.3596 – 0.00386.AC.FL + 0.0064.HC + 0.00061.BPD.AC + 0.0424.AC + 0.174.FL 
 Weight and length at birth were extracted from hospital maternity records.  
 Infants were weighed and measured at 1 and 3 years during study specific 
examinations. Additionally, at 4, 8, 12, 24 and 36 months, mothers reported by self-
questionnaires the weight and height measures contained in the child health booklet which is 
filled in by the family pediatrician in routine follow-up. We used these repeated 
measurements to model child growth individually using an adaptation of the Jenss growth 
curve model (see Box 2 for more detail on this model). This model was used to predict weight 
and height at 6, 12, 24 and 36 months. Head circumference was assessed in duplicate within 4 
days after birth and at 3 years; in main analyses we used the average of the two measures at 
each age. At 3 years, children tricipital and subscapular skinfold thicknesses were measured 
in triplicate and abdominal circumference in duplicate. We used the average of these 
measures. 
 For growth parameters measured three times or more, we additionally computed an 
average growth rate between two successive measurements: 
growth rate = (measurement at t2 - measurement at t1) / (t2 - t1). 
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Box 2: Prediction of individual postnatal growth curves in the EDEN cohort 
Postnatal growth modeling was done by J. Botton (Inserm, U1018 - Univ Paris-Sud). 
 
 A neonatal weight loss is usually observed the first few days after birth. After this few 
days, growth velocity is very high but steadily declines over time in order to reach a constant 
value around 2 years. Growth velocity is then constant until puberty where growth accelerates 
again. Several mathematical equations have been used to describe this shape of growth; Jenss, 
Reed and Count models were shown to be efficient for studying growth between birth and 3 
years (Hauspie et al. 2004). The Jenss model (see equation below) was the one with the 
highest fit in the EDEN cohort.  
 = 	
	 +		.  + 	 . 1 − 
 . + εi 
t: age in months 
Yi: weight (kg) or height (cm) of the child at age t 
εi residual error at age t 
:	birth weight 
 
 The first part of the model 	 +		.  is a straight line allowing to describe the 
straight trend of growth between 2 years and puberty. The other part is an exponential term 
that fits the increase observed in the first months of life and the following weight growth 
deceleration (Botton et al. 2008). This model allows to take into account the nonlinearity of 
weight and height growth during the first years of life and to investigate different periods of 
growth between birth and 3 years. 
Figure 14: Fitted weight and height growth curve between birth and 3 years for 5 randomly 
selected children of the EDEN cohort (points correspond to observations, lines to modeled curves). 
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c) Statistical methods 
 We replaced phenol biomarker concentrations below the limit of detection (LOD) by 
instrumental reading values. Concentrations were standardized for collection conditions using 
a previously defined approach (See method section of the chapter II, II.2, page 50, 
(Mortamais et al. 2012)). In contrast to Mortamais et al. (2012), we only standardized for 
sampling conditions associated with the phenol concentrations (p-value < 0.2). Phenol 
concentrations were coded either as continuous variables (ln-transformed concentration) or in 
tertiles. Unless otherwise specified, β estimates are given for an increase by one interquartile 
range (IQR) of phenol concentration. 
 To study the associations between phenol concentrations and fetal growth 
measurements (ultrasound and birth measurements), we used linear regression models with a 
random effect variable corresponding to the mother–child pair. To allow effect modifications 
along pregnancy we included interaction terms between phenol concentration and gestational 
age (longitudinal analyses, see Box 3 page 71). Models were adjusted for factors possibly 
related to prenatal growth (based on a priori knowledge). This included maternal and paternal 
height (continuous) and weight (continuous), maternal weight gain during pregnancy 
(continuous), maternal active (continuous) and passive (yes / no) smoking before the 
ultrasound measurement, maternal education level (3 categories: high school or less, up to 2 
years after high school, ≥ 3 years after high school), parity, gestational age at measurement 
(third order polynomial) and recruitment center. Gestational age was estimated using the date 
of last menstrual period (LMP) or gestational duration assessed by the obstetrician if it 
differed from the LMP-based estimate by > 2 weeks. 
 In order to study the associations between phenol concentrations and measures of 
postnatal growth (predicted weight and height at 6, 12, 24 and 36 months, skin fold thickness 
abdominal and head circumference at 36 months), we used linear regression models adjusted 
for maternal and paternal height (continuous) and weight (continuous), maternal active 
(continuous) and passive (yes/no) smoking during pregnancy, maternal education level (high 
school or less, up to 2 years after high school, ≥ 3 years after high school), recruitment center, 
parity and breastfeeding (never, ≤ 3 months, > 3 months).  
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Sensitivity analyses  
 In sensitivity analyses, models for postnatal weight were additionally adjusted for 1) 
birth weight, 2) height predicted at the same age, 3) average caloric intake at 4 months for 
growth parameters measured at 6 months and average calorie intake at 8 months for growth 
parameters measured at 12 months and more. Average caloric intake was computed based on 
three days dietary inquiry occurring at 4 and 8 months). In order to test for effect modification 
by breastfeeding (postnatal growth only), we performed additional models including an 
interaction term between these variables and exposure. 
 Head circumference of the newborn was also measured at birth. We tested in what 
extend using this measure rather than the measure performed few days after birth, affect our 
results. 
 In order to allow comparisons with the results published in 2012 among 191 pregnant 
women from the EDEN cohort (see Chapter II, II.2, page 44), we performed cross sectional 
analyses to study the associations between phenol exposures and birth measurements (weight, 
height, head circumference).  
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Box 3: Description of two different approaches commonly used to estimate the effects of 
environmental exposures on pre-natal growth (Slama et al, submitted) 
 We consider Yit a measure of fetal size assessed by ultrasonography at various time 
points throughout pregnancy; Y can for example be estimated fetal weight or biparietal 
diameter (assessed on a continuous scale). 
 The first approach corresponds to a linear regression model with a random effect 
variable corresponding to the mother–child pair and interaction terms of gestational age with 
exposure and covariates (Slama et al. 2009). The model can be written:  
Yit = β0 + β1 x Ei + β2 x f(GAit) + β3Ei x f(GAit) + β4Xi + β5Xi x f(GAit) + Ri + εit    (1) 
Yit:  ultrasound measurement for woman i, at time j (for example, biparietal diameter). 
E: biomarker concentrations (standardized for sampling conditions). 
f(GA): gestational age, where f is a third order polynomial (other functional forms could be used). 
Xi: adjustment variables. 
Ri: random effect variable corresponding to the mother–child pair. 
 The model can be used to test an effect measure modification of exposure by 
gestational duration. The main results correspond to the parameters associated with exposure 
at a given gestational age. This approach was used in the work presented in the thesis. 
Examples of the growth curves obtained using this model are presented in Figure 15 
Figure 15: Biparietal diameter (mm) and estimated fetal weight (kg) as a function of 
gestational age at measurement among 520 mother-child pairs from EDEN cohort. 
 
The predicted curves are adjusted for gestational age, maternal age, maternal height and weight before 
pregnancy, maternal weight gain during pregnancy, paternal height and weight, maternal active and passive 
smoking during pregnancy, maternal education level, parity, and recruitment center.  
 The second approach (2-step approach based on Z-Scores, (Aguilera et al. 2010; 
Iniguez et al. 2012a)) is an extension of what has been proposed by Royston and Altman 
(Royston and Altman 1995). The main steps are:  
1) Build an adjusted regression model that does not include the exposure variable: 
Yit = β0 + β1 x f(GAit) + β2Xi + β3Xi x f(GAit) + Ri + εit     (2) 
Yit:  ultrasound measurement for woman i, at time t (for example, biparietal diameter). 
f(GA): gestational age, where f is a third order polynomial (other functional forms could be used). 
Xi: adjustment variables including maternal weight, height and age, maternal education level, active and passive 
smoking, parity, center. 
Ri: random effect variable corresponding to the mother–child pair. 
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 The values of Y according to gestational age predicted by this model for a given set of 
values of the adjustment variables correspond to what can be seen as a standardized growth 
curve.  
2) Z-score computation 
 If ultrasound measurements occurred at the same gestational age for all subjects, then 
one could compute a Z-score at time t using the following formula: 
 =
 !
"# !
        (3) 
Y it(obs): Ultrasound measurement observed at t. 
Yit(sdz): Ultrasound measurement predicted at t using standardized growth curve.  
SDt(sdz): Standard deviation of predicted biparietal diameter (estimated using standardized growth curve). 
 
 However ultrasound measurements may not all have taken place exactly at the same 
time t but at some time t±∆. The ultrasound parameter observed at t will be approximated 
using Y observed at t±∆and the growth curve defined in (2): 
% 	= 		 ,±∆ 	× 	
, !	
,±∆ !
	
        (4) 
% 	: Approximated ultrasound measurement at t. 
,±∆ : Ultrasound measurement observed at t±∆  
,)*+: Ultrasound measurement predicted at t using standardized growth curve. 
,±∆)*+ : Ultrasound measurement predicted at t±∆	using standardized growth curve. 
 
With this approximation, one can then perform the Z-score computation as if all ultrasound 
measures had occurred at time t.  
 =
,- !
"# !
        (5) 
3) Regress the Z-score at time t on the exposure variable E:  
Z it =  β0 + β1 x Ei + β2 x Xi + εit   (6) 
Ei: Exposure variable. 
Xi: adjustment variables (may include the adjustment variables of model 2 and possibly additional ones).  
 
 The parameter associated with E provides an estimate of the effect of exposure on the 
fetal size measure at time t. In a previous paper related on air pollution and fetal growth this 
approach was slightly modified; author did not standardized the difference between 
./)and	)*+ (step 3, (Hansen et al. 2008)).   
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3. Results 
a) Population and growth characteristics  
 Average maternal age was 29.7 years. Women were mostly non-smokers during 
pregnancy (87%), 26% were overweight (BMI > 25 kg/m²). Regarding their babies, 23 (4%) 
were born before 37 gestational weeks and 11 (2%) had a weight at birth below 2500 g (Table 
10). 
 Compared to all women from EDEN cohort delivering boys and to the women studied 
in the framework of the Gona_PE study (chapter II, paragraph 2.1), women of the PEnDevE 
study population were less exposed to active and passive smoking (Table 10). The percentage 
of women recruited in Poitiers was higher in the PEnDevE population than in the two sub-
mentioned populations (60% versus to 53% in the whole EDEN cohort and 48% among 
women included in the Gona_PE project, Table 10).   
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Table 10: Characteristics of the whole EDEN cohort delivering boys and comparison with 
PEnDevEb and Gona_PEc population. 
Characteristic 
All male 
newborns, 
EDEN cohort 
 (n = 995)a 
 Women of EDEN 
cohort included in 
PEnDevE study  
 (n = 520)b 
  
Women of EDEN  
cohort included in 
Gona_PE study  
(n = 191)c 
n (%)  n %   n % 
Maternal age (years) 
< 25 
25-29 
30-34 
≥ 35 
 
200 
376 
285 
134 
 
(20) 
(38) 
(29) 
(13) 
 
85 
200 
159 
76 
(16) 
(38) 
(31) 
(15)   
35 
71 
57 
28 
(18) 
(37) 
(30) 
(15) 
Parity 
0 
1 
≥ 2  
Missing  
434 
373 
187 
1 
(44) 
(37) 
(19) 
(0) 
 
248 
192 
79 
1 
(48) 
(37) 
(15) 
(0) 
71 
75 
44 
 
(38) 
(39) 
(23) 
 
BMI (kg/m2) 
<18.5 
≥ 18.5 to <25 
≥ 25 
Missing 
91 
634 
249 
21 
(9) 
(64) 
(25) 
(2) 
 
45 
331 
137 
7 
(9) 
(64) 
(26) 
(1) 
19 
115 
54 
3 
(10) 
(60) 
(28) 
(2) 
Maternal Education 
Less than 2y after high school 
High school + 2 years 
≥ High school + 3 years 
Missing 
457 
218 
297 
23 
(46) 
(22) 
(30) 
(2) 
 
211 
124 
178 
7 
(41) 
(24) 
(34) 
(1) 
95 
39 
51 
6 
(50) 
(20) 
(27) 
(3) 
Active smoking (cig/day)d 
0 
1 to 5 
> 5 
Missing  
825 
81 
86 
3 
(83) 
(8) 
(9) 
(0) 
 
453 
39 
27 
1 
(87) 
(8) 
(5) 
(0) 
159 
15 
17 
 
(83) 
(8) 
(9) 
 
Passive smoking 
No 
Yes 
Missing  
710 
277 
8 
(71) 
(28) 
(1) 
 
411 
108 
1 
(79) 
(21) 
(0) 
131 
59 
1 
(69) 
(31) 
(1) 
Center 
Poitiers 
Nancy 
530 
465 
(53) 
(47) 
 
312 
208 
(60) 
(40) 
91 
100 
(48) 
(52) 
Gestational duration 
< 37 gestational week 
≥ 37 gestational week 
63 
932 
(6) 
(94) 
 
23 
497 
(4) 
(96) 
5 
186 
(3) 
(97) 
Birth weight 
< 2500 g 
≥ 2500 g 
47 
948 
(5) 
(95) 
 
11 
509 
(2) 
(98) 
4 
187 
(2) 
(98) 
Year of birth 
2003-2004 
2005-2006  
560 
440 
(56) 
(44) 
 
286 
234 
(55) 
(45) 
89 
102 
(47) 
(53) 
Breastfeeding 
Never  
≤ 3months 
> 3months  
Missing 
268 
422 
298 
7 
(27) 
(42) 
(30) 
(1) 
 
135 
209 
176 
0 
(26) 
(40) 
(34) 
(0) 
51 
84 
56 
0 
(27) 
(44) 
(29) 
(0) 
a Singleton live births.  
b Study population for the intrauterine and postnatal growth analyses (inclusion criteria: deliver boys with 
complete data on pre and post natal growth). 
c Study population for the birth outcome analyses (See Chapter II; paragraph II.2).   
d Second trimester of pregnancy. 
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 The first, second and third ultrasound examination were performed on average at 12.6 
(5th-95th centiles, 11.1-14.0), 22.5 (5th-95th centiles, 20.7-24.4) and 32.6 (5th-95th centiles, 
30.6-34.2) gestational weeks. Fetal and child biometry are described in details in Table 11. On 
average fetal weight and head circumference were multiplied by 6 and 2 between the second 
ultrasound examination and birth, respectively. On average, weight doubled between birth and 
6 months of life (Table 11, Figure 14).   
Table 11: Descriptive statistics of growth measurements in the PEnDevE population (n = 520, 
EDEN cohort, 2003-2006). 
Measurements   Percentiles 
  mean  5th 50th 95th 
Biparietal diameter (mm)    
US 1 22 17 22 27 
US 2  55 49 55 61 
US 3  83 77 83 90 
Head circumference (mm)   
US 2  202 181 201 223 
US 3  300 280 300 323 
Birth 349 330 349 370 
36 months  506 483 506 529 
Abdominal circumference (mm) 
US 2  180 160 179 202 
US 3  284 256 283 314 
36 months  499 457 500 546 
Femur length (mm)   
US 2  39 34 38 44 
US 3  62 57 62 67 
Height (mm)   
Birth 501 460 500 530 
6 months a 675 643 675 710 
12 months a 762 727 762 802 
24 months a 874 827 874 924 
36 months a 966 912 966 1023 
Weight (g) 
US 2 (estimated) 527 388 522 699 
US 3 (estimated) 2003 1530 1977 2556 
Birth 3371 2620 3370 4105 
6 months a 7877 6752 7819.6 9204.8 
12 months a  9975 8559 9911 11648 
24 months a 12543 10685 12519 14551 
36 months a 14723 12453 14551 17226 
Skinfold thickness at 36 months (mm)   
Tricipital  8.3 5.3 8 11.7 
Subscapular  5.2 3.9 5.1 7.1 
a Predicted by the Jenss growth curve model, based on postnatal measures, 
US: ultrasound measurement. 
Only biparietal diameter has been measured at US 1.  
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 Correlations observed between repeated measures of the same fetal growth parameter 
were lower than those observed between different fetal parameters measured at the same 
ultrasound examinations. Biparietal diameter measured at the second ultrasound examination 
was correlated at 0.3 with biparietal diameter measured in the other ultrasound examinations 
while the correlation observed between this measurement and the other parameters measured 
at the second ultrasound examination were greater than 0.7 (Table 12). Head circumference 
measured in duplicate within 4 days after birth was correlated at 0.8 with head circumference 
at birth and these measurements were correlated at 0.3 (head circumference at birth) and 0.4 
(measurement performed within 4 days after birth) with head circumference measured in third 
ultrasound examination.  
 Correlations between measurements of child weight between 6 and 36 months were 
high (ρ > 0.67). These measurements were moderately correlated with birth weight (ρ < 0.5). 
Similar pattern was observed for child height (Table 12). We observed relatively high 
correlations between child weight and size predicted at the same age (correlation coefficients 
ranged between 0.65 and 0.73, Table 12). 
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Table 12: Correlations between pre- and post-natal growth measurements in the PEnDevE population (n = 520 male newborns from the EDEN 
cohort, 2003-2006). 
  
Biparietal 
diameter   
Head 
circumference   
Femur 
length   Size   
Abdominal 
  Weight circumference  
  US 1  US 2 US 3    US 2 US 3 Birtha    US 2 US 3   Birth 6 mo 12 mo 24 mo 36 mo    US 2 US 3 36 mo    US 2 US 3 Birth 6 mo 12  mo 24 mo  
Biparietal diameter   
US 2 0.26 1 
US 3 0.09 0.31 1 
Head circumference 
US 2 0.23 0.88 0.26 1 
US 3 0.12 0.23 0.79 0.24 1 
Birth a 0.01 0.18 0.32 0.21 0.41 1 
Femur length 
US 2 0.20 0.74 0.15 0.79 0.19 0.18 1 
US 3 0.05 0.16 0.55 0.18 0.59 0.26 0.27 1 
Size  
Birth -0.08 0.03 0.14 0.07 0.16 0.55 0.10 0.22 1 
6 months -0.02 0.06 0.21 0.10 0.23 0.36 0.18 0.38 0.48 1 
12 months -0.02 0.02 0.17 0.06 0.17 0.25 0.14 0.34 0.35 0.90 1 
24 months -0.02 0.02 0.15 0.06 0.14 0.19 0.13 0.32 0.28 0.73 0.94 1 
36 months  -0.02 0.03 0.15 0.07 0.15 0.19 0.15 0.34 0.29 0.74 0.89 0.97 1 
Abdominal circumference  
US 2 0.24 0.72 0.23 0.76 0.22 0.16 0.73 0.21 0.10 0.15 0.11 0.09 0.10 1 
US 3 0.09 0.20 0.60 0.22 0.60 0.29 0.18 0.61 0.20 0.26 0.21 0.18 0.18 0.34 1 
3 years -0.03 0.06 0.11 0.04 0.10 0.12 0.03 0.16 0.17 0.31 0.35 0.38 0.40 0.08 0.18 1 
Weight 
US 2 (est) 0.25 0.82 0.22 0.87 0.23 0.19 0.90 0.24 0.10 0.16 0.12 0.11 0.12 0.94 0.28 0.06 1 
US 3 (est) 0.10 0.23 0.74 0.25 0.74 0.33 0.22 0.79 0.21 0.32 0.27 0.24 0.24 0.32 0.94 0.19 0.30 1 
Birth 0.02 0.12 0.26 0.18 0.28 0.70 0.18 0.30 0.73 0.49 0.34 0.26 0.26 0.21 0.38 0.16 0.20 0.37 1 
6 months -0.04 0.02 0.18 0.03 0.17 0.33 0.06 0.24 0.39 0.66 0.61 0.52 0.51 0.10 0.26 0.49 0.08 0.27 0.44 1 
12 months -0.04 -0.01 0.14 0.00 0.14 0.25 0.03 0.21 0.29 0.59 0.65 0.63 0.61 0.07 0.23 0.58 0.05 0.24 0.33 0.92 1 
24 months -0.02 0.04 0.15 0.04 0.15 0.21 0.06 0.23 0.23 0.55 0.66 0.70 0.70 0.08 0.22 0.69 0.07 0.24 0.28 0.77 0.93 1 
36 months  0.00 0.08 0.18   0.08 0.18 0.21   0.10 0.25   0.22 0.54 0.63 0.69 0.72   0.10 0.22 0.73   0.10 0.26 0.27 0.67 0.80 0.95 
a assessed in duplicate within 4 days after birth  
Abbreviation: mo: months, US: Ultrasound measurement 
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b) Exposure 
 We detected 6 of the 9 assayed phenols in at least 93% of the samples. Highest 
medians were observed for methyl paraben (122 µg/l), followed by triclosan (30 µg/l) and 
propyl paraben (17 µg/l, Table 13). Pearson correlation coefficients between 2,4- and          
2,5-dicholorphenol was 0.83 and they ranged from 0.52 to 0.81 for the four parabens. 
Table 13: Concentrations of phenol biomarkers in maternal urine in the PEnDevE population 
(EDEN cohort, 2003-2006, n = 520). 
Phenols 
 
 
LOD 
(µg/L) 
 
%> 
LOD 
Standardized 
concentrationsa (1) 
  Measured 
concentrations (2) Spearman 
correlation between 
(1) and (2) 
Percentiles (µg/L)   Percentiles (µg/L) 
5th 50th 95th   5th 50th 95th 
          
 
2,4-dichlorophenol 0.2 98 0.3 1.0 9.8  0.3 1.0 10.1 
0.92 
2,5-dichlorophenol 0.2 100 1.7 9.2 305  1.6 9.8 291 
0.96 
Bisphenol A 0.4 99 0.8 2.3 9.5  0.7 2.5 11 
0.85 
Benzophenone-3 0.4 93 <LOD 2.1 72  <LOD 2.2 85 
0.95 
Triclosan 2.3 81 <LOD 31 763  <LOD 30 755 
0.99 
Methyl paraben 1 100 8.3 106 1148  8.1 122 2020 
0.94 
Ethyl paraben 1 73 <LOD 3.6 66  <LOD 4.7 72 
0.93 
Propyl paraben 0.2 99 0.5 14 250  0.6 17 317 
0.96 
Butyl paraben 0.2 84 <LOD 2.1 61 
 
<LOD 2.0 59 0.96 
∑Parabens (µmol/L) 
  0.1 0.9 9.8  0.1 1.1 17 
0.94 
a All concentrations were standardized for creatinine concentrations. Bisphenol A concentration was additionally 
standardized for gestational age at sampling and time elapsed between urine collection and freezing; 
benzophenone-3 was standardized for gestational age at sampling and hour of sampling. All of the parabens 
were standardized for hour of sampling ; butyl paraben was additionally standardized for day of 
sampling and gestational age at sampling  
LOD: limit of detection. 
 
 We did not observe strong differences in exposure pattern between the subpopulation 
with phenol assessments in 2008 and the subpopulation with assessments in 2011: p-values 
for Student tests were above 0.4 for all phenols, except 2,4-dichlorophenol, which tended to 
increase from 2008 to 2011 (p, 0.11). 
c) Association between phenols and growth parameters 
 We observed negative associations between triclosan concentrations and all of the 
growth parameters measured at the third ultrasound examinations (p-values ranged between 
0.01 for abdominal circumference and 0.16 for head circumference), but not earlier in 
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pregnancy (p-values > 0.30, Table 14). At birth, this phenol was also negatively associated 
with head circumference (β = - 1.4 mm, 95% CI; -2.8; 0.0) but not with weight (β = 8.7 g, 
95% CI; -27; 44), nor height (β = 0.1 mm, 95% CI; -2.3; 2.5). The negative association with 
head circumference observed at birth was less marked at 36 months (β = - 1.0 mm, 95% CI;    
-2.8; 0.8). Triclosan concentration was not associated with postnatal heights and weights nor 
as with abdominal circumference and skinfold thicknesses at 36 months (p-values ≥ 0.2, Table 
14).  
 Regarding prenatal growth rate, triclosan was negatively associated with growth in 
biparietal diameter between US examination one and two (β = -0.03 mm/week; 95% CI;          
-0.07; -0.02). This phenol was positively associated with weight growth between US 
examination two and three (β = -3.1 g/week; 95% CI; -5.9; -0.3) and US examination three 
and birth (β = 7.6 g/week; 95% CI; 1.1; 14, Table 15).  
 The strongest association between parabens and ultrasound measurements was 
observed between butylparaben and head circumference at the third ultrasound (β = - 1.3 mm, 
95% CI; -0.2; 2.7); This association did not remain at birth (β = 0.1 mm, 95% CI; -1.4; 1.5, 
Table 14) and butylparaben tended to be negatively associated with head circumference 
growth between both measurements (β = -0.3 mm/week; 95% CI; -0.7; 0.1). At birth, all 
parabens, as well as their molecular sum, were positively associated with weight                  
(p-values < 0.05). This might be explained by an effect on growth in late pregnancy since all 
of these phenols are also positively associated with weight growth between the third 
ultrasound examination and birth (Table 15). Positive associations were observed between 
methyl- and propyl-paraben and weight at 6, 12, 24 and 36 months and abdominal 
circumference at 36 months (p-values ranged between 0.02 and 0.14, Table 14). These 
phenols tended to be positively associated with subscapula skinfold thickness at 36 months    
(β = 0.08 mm, 95% CI; -0.04; 0.21 and β = 0.11 mm, 95% CI; -0.03; 0.24 for methyl- and 
propyl-paraben respectively). Similar but weaker patterns of association were observed for 
butyl paraben (Table 14). Additional adjustment for birth weight weakened the positive 
associations observed between parabens and postnatal weight, and only the positive 
association between methylparaben and weight at 36 months was maintained (β = 167 g;    
95% CI; 1; 332). Regarding postnatal growth rate, parabens tended to be positively associated 
with average weight growth between 12 and 24 months and between 24 and 36 months but 
not earlier in the child life (intervals birth - 6 months and 6 - 12 months, Table 15). Only 
Phenols and pre-and early post-natal growth: Results 
80 
 
methylparaben tended to be positively associated with size at birth and during early childhood 
(p-values ranged between 0.05 and 0.14, Table 15). 
 Bisphenol A tended to be positively associated with abdominal circumference            
(β = 1.4 mm; 95% CI -0.2; 2.9) but negatively with femur length (β = -0.2 mm; 95% CI       -
0.5; 0.04) at the third ultrasound examination. This phenol was not clearly associated with the 
other pre- and post-natal measurements (p-values ≥ 0.18, Table 14). After adjustment for 
height, bisphenol A was not associated either with weight at birth and 6 months, but tended to 
be associated with weight at 12, 24 and 36 months which respectively increased by 59 g   
(95% CI; -22; 140), 100 g (95% CI; 0.3; 200) and 102 g (95% CI; -18; 221) for each IQR 
increase in bisphenol A concentration.  
 2,4 dichlorophenol was negatively associated with abdominal circumference at the 
third ultrasound examination (β = -1.2 mm, 95% CI; -2.3; 0.0), but positively with this 
outcome recorded at 36 months (β = 2.4 mm, 95% CI; -0.2; -4.9, Table 15). This phenol was 
also positively associated with weight growth between 24 and 36 months which increased by 
0.9 g/weeks for each IQR increase in 2,4-dichlorophenol concentration (Table 15). It was not 
clearly associated with weight measured at the endpoint of this period (β = 31 g; 95% CI,        
-94; 155). We observed isolated associations between 2,5-dichlorophenol and head 
circumference (β =1.2 mm, 95% CI; 0.1; 2.3) at the third ultrasound examination.  
 For benzophenone-3, the strongest association was observed with weight at birth       
(β = 17 g; 95% CI, -6.1; 40, Table 14). 
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Table 14: Adjusted associations between phenol maternal urinary concentrations and pre- and post-natal size in the PEnDevE population (EDEN 
cohort, 2003-2006, n = 520 male newborns). 
Growth 
parameter  
Phenolic compounds  
2,4-DCP   2,5-DCP   BPA   BP3   TCS   MP   EP   PP   BP   ∑PB 
β p   β p   β p   β p   β p   β p   β p   β p   β p   β p 
Biparietal diameter (mm)                            
1st US -0.09 0.49 
 
-0.11 0.49 
 
-0.03 0.87 
 
-0.02 0.87 
 
0.19 0.33 
 
0.09 0.61 
 
-0.01 0.94 
 
0.04 0.85 
 
-0.05 0.81 
 
0.09 0.62 
2nd US -0.06 0.64 
 
-0.03 0.85 
 
-0.05 0.79 
 
-0.13 0.30 
 
-0.16 0.42 
 
0.07 0.69 
 
0.12 0.55 
 
0.02 0.90 
 
0.28 0.16 
 
0.06 0.73 
3rd US -0.04 0.74 
 
0.26 0.10 
 
-0.23 0.18 
 
0.06 0.62 
 
-0.41 0.04 
 
-0.11 0.53 
 
0.02 0.90 
 
-0.13 0.51 
 
0.34 0.10 
 
-0.12 0.52 
Head circumference (mm)                          
2nd US -0.37 0.44 
 
0.02 0.98 
 
0.26 0.67 
 
-0.28 0.55 
 
-0.06 0.93 
 
0.57 0.38 
 
1.04 0.14 
 
0.05 0.94 
 
1.01 0.17 
 
0.56 0.40 
3rd US 0.11 0.81 
 
1.19 0.03 
 
-0.49 0.42 
 
0.33 0.46 
 
-0.97 0.16 
 
-0.11 0.86 
 
1.00 0.15 
 
0.14 0.84 
 
1.25 0.08 
 
0.04 0.96 
Birth  -0.23 0.63 
 
0.03 0.96 
 
0.08 0.90 
 
0.35 0.46 
 
-1.39 0.05 
 
-0.09 0.90 
 
0.03 0.97 
 
0.20 0.77 
 
0.05 0.95 
 
-0.02 0.98 
36 months -0.18 0.77 
 
0.10 0.90 
 
0.16 0.84 
 
-0.38 0.51 
 
-0.98 0.27 
 
0.28 0.73 
 
-0.75 0.40 
 
0.19 0.82 
 
-0.58 0.54 
 
0.19 0.82 
Femur length (mm)                           
2nd US -0.03 0.81 
 
0.08 0.54 
 
0.16 0.24 
 
-0.02 0.85 
 
0.01 0.94 
 
0.06 0.66 
 
0.08 0.63 
 
0.01 0.94 
 
0.11 0.50 
 
0.07 0.65 
3rd US -0.12 0.24 
 
0.00 0.98 
 
-0.23 0.09 
 
0.04 0.70 
 
-0.30 0.05 
 
-0.04 0.80 
 
0.15 0.34 
 
-0.20 0.19 
 
0.10 0.54 
 
-0.03 0.83 
Length (mm)                              
Birth  -0.53 0.50 
 
-0.53 0.58 
 
1.08 0.30 
 
0.45 0.56 
 
0.09 0.94 
 
2.21 0.05 
 
0.84 0.49 
 
1.52 0.20 
 
1.73 0.17 
 
2.24 0.05 
6 monthsa -0.07 0.94 
 
0.22 0.84 
 
-0.09 0.94 
 
0.59 0.48 
 
-0.11 0.93 
 
2.19 0.07 
 
0.04 0.97 
 
1.28 0.31 
 
0.77 0.57 
 
2.21 0.07 
12 monthsa -0.70 0.45 
 
-0.55 0.63 
 
-1.03 0.40 
 
0.53 0.55 
 
-0.47 0.73 
 
1.89 0.14 
 
-0.38 0.79 
 
0.77 0.57 
 
0.69 0.64 
 
1.91 0.14 
24 monthsa -1.05 0.35 
 
-0.91 0.51 
 
-1.63 0.27 
 
0.52 0.63 
 
-0.85 0.61 
 
2.25 0.14 
 
-0.11 0.95 
 
0.84 0.61 
 
1.39 0.43 
 
2.26 0.15 
36 monthsa  -0.57 0.65 
 
-0.59 0.70 
 
-1.53 0.36 
 
0.48 0.70 
 
-0.71 0.71 
 
3.21 0.07 
 
0.45 0.81 
 
1.29 0.49 
 
1.96 0.33 
 
3.16 0.08 
Abdominal circumference (mm)                          
2nd US -0.07 0.90 
 
0.22 0.76 
 
0.58 0.45 
 
0.17 0.76 
 
0.33 0.71 
 
0.22 0.79 
 
0.29 0.74 
 
0.04 0.96 
 
0.73 0.44 
 
0.19 0.82 
3rd US -1.16 0.05 
 
-0.05 0.95 
 
1.35 0.08 
 
0.33 0.58 
 
-2.24 0.01 
 
0.30 0.72 
 
0.98 0.27 
 
0.03 0.97 
 
1.44 0.12 
 
0.29 0.73 
36 months 2.36 0.07 
 
2.19 0.17 
 
0.61 0.72 
 
1.14 0.36 
 
2.49 0.20 
 
4.15 0.02 
 
1.88 0.34 
 
3.37 0.07 
 
3.52 0.08 
 
4.15 0.02 
Weight (g)                             
2nd US 4.68 0.70 
 
6.07 0.68 
 
7.62 0.63 
 
-1.53 0.90 
 
6.57 0.72 
 
18.86 0.25 
 
25.3 0.16 
 
12.8 0.46 
 
17.9 0.34 
 
18.8 0.27 
3rd US -18.1 0.12 
 
-0.91 0.95 
 
3.37 0.83 
 
7.09 0.53 
 
-37.3 0.03 
 
-8.06 0.61 
 
6.69 0.70 
 
-10.1 0.55 
 
21.7 0.23 
 
-6.86 0.67 
Birth  -3.82 0.76 
 
6.96 0.64 
 
0.52 0.97 
 
17.4 0.15 
 
8.68 0.63 
 
33.1 0.05 
 
47.4 0.01 
 
38.9 0.03 
 
52.4 0.01 
 
38.9 0.02 
6 monthsa -12.1 0.71 
 
-15.5 0.70 
 
-1.93 0.96 
 
23.3 0.46 
 
3.72 0.94 
 
84.9 0.06 
 
6.00 0.90 
 
80.6 0.09 
 
45.0 0.38 
 
84.7 0.06 
12 monthsa -33.8 0.40 
 
-32.4 0.51 
 
30.8 0.56 
 
39.4 0.31 
 
6.23 0.92 
 
86.2 0.12 
 
-4.88 0.94 
 
86.9 0.14 
 
38.5 0.54 
 
85.1 0.13 
24 monthsa -17.8 0.73 
 
-13.2 0.83 
 
50.8 0.45 
 
28.8 0.56 
 
33.9 0.66 
 
137 0.05 
 
35.9 0.64 
 
134 0.07 
 
88.3 0.27 
 
138 0.06 
36 monthsa  30.5 0.63 
 
34.4 0.66 
 
50.1 0.55 
 
-1.13 0.99 
 
69.8 0.46 
 
208 0.02 
 
102 0.28 
 
188 0.04 
 
153 0.12 
 
210 0.02 
Skinfold at 36 months (mm)                            
Triceps -0.03 0.73 
 
-0.08 0.40 
 
0.03 0.79 
 
-0.01 0.86 
 
0.07 0.55 
 
0.01 0.96 
 
-0.02 0.90 
 
-0.02 0.87 
 
-0.07 0.58 
 
-0.01 0.94 
Subscapula 0.05 0.34   0.02 0.75   0.03 0.59   0.00 0.95   0.12 0.10   0.08 0.20   0.08 0.28   0.11 0.12   0.03 0.66   0.08 0.22 
a Parameter individually estimated by the Jenss growth curve model, based on postnatal measures. Abbreviations: BP: butlyparaben, BPA: bisphenol A,                              
BP3: benzophenone-3, DCP: dichlorophenol, EP: ethylparaben, MP: methylparaben, PP, propylparaben, TCS: triclosan, ∑PB: molecular sum of paraben concentrations. 
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Table 15: Adjusted associations between phenol maternal urinary concentrations and growth rate in the PEnDevE population (EDEN cohort, 
2003-2006, n = 520 male newborns).  
  Phenolic compounds  
Growth rate  
2,4-DCP 2,5-DCP BPA BP3 TCS MP EP PP BP ∑PB 
β p   β P   β p   β p   β p   β p   β p   β p   β p   β p 
Biparietal diametera 
1st to 2nd US 0.00 0.98 0.01 0.61 0.00 0.96 -0.01 0.43 -0.03 0.06 -0.01 0.51 0.00 0.81 -0.01 0.58 0.03 0.18 -0.01 0.48 
2nd to 3rd US 0.01 0.49 0.02 0.21 -0.02 0.34 0.01 0.70 -0.03 0.25 0.00 0.95 0.01 0.53 0.00 0.97 0.01 0.65 0.00 0.95 
Head circumferencea 
2nd to 3rd US 0.06 0.25 0.07 0.26 -0.04 0.54 0.03 0.56 -0.07 0.37 0.01 0.93 0.05 0.52 0.10 0.18 0.06 0.51 0.02 0.76 
3rd US to birth -0.12 0.32 -0.23 0.12 0.15 0.35 0.05 0.66 -0.09 0.64 -0.07 0.70 -0.27 0.14 -0.21 0.24 -0.31 0.11 -0.09 0.58 
Weightb 
2nd to 3rd US -1.29 0.18 -0.15 0.90 0.97 0.44 0.22 0.81 -3.12 0.03 0.07 0.96 1.68 0.24 0.04 0.98 2.10 0.17 0.16 0.91 
3rd US to birth 2.71 0.22 0.68 0.80 -1.86 0.53 1.77 0.41 7.64 0.02 7.02 0.02 6.98 0.04 7.83 0.02 5.67 0.11 8.00 0.01 
0 to 6 months -0.15 0.89 -0.81 0.57 -0.71 0.64 0.58 0.61 -0.83 0.63 1.19 0.45 -1.37 0.43 -0.23 0.89 -0.04 0.98 0.89 0.58 
 6 to 12 months -0.83 0.21 -0.65 0.42 1.26 0.15 0.62 0.34 0.10 0.92 0.05 0.96 -0.42 0.67 0.24 0.80 -0.25 0.81 0.02 0.99 
12 to 24 months 0.31 0.44 0.37 0.45 0.39 0.46 -0.20 0.60 0.53 0.38 0.98 0.08 0.78 0.19 0.91 0.12 0.96 0.13 1.01 0.07 
24 to 36 months 0.93 0.03 0.92 0.07 -0.01 0.98 -0.57 0.16 0.69 0.28 1.36 0.02 1.27 0.04 1.03 0.09 1.25 0.06 1.39 0.02 
Sizea  
0 to 6 months 0.03 0.44 0.03 0.51 -0.07 0.12 0.02 0.47 -0.04 0.42 -0.02 0.74 0.00 0.95 -0.07 0.15 -0.02 0.78 -0.02 0.71 
6 to 12 months -0.02 0.16 -0.03 0.16 -0.04 0.11 0.00 0.89 -0.01 0.59 -0.01 0.63 -0.02 0.53 -0.02 0.44 0.00 0.90 -0.01 0.64 
12 to 24 months -0.01 0.44 -0.01 0.51 -0.01 0.31 0.00 0.98 -0.01 0.58 0.01 0.56 0.01 0.69 0.00 0.92 0.01 0.32 0.01 0.58 
24 to 36 months 0.01 0.21   0.01 0.50   0.00 0.84   0.00 0.91   0.00 0.81   0.02 0.07   0.01 0.33   0.01 0.42   0.01 0.35   0.02 0.09 
a mm/week 
b g/week 
Abbreviations: BP: butlyparaben, BPA: bisphenol A, BP3: benzophenone-3, DCP: dichlorophenol, EP: ethylparaben, MP: methylparaben, PP, propylparaben, TCS: triclosan, 
∑PB: molecular sum of paraben concentrations.   
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d) Sensitivity analyses 
 When we used head circumference at birth rather than the duplicate assessment 
performed few days after birth, the negative association observed with triclosan was 
weakened (βHC at birth = -1.1 mm; 95% CI -3.0; 0.5 compared to βHC duplicate assessment = 1.4 mm, 
95% CI, -2.8; 0.0, Table 14), while a positive association with benzophenone-3 (β = 1.0 mm; 
95% CI 0.0; 2.0), not observed with the duplicate assessment (β = 0.4 mm; 95% CI -0.6; 1.3), 
appeared. 
  Adjustment for the child caloric intake at 4 and 8 months did not strongly affect our 
results and the positive associations between parabens and postnatal weight were maintained. 
Similarly, after taking into account child caloric intake at 8 months (child caloric intake was 
not available later in child life) and child height, bisphenol A was still positively associated 
with weight at 24 and 36 months. The association between bisphenol A and weight at 12 
months was weakened after adjustment for caloric intake at 8 months (β = 36 g; 95% CI,        
-52, 124) compared to in the analysis not adjusted for caloric intake (β = 61g; 95% CI;            
-27; 149; n = 403, analysis restricted to children with data on caloric intake).  
 We did not find clear evidence of effect modification by breastfeeding duration for any 
of the phenolic chemicals (p-values for interaction > 0.1).  
 In order to compare our results with those previously observed among a smaller 
subsample of the EDEN cohort (Gona_PE study, see Chapter II, paragraph II.1) we performed 
transversal analyses for weight and head circumference at birth. The negative associations 
observed between dichlorophenols, birth weight and head circumference were only observed 
in the subsample of 191 women (Gona_PE study). The positive associations between 
parabens and weight at birth were not observed in women of the Gona_PE study, however the 
confidence interval of the estimated β tended to overlap between both studies (Figure 16). 
 
  
 
Figure 16: Adjusteda associations between phenols and weight and head circumference
(transversal analysis, β given for an IQR increase in phenol concentration)
 n = 191, population of the case-control study with phenol measurement
 n = 410, PEnDevE population not in Gona_PE 
 n = 520, all women delivering boys with complete data on pre
 
Abbreviations: BP: butylparaben, BPA: bisphenol A, BP3: 
a Adjustment factors were: maternal and paternal height and weight, maternal weight gain during pregnancy, maternal active and 
education level, parity, gestational duration (3rd order polynomial) and re
between birth and measurements.  
b  Head circumference was assessed in duplicate within 4 days after birth; results
used head circumference measured at birth rather than the duplicate measurement preformed within 4 days after birth.
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4. Discussion  
 Within our study population of male newborns, triclosan concentration was negatively 
associated with fetal growth measurements in late pregnancy, head circumference at birth and 
less strongly with head circumference at 36 months. The parabens were not associated with 
fetal weight during pregnancy but were positively associated with weight at birth. This 
positive association with weight remained until 36 months for methyl- and propyl-paraben; 
which were also positively associated with abdominal circumference and subscapula skinfold 
thickness at 36 months.  
 The negative association observed between triclosan and head circumference at birth is 
consistent with the results obtained in the subsample of 191 male newborns from the EDEN 
cohort (Gona_PE study, β = - 2.0 mm; 95% CI; -5.3; 1.3, β given for an IQR increase in log-
transformed TCS concentrations). A negative association has been previously suggested in 
one study among boys and girls (β = - 0.4 mm; 95% CI; -1.3; 0.04, β given for an increase by 
one in log-transformed TCS concentrations, results for boys only were not reported (Wolff et 
al. 2008)). Head circumference has been shown to be a predictor of the brain volume 
(Bartholomeusz et al. 2002) and both brain size and head circumference have been correlated 
with intelligence quotient and cognitive ability (Castellanos et al. 2002; Gale et al. 2006; 
Ounsted et al. 1988). To our knowledge no study has evaluated the association between 
triclosan and neurodevelopment. Animal studies have shown that perinatal exposure to 
triclosan may disturb the homeostasis of thyroid hormones, which are required for the fetus 
and infant normal growth and brain development (Paul et al. 2010; Paul et al. 2012). In 
Human, no study has specifically focused on triclosan exposure and thyroid hormone levels in 
pregnant women. Among a subset of the NHANES population, a positive association between 
this phenol, measured in spot urine samples, and the total triiodothyonine concentration in 
blood has been observed in adolescents (ages 12–19), but not in adults; no association was 
observed with the other thyroid hormones as thyroxin (Koeppe et al. 2013).  
 Methylparaben is one of the most commonly used parabens in food and cosmetics 
(Soni et al. 2005) and in our population, methylparaben urine concentration was around 10 
fold higher than those observed for the other parabens. The positive associations observed 
with postnatal growth measurements tended to be stronger for this paraben than for the other 
ones. Our findings suggested that the associations observed between parabens and weight at 6 
and 12 months may result of an accelerated weight growth at the end of pregnancy. These 
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associations were indeed weakened by birth weight adjustment and parabens were positively 
associated with weight growth between the third ultrasound examination and birth, but not 
between birth and 6 months nor as between 6 and 12 months. Inversely, the positive 
association between parabens and weight at 36 months was not affected by birth weight 
adjustment and may results of an accelerated weight growth between 12 and 36 months. A 
recent in vitro study has reported that parabens may promote adipocyte differentiation in 
murine cells by an activation of the glucocorticoid receptor (GR) and / or the peroxisome 
proliferator activated receptor gamma (PPARγ, (Hu et al. 2012; Taxvig et al. 2012)). These 
mechanisms may play a role in the positive associations observed with postnatal weight and 
skinfold thickness. Paraben estrogenic activities (Chen et al. 2007; Golden et al. 2005; van 
Meeuwen et al. 2008) may also be implied in the positive association observed with child 
growth since the estrogenic receptors ER∝ and ERβ are implied in the growth of diverse 
tissues. In Human, a positive association between the placental total effective xenoestrogen 
burden and birth weight has been observed in boys (Vilahur et al. 2013). To our knowledge, if 
we except our previous study among a subsample of 191 male newborns from EDEN cohort 
(Philippat et al. 2012) and in which we did not observe any association between parabens and 
weight at birth (β = - 3 g; 95% CI, - 39, 33) no other study has explored associations between 
these chemicals and pre- and early post-natal growth in Human.  
 In our population, bisphenol A was negatively associated with femur length and 
positively associated with abdominal circumference measured at the third ultrasound 
examination. This chemical was not associated with weight, height or length at birth. A few 
studies have already assessed the effect of bisphenol A on fetal growth in Human; some have 
reported positive associations with weight and head circumference at birth (Philippat et al. 
2012; Wolff et al. 2008) while others, with repeated ultrasound measurements during 
pregnancy, have reported negative associations with fetal femur length, head and abdominal 
circumference (Lee et al. 2010), and with fetal weight (Snijder et al. 2013). Urinary 
concentrations of bisphenol A have been shown to be highly variable during pregnancy with 
an Intraclass Correlation Coefficient (ICC) around 0.10 (Braun et al. 2011b). All of the sub-
mentioned studies used a small numbers of urine samples to assess exposure (one sample; 
except for Snijder et al. who performed three measurements) and their findings are likely to 
be affected by exposure misclassification. This may explain the lack of consistency observed 
across human studies for bisphenol A. This issue is further discussed and studied in chapter 
III.  
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 In our population, bisphenol A was positively associated with weight at 12, 24 and 36 
months, after height adjustment. In vitro studies have reported an adipogenic activity for 
bisphenol A (Masuno et al. 2005; Sargis et al. 2010) and in animal, obesogenic effects have 
been reported (doses: 0.1 to 1.2 mg/kg of body weight/day of bisphenol A, (Rubin et al. 2001; 
Ryan et al. 2010; Somm et al. 2009)). Previous studies exploring the effects of bisphenol A on 
growth during childhood focused on older children than those of our study (6 to 19 years, 
Harley et al. 2013; Trasande et al. 2012). Only the study published by Harley et al. relies on 
measurements in maternal urine collected during pregnancy and no association between 
prenatal exposure to bisphenol A and BMI or waist circumference at 9 years was observed in 
boys.  
 The main source of bisphenol A is probably diet and eating behaviors may affect 
urinary concentrations of bisphenol A (Agence nationale de sécurité sanitaire de 
l’alimentation de l’environnement et du travail 2013; Rudel et al. 2011). It is likely that 
women and children who regularly consume heavily-packaged, processed and canned foods 
have higher levels of bisphenol A. In our study, we cannot exclude that higher urinary 
concentration of bisphenol A is a surrogate for factors predictive of child overweight such as 
maternal and child (when food diversification began) eating behaviors, rather than a direct 
cause of overweight (Figure 17). We were limited in studying confounding of the observed 
associations between bisphenol A and child postnatal weight by eating behaviors because we 
only had an estimation of the mother and child caloric intake rather than data on the kind of 
food (canned, processed or fresh food) they usually eat. In addition, data on the child and 
mother alimentation were collected by questionnaires and our estimation are likely to suffer 
from lack of precision. Nevertheless, in our study the association of maternal pregnancy 
bisphenol A level with child weight at 12 months was weakened by adjustment for the child 
caloric intake at 8 months, which is suggestive of confounding by child diet. Adjustment for 
maternal caloric intake did not affect the association.  
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Figure 17: Assumed associations of maternal pregnancy bisphenol A level with child weight 
at 12 months and potential confounding by maternal and child eating behaviors.  
 
 
 Some of our findings, including the negative association between triclosan and head 
circumference at birth and the positive association between benzophenone-3 and weight at 
birth were consistent with those previously reported in a smaller subsample of the EDEN 
cohort (Gona_PE study, chapter II, paragraph II.2). However, the negative associations 
between dichlorophenols and weight at birth observed among the 191 mother-child pairs from 
the EDEN cohort (Gona_PE study) were not replicated in the largest PEnDevE group             
(n = 520); a few associations not observed in the Gona_PE population also appeared (e.g., 
positive association between parabens and weight at birth). Differences in findings between 
our two studies might be explained by 1) random variations, we explored a high number of 
associations and we cannot exclude that a part of our findings are due to chance; 2) exposure 
measurement errors; our results might be biased because of exposure misclassification 
resulting from the use of one urine sample to assess exposure to short half-life chemicals (this 
issue is further discussed and studied in chapter III). Less likely sources of finding differences 
across our studies are 3) confounding; we indeed cannot discard that unmeasured factors 
which confound the associations between phenols and birth outcomes differed across 
subpopulations. However both subpopulations are from the EDEN cohort and we did not 
observed strong differences between them; 4) difference in urine processing; phenol 
measurements were performed in 2008 for the Gona_PE study and in 2011 for the PEnDevE 
study. Differences in urine processing, which may differently impact the phenol measured 
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concentrations in both subpopulations, might have occurred. However, the fact that all 
measurements were performed by the same laboratory (CDC, Atlanta, USA) and that we did 
not observe strong differences in concentration distributions between samples analyzed in 
2008 and 2011 were not in favor of that explanation.  
 Errors in outcome measurements will also impact effect estimates. We indeed 
observed different results using head circumference measured at birth rather than head 
circumference measured in duplicate few days after birth. Because head circumference could 
be distorted by the labor of giving birth (Bronfin 2001), we recommend to use a measure of 
head circumference performed few days after birth rather than at birth.  
 Strengths of the study are the prospective design, allowing exposure assessment during 
one of the biologically relevant windows (fetal period); the use of repeated measurements of 
growth during fetal and early postnatal life and the sample size, larger than those of the 
previous studies (Philippat et al. 2012; Snijder et al. 2013; Wolff et al. 2008). One of the main 
limitations is the availability of only one urine sample during pregnancy in the EDEN cohort 
to assess phenol concentrations.  
5. Conclusion  
 Our study lends support to a potential effect of prenatal exposure to some phenols on 
pre- and early post-natal growth. However, because of the short half-life of the studied 
phenols and the likely episodic nature of the exposures, our findings may be affected by 
exposure misclassification. Replications are needed in other populations with repeated urine 
samples during pregnancy. 
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Estimation des expositions prénatales aux phénols et aux phtalates : questions méthodologiques  
Contexte : Les phénols et les phtalates sont rapidement métabolisés et éliminés dans les urines qui sont 
de ce fait, couramment utilisées dans les études épidémiologiques pour estimer l'exposition à ces 
composés (dosage de biomarqueurs). Dans le cadre des études s'intéressant aux expositions prénatales 
c'est l'urine maternelle, recueillie en général un faible nombre de fois pendant la grossesse (1 à 3), qui 
est utilisée. L'utilisation de biomarqueurs d'exposition permet de prendre en compte l'ensemble des 
sources d'exposition mais est, dans certain cas, associée à de l'erreur de mesure. Du fait de la courte 
demi-vie dans l'organisme des composés étudiés et de la nature épisodique des expositions, les 
concentrations urinaires de phénols et de phtalates sont susceptibles de varier au cours du temps et il 
est probable qu'un faible nombre de mesures ne reflète qu'imparfaitement l'exposition durant la 
grossesse entière. Lorsque que ce travail de thèse a été initié, une variabilité importante avait été 
reportée pour les concentrations de bisphénol A pendant la grossesse mais aucune étude concernant les 
autres phénols n'avait été publiée. 
 
D'autres matrices tel que le méconium ou le liquide amniotique pourraient être plus proche de 
l'exposition fœtale que l'urine maternelle, néanmoins elles n'ont été que très peu utilisées en 
Epidémiologie Environnementale. Le bisphénol A et le 2,5-dichlorophénol ont déjà été détectés dans 
des échantillons de liquide amniotique recueillis auprès de femmes enceintes recevant une 
amniocentèse dans le cadre de leurs soins prénataux. Cependant, à notre connaissance, les autres 
phénols n'ont jamais été dosés dans ce liquide et aucune étude n'a comparé les concentrations de 
phénols dosées dans le liquide amniotique et l'urine maternelle recueillie en cours de grossesse.  
 
Objectifs : Nous avons étudié la variabilité des concentrations urinaires de phénols pendant la 
grossesse et la relation entre les niveaux dosés dans les urines et le liquide amniotique recueillis le 
même jour, chez des femmes enceintes de la ville de New York. 
 
Méthodes : Soixante et onze femmes se présentant pour une amniocentèse ont été incluses. Le liquide 
amniotique restant à la fin des tests cliniques a été utilisé pour cette étude. Un échantillon d'urine 
maternelle a été recueilli le jour de l'amniocentèse, puis à deux reprises durant la grossesse. Les 
phénols suivants : 2,4 et 2,5-dichlorophénol, bisphénol A, triclosan, benzophénone-3, méthyle, éthyle, 
propyle et butyle parabènes ont été dosés dans les urines et le liquide amniotique par le Center for 
Disease Control and Prevention (Atlanta, USA).  
 
Résultats : Dans l'ensemble, le pourcentage de détection des phénols dans le liquide amniotique était 
faible, seuls la benzophénone-3 et le propylparabène ont été détectés dans plus de la moitié des 
échantillons. Le bisphénol A a été détecté dans seulement deux échantillons de liquide amniotique. 
Les concentrations de benzophénone-3 et de propyle parabène dosées dans le liquide amniotique et 
l'urine de la mère recueillie le jour de l'amniocentèse, étaient positivement associées. En ce qui 
concerne la variabilité des concentrations urinaires, le Coefficient de Corrélation Intra-classe (CCI) 
variait entre 0,48 et 0,61 pour la plupart des phénols, sauf pour le bisphénol A (CCI = 0,11). 
 
Discussion : Les taux de détection des phénols dans le liquide amniotique étaient faibles et seuls la 
benzophénone-3 et le propyle parabène ont détectés dans plus de 50 % des échantillons de liquide 
amniotique. Pour ces deux phénols, une corrélation positive a été observée entre les concentrations 
dosées dans le liquide amniotique et l'urine maternelle. La variabilité temporelle observée dans notre 
étude pour les concentrations urinaires de phénols suggère qu'il est nécessaire de recueillir plusieurs 
échantillons d'urine pour évaluer de façon correcte l'exposition aux phénols pendant toute la grossesse. 
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I. Prenatal exposure to short half-life chemicals: concentrations in 
amniotic fluid and variability in phenol urinary concentrations during 
pregnancy6. 
1. Aims of the chapter  
 Our objectives were to assess the relationship between phenol biomarker 
concentrations measured in maternal urine and amniotic fluid collected on the same day, and 
to study the temporal variability in urinary phenol concentrations over the course of 
pregnancy. A secondary aim was to evaluate if concentration standardization for collection 
conditions could improve reliability in phenol concentrations during pregnancy. 
2. Population and methods  
a) Study population  
 The Study of Advanced Reproductive Age and Environmental Health (SARAEH) 
recruited 97 women who were referred for amniocentesis screening at the Mount Sinai 
Medical Center in New York, NY. Recruitment occurred between 2005 and 2008. Study 
eligibility requirements were fluency in English or Spanish, maternal age between 18 and 40 
years, singleton pregnancy and intent to deliver at Mount Sinai Hospital. Women were 
approached for participation in the waiting area prior to their amniocentesis and provided their 
first spot urine sample immediately following their procedure. Two additional spot urine 
samples were collected from the participant later in their pregnancy, with collections planned 
at least two weeks apart and the final sample collected after the 27th week of gestation. This 
current study includes participants providing all three urine samples (n=71). Of these, an 
amniotic fluid sample was available for 69 participants (97%). Following delivery, medical 
records were abstracted for information pertaining to fetal health.  
 This study was approved by the Mount Sinai Program for the Protection of Human 
Subjects and women gave informed consent to be part of the study. The involvement of the 
Centers for Disease Control and Prevention (CDC) laboratory was determined not to 
constitute engagement in human subjects research. 
                                                 
6 This part of the thesis has been done in collaboration with the Pr Stephanie Engel during my stay at the 
University of North Carolina, Chapel Hill, USA (January to June 2012). 
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b) Exposure assessment 
 Following collection, amniotic fluid was delivered to the Mount Sinai Medical Center 
clinical cytogenetics laboratory for standard clinical care processing, which includes 
centrifugation and cell separation. Before being released for research purposes amniotic fluid 
supernatant was stored in polypropylene containers at -20 °C (time range: 0 to 38 weeks). 
Once released, SARAEH research personnel thawed the amniotic fluid overnight at 4°C, and 
then aliquoted the supernatant into 2 mL cryovials for storage at -80 °C. Following collection, 
urine was immediately aliquoted into 2 mL cryovials and stored at -80 °C. Urine and amniotic 
fluid samples were shipped overnight on dry ice to the CDC for measurements of 
environmental phenols (free + conjugated forms): 2,4- and 2,5-dichlorophenols, bisphenol A, 
benzophenone-3, triclosan, and methyl-, ethyl-, propyl- and butyl-parabens7. Phenols were 
quantified using online solid phase extraction–high performance liquid chromatography–
isotope dilution tandem mass spectrometry (Ye et al. 2005). Specific gravity of urine was 
measured using a handheld refractometer in each thawed aliquot prior to shipment to the 
CDC, with the exception of 11 urine samples which had specific gravity measured at the 
CDC. Creatinine concentration in urine was measured using an enzymatic reaction at the 
CDC.  
c) Statistical analyses 
 Analyses were conducted on natural-log-transformed concentrations (ln). For phenols 
detected in at least 50% of the samples we replaced amniotic fluid concentrations below the 
limit of detection (LOD) by the instrumental reading values. We replaced the undetectable 
urine concentrations by LOD/√2 because the instrumental reading values were not available. 
The following formula was used to correct urinary concentrations for specific gravity:         
CSG = C × [(SGmean – 1)/(SG – 1)], where CSG is the specific gravity corrected biomarker 
concentration, SGmean is the specific gravity arithmetic mean in our population and C is the 
measured biomarker concentration. Creatinine corrected concentrations were computed by 
dividing the phenol concentrations by the creatinine concentration. 
                                                 
7 Biomarkers of exposure to phthalates have also been measured in maternal urine and aminotic fluid. K. 
Hoffman (University of North Carolina, Chapel Hill, USA) is working on the data. Analyses are not finalized yet 
and so are not presented in this thesis. 
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d) Relation between maternal urine and amniotic fluid biomarker concentrations 
 We used graphical techniques to compare amniotic fluid and urinary biomarker 
concentrations collected on the same day, and computed ratios of urinary (not corrected for 
urine dilution) to amniotic fluid concentrations.  
 For benzophenone-3 and propylparaben, the two phenols detected in more than 50% 
of the amniotic fluid samples, we computed Spearman correlation coefficients between 
urinary (uncorrected and specific gravity corrected) and amniotic fluid concentrations, 
collected on the same day. To explore the possible predictors of amniotic fluid benzophenone-
3 and propylparaben concentrations, we performed Tobit regression models for a left-
censored dependent variable (Lubin et al. 2004). We regressed amniotic fluid biomarker 
concentrations on maternal urinary concentrations taken on the same day, fetal sex, 
gestational age at amniocentesis (<17, 17 to 18.9, ≥ 19 gestational weeks), maternal age    
(<31, 31 to 35.9, ≥ 36), maternal pre-pregnancy body mass index (BMI, <25, ≥ 25), race 
(white versus non-white), pregnancy complications related to placental function (including 
preeclampsia, placenta previa, small placenta, oligohydroamnios and chorioamnionitis), and 
time that elapsed between amniotic fluid collection and processing (≤ 4, 4 to 16, 16 to 20,       
> 20 weeks). Models were simultaneously adjusted for all of these factors. We also performed 
sensitivity analyses excluding four women with abnormal amniotic fluid conditions, namely 
oligohydramnios and polyhydramnios. 
e) Variability in urinary concentrations  
 We evaluated variability in measures of dilution in spot urine samples across 
pregnancy by plotting creatinine urinary concentrations and urine specific gravity as a 
function of gestational age. To assess variability in phenol concentrations across pregnancy, 
we computed Intraclass Correlation Coefficients (ICCs) between phenol concentrations, 
measured in the three spot urine samples, using random intercept linear mixed models (Rabe-
Hesketh 2008). The ICC is the ratio of the between-woman variability to the total variability 
(between- plus within- woman variability). We also computed Spearman correlations between 
pairs of phenol concentrations from the first, second and third spot urine collections. Our 
interpretation for ICCs and Spearman correlation coefficients was based on the following 
general guidelines: < 0.4: weak association, 0.4 to 0.6: moderate, > 0.6: good. Analyses of 
urinary concentration variability were performed using uncorrected, specific gravity-corrected 
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and creatinine-corrected concentrations. We were missing creatinine concentrations for 11 of 
the first spot urine samples. Thus, analyses based on creatinine-corrected concentrations were 
restricted to 60 women with complete creatinine and environmental phenol biomarker data.  
 In a secondary analysis, we computed Spearman correlations among pairs of urine 
samples collected in specific time intervals: fewer than 4 weeks apart, 4-6 weeks apart,         
6-10 weeks apart, 10-12 weeks apart, 12-14 weeks apart, 14-16 weeks apart, and greater than 
16 weeks apart. Samples were not independent within a given category (e.g., women can be 
included twice in the same category if they have equally spaced intervals between their three 
collections). 
f) Influence of sampling conditions on phenol urinary concentrations 
 Finally, we estimated associations between urinary phenol biomarker concentrations 
and collection conditions (gestational age at collection, hour, day and season of sampling, 
urine specific gravity) using a random intercept linear mixed model simultaneously adjusted 
for each collection condition along with BMI, maternal age, year of collection, maternal 
education and maternal race (Mortamais et al. 2012). We used the measured urinary 
biomarker concentrations and the estimated effects of collection conditions on the measured 
urine concentrations to predict concentrations that would have been observed if all samples 
had been collected under the same conditions (concentrations standardized for collection 
conditions (Mortamais et al. 2012)). We only considered collection conditions associated with 
the measured concentration (p < 0.2) for the standardization. We evaluated whether 
standardization of urinary concentrations improved the calculated reliability across repeated 
spot urine samples by computing ICCs using concentrations standardized for collection 
conditions. 
All analyses were performed using STATA/SE, version 12 (StataCorp, College Station, TX, 
USA).
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3. Results 
a) Study population and exposure 
Women were 35.5 years old on average; mostly white (72%) and 55% went to graduate 
school (Table 16). The first, second and third urine samples were collected on average 
(±standard deviation (SD)), at 17.6 (±1.6), 22.8 (±3.5) and 32.8 (±3.1) gestational weeks. The 
average (±SD) time elapsed between urine sampling was 5 (±2.8) weeks between the first and 
second samples and 10 (±3.9) weeks between the second and third samples. 
Table 16: Characteristics of the 71 women with three repeated urine measurements during 
pregnancy (SARAEH study, 2005 to 2008). 
Characteristic N % 
 
Maternal age (years) 
< 30 5 7 
30 to 34.9 21 30 
≥ 35  45 63 
Race 
White 51 72 
Black 5 7 
Hispanic 11 15 
Asian 3 4 
American Indian 1 1 
Pre-pregnancy BMI (kg/m2) 
< 18.5 3 4 
18.5 to 24.9 53 75 
≥ 25 15 21 
Maternal education  
High school 9 13 
Any college 23 32 
Graduate school, graduate degree 39 55 
Conception methods 
Reproductive Techniques 3 4 
Natural 68 96 
Amniotic fluid sampling reason 
Advanced Maternal Age 49 69 
Abnormal Genetic Screen 10 14 
Elective 11 15 
Other 1 1 
 
 Overall, the first sample was collected later in the day than the others (the number of 
women with urine collections before 10 a.m. was 1, 15 and 16 for the first, second and third 
samples, respectively). With the exception of ethylparaben, the medians of the uncorrected 
phenol concentrations, as well as creatinine concentrations and specific gravity, were lower in 
the first urine samples as compared to samples collected later in pregnancy (Table 17). 
Detection frequencies of environmental phenols in urine were high; 2,5-dichlorophenol, 
Amniotic fluid concentrations and Variability in urine concentrations: Results  
98 
 
benzophenone-3, methyl- and propyl- parabens were detected in at least 99% of the samples 
(Table 17). Detection frequencies in amniotic fluid were much lower; only benzophenone-3 
and propylparaben were detectable in at least half of the samples. Bisphenol A was detected 
only in two amniotic fluid samples at a concentration equal to the LOD (0.4 µg/L); it was 
detected in 62% of the urine samples collected on the same day (Table 17).  
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Table 17: Distribution of phenol concentrations (µg/L) measured in amniotic fluid and in urine collected at three time periods during pregnancy 
among women of the SARAEH study, 2005 to 2008.  
 Analyte 
  Urine (n=71)a   
Amniotic fluid (n=69)b (2) 
  
Ratio (1)/(2)c 
1st sample (1)   2nd sample    3rd sample      
  LOD 
% 
>LOD 5th 50th 95th   
%> 
LOD 5th 50th 95th   
%> 
LOD 5th 50th 95th   
%> 
LOD 5th 50th 95th   5th 50th 95th 
Phenols (µg/L)       
2,4-DCP 0.2 68 <LOD 0.6 5.7 94 <LOD 1.1 8.3 
 
93 <LOD 1.0 14 
 
1c <LOD <LOD LOD 1.4 1.4 9 
2,5-DCP 0.2 100 0.8 7.5 178   100 1.8 12.8 364 
 
100 1.7 14.2 466  
 
16 <LOD LOD 5.2 3.5 297 1756 
BPA 0.4 62 <LOD 0.6 7.0   92 <LOD 1.8 9.5   82 <LOD 1.2  5.0   3 <LOD <LOD LOD 1.4 12 85 
BP3 0.4 100 4.1 53.5 2220   100 5.7 77 6740   100 8.9 76.1  3180   61 <LOD 0.8 15.7 8 110 1648 
TCS 2.3 79 <LOD 6.5 789   75 <LOD 15.4 734   80 <LOD 16.2  514   6 <LOD <LOD 19.4 1.4 16 354 
MP 1.0 100 9.6 100 985   100 19 272 1670   100 9.7 156  1830   42 <LOD <LOD 3.3 23 196 827 
EP 1.0 59 <LOD 2.8 58 65 <LOD 4.5 347 59 <LOD 1.7 144 0 <LOD <LOD <LOD 3.5 30 304 
PP 0.2 100 0.5 28.7 424   100 1.6 45.6 531   99 0.8 36.5  589   58 <LOD 0.3 1.4 7 116 2130 
BP 0.2 70 <LOD 1.5 26   85 <LOD 1.9 56.3   73 <LOD 1.7  58.2   6 <LOD <LOD 0.3 1.4 22 179 
Markers of urine dilution                 
Creat (mg/dL)d 3.5 100 13.7 44.1 256   100 15.3 86.8 221   100 16 90.9 175     
Specific gravity     1.003 1.008 1.026     1.003 1.02 1.03     1.004 1.015 1.026                   
a Concentrations not corrected for urine dilution, concentrations below LOD were replaced by LOD/√2. 
b Concentrations below LOD were replaced by instrumental reading values. 
c 2,4-DCP was only assessed in 11 amniotic fluid samples. 
d n = 60, creatinine concentration was missing for 11 urine samples from the first sampling. 
Abbreviations: DCP: dichlorophenol, BP: butylparaben, BPA: bisphenol A, BP3: benzophenone-3, creat: creatinine, EP: ethylparaben, MP: methylparaben, PP, 
propylparaben, TCS: triclosan. 
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b) Relation between maternal urine and amniotic fluid biomarker concentrations 
 Among women with no abnormal amniotic fluid condition (i.e. excluding our four 
subjects with oligohydramnios and polyhydramnios), ratios of urine concentration in the first 
sample (not corrected for urine dilution) to amniotic fluid concentration were greater than one 
(Table 17). However, we observed higher benzophenone-3 and butylparaben concentrations 
in amniotic fluid than in the first urine sample for one women with oligohydramnios (urine - 
amniotic fluid ratio = 0.2 for benzophenone-3 and 0.7 for butylparaben). Median urinary 
concentrations of phenol biomarkers, whether corrected or not for urinary dilution, were 
higher in women with detectable amniotic fluid concentrations, with the exception of 
butylparaben, which was detected in only four amniotic fluid samples (Figure 18).  
Figure 18: Box plots of the distribution of specific-gravity corrected urinary phenol 
concentrations are presented according to whether detectable levels of phenol metabolites 
were measured in amniotic fluid taken at the same time. Bisphenol A, 2,4-dichlorophenol and ethyl 
paraben were not displayed in the graphic form because they were detected in too few amniotic fluid samples. 
Lower whiskers represent the lowest value within 1.5 IQR of the 25
th
 percentile. The bottom of box is the 25
th
 
percentile, the line is the median, and the top of box is the 75
th
 percentile. Upper whisker is the highest value 
within 1.5 IQR of the 75
th
 percentile. Dots represents outlier values. 
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 The correlation between amniotic fluid and urinary concentration (uncorrected for 
urine dilution) was moderate for benzophenone-3 (ρ = 0.53) and weak for propylparaben      
(ρ = 0.32). Correction for urinary dilution did not change these correlation. After adjustment, 
for each one-unit increase in ln-transformed, specific gravity corrected urinary biomarker 
concentration, ln-amniotic fluid concentration increased by 0.52 (95% CI: 0.3; 0.7) for 
benzophenone-3, and by 0.36 (95% CI: 0.2; 0.5) for propylparaben (Table 18). Including 
urine specific gravity as a covariate instead of using phenol concentrations corrected for 
specific gravity did not change the results (data not shown). There was no clear association 
between gestational age at urine collection and amniotic fluid concentrations, although there 
was a limited range of gestational ages. After adjustment for the urinary concentration of the 
considered phenol, maternal age was negatively associated with amniotic concentrations of 
benzophenone-3 (p for trend = 0.09). Propylparaben amniotic fluid concentration varied 
according to fetal sex (Table 18) and we observed lower amniotic fluid concentrations among 
girl fetuses as compared to boy fetuses (β = -0.56; 95% CI: -1.2; 0.1). Compared to a storage 
time shorter than 4 weeks, we observed higher propylparaben concentration in amniotic fluid 
samples stored at -20°C for 4 to 16 weeks before being processed (β = 0.93; 95% CI: 0.0; 1.9, 
n = 12 samples); no change was observed for longer storage times (Table 18). Excluding four 
women with abnormal amniotic fluid conditions (oligohydramnios and polyhydramnios) did 
not change the positive associations observed between urine and amniotic fluid biomarker 
concentrations. 
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Table 18: Adjusted associations between ln-transformed amniotic fluid concentrations of 
selected phenolsa and their potential predictors among 68 pregnant women from the SARAEH 
study, 2005 to 2008. 
Characteristics 
  
  
Change in BP3 AF 
concentration  
(ln-unit, (µg/L))  
Adjusted BP3 
AF 
concentration 
(GM, µg/L) 
p-
trendb   
Change in PP AF 
concentration 
Adjusted PP 
AF 
concentration 
(GM, µg/L) 
p-
trendb  (ln-unit, (µg/L))  
n β 95% CI   β 95% CI 
Urine concentration  
 (ln-unit, µg/L)c   0.5 [0.3;0.7]     0.4 [0.2; 0.5]   
Time of amniotic fluid 
storage at -20 C (weeks) 0.35 0.35 
≤ 4 17 Reference 0.71 Reference 0.20 
4 to 16  12 -0.3 [-1.6; 1.0] 0.54 0.9 [0.0; 1.9] 0.50 
16 to 20 14 -0.4 [-1.7; 0.9] 0.48 0.0 [-0.9; 1.0] 0.20 
> 20 27 -0.6 [-1.9; 0.7] 0.39 -0.3 [-1.3; 0.6] 0.14 
Gestational age at 
sampling (weeks) 0.71 0.49 
15 to 16.9 31 Reference 0.51 Reference 0.20 
17 to 18.9  26 0.1 [-0.7;0.9] 0.57 -0.2 [-0.8; 0.4] 0.17 
19 to 23 11 -0.4 [-1.8; 1.1] 0.36 0.6 [-0.4; 1.5] 0.35 
Maternal age (year)  0.09 0.56 
<31 10 Reference  1.03 Reference 0.18 
31 to 35.9  24 -0.6 [-1.8; 0.7] 0.58 0.1 [-0.9; 1.0] 0.20 
36 to 40  34 -1.0 [-2.3; 0.2] 0.37 0.2 [-0.7; 1.1] 0.23 
BMI 0.67 0.34 
< 25 53 Reference 0.53 Reference 0.23 
≥ 25 15 -0.2 [-1.3; 0.9] 0.42 -0.4 [-1.2; 0.4] 0.15 
Race  
White  48 Reference 0.63 Reference 0.20 
Non-white 20 -0.8 [-1.9; 0.3] 0.29 0.2 [-0.6; 0.9] 0.23 
Pregnancy complications 
related to placentad 
No 58 Reference 0.50 Reference 0.23 
Yes 10 -0.1 [-1.3; 1.2] 0.48 -0.8 [-1.7; 0.1] 0.11 
Baby sex 
Boy 36 Reference 0.59 Reference 0.27 
Girl 32 -0.4 [-1.2; 0.4] 0.41     -0.6 [-1.2; 0.1] 0.15    
a  Phenols detected in at least 50% of the amniotic fluid samples.  
b p-trend was estimated using categorical variables whose values corresponded to the category-specific median 
value (Rothman et al. 2008).  
c Corrected for specific gravity. 
d Including oligohydroamnios, choriamniotis, small placenta, placenta praevia and pre-eclampsia. 
Abbreviations: BP3: benzophenone-3, GM: geometric mean, PP: propyl paraben. 
c) Variability in urinary concentrations 
We observed similar variations in urinary specific gravity and creatinine 
concentrations throughout pregnancy (Figure 19), and both measures of urinary dilution were 
highly correlated (spearman correlation coefficient = 0.93).  
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Figure 19: Means of urine specific gravity (A) and urine creatinine concentrations (B) by 
gestational age (SARAEH study, 2005 to 2008). 
  
I are confidence intervals. 
n = 213 urine samples for specific gravity and 202 for creatinine. 
ICCs and Spearman correlations using phenol concentrations corrected for creatinine 
or specific-gravity were very similar to one another, and with the exception of ethylparaben 
and bisphenol A, higher than those based on concentrations that were not corrected for urine 
dilution (Table 19, Table 23). ICCs were moderate to good, and of comparable magnitude for 
2,4-, 2,5-dichlorophenol, benzophenone-3, triclosan, methyl-,ethyl- propyl- and butyl-
parabens (Table 19). For these phenols, we observed similar trends with the Spearman 
correlation coefficients, which ranged from 0.41 to 0.77 (specific-gravity corrected 
concentrations), 0.40 to 0.86 (creatinine corrected concentrations) and 0.35 to 0.70 
(concentrations not corrected for urine dilution, Table 19). ICCs for bisphenol A ranged 
between 0.11 (specific gravity corrected) to 0.23 (uncorrected). Although collections of spot 
urines were planned to occur at least two weeks apart, four women had less than a two week 
interval between successive collections. Excluding these women did not change our results 
(data not shown). 
 
 
 
A B 
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Table 19: Intraclass Correlation Coefficients (ICC) for phenol biomarker concentrations 
measured in urine samples collected at several times during pregnancy (n = 71 women from 
the SARAEH study, 2005 to 2008). 
Analyte 
Specific gravity 
corrected concentrationsa 
Creatinine 
corrected 
concentrationsb 
Uncorrected 
concentrationsa 
Concentrations 
standardized for 
collection conditionsa,c 
2,4-dichlorophenol 0.60 0.48 0.47 0.60 
2,5-dichlorophenol 0.61 0.62 0.52 0.60 
Bisphenol A 0.11 0.14 0.23 0.15 
Benzophenone-3 0.62 0.70 0.57 0.61 
Triclosan 0.58 0.61 0.56 0.60 
Methylparaben 0.61 0.61 0.52 0.62 
Ethylparaben 0.48 0.44 0.48 0.48 
Propylparaben 0.55 0.54 0.51 0.54 
Butylparaben 0.56 0.64 0.54 0.61 
a n = 213 samples  
b n = 180 samples  
c All concentrations were standardized for specific gravity. Bisphenol A concentration was additionally 
standardized for gestational age at sampling and sampling hour. Butylparaben, triclosan and 2,4-dichlorophenol 
were additionally standardized for hour of sampling. Benzophone-3 and methylparaben were additionally 
standardized for hour and season of sampling, propylparaben for season of sampling and ethylparaben for day of 
sampling. 
 Correlations between urinary concentrations measured within different time intervals 
are shown in Table 20. Our expectation was that correlations would be higher for samples 
collected with shorter intervening time intervals, and longer for samples collected with longer 
intervening time intervals. As expected, for 2,4-, 2,5-dichlorophenol and benzophenone-3, we 
overall observed lower coefficients (i.e., less reliability) for samples with longer time intervals 
between collections. However, correlations for bisphenol A continued to be weak, regardless 
of the length of the intervening time between sample collections.   
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Table 20: Spearman correlation coefficients between urine samples collected at specific time 
intervals using specific gravity corrected (A), creatinine corrected (B) and uncorrected (C) 
phenol concentrations (SARAEH study, 2005 to 2008). 
Interval between samples (weeks) 
Analytes  <4   4 to 6   6 to 10   10 to 12   12 to 14   14 to 16   ≥ 16 
A) Specific gravity corrected concentrations 
Nb of sample pairs  32 32 30 36 24 29 30 
2,4-dichlorophenol 0.79 0.71 0.70 0.67 0.69 0.49 0.29 
2,5-dichlorophenol 0.83 0.71 0.70 0.61 0.59 0.71 0.40 
Bisphenol A 0.29 -0.10 0.34 0.25 0.43 0.38 -0.32 
Benzophenone-3 0.80 0.74 0.59 0.7 0.75 0.58 0.29 
Triclosan 0.57 0.70 0.71 0.46 0.70 0.28 0.35 
Methyl paraben 0.59 0.56 0.61 0.58 0.70 0.61 0.63 
Ethyl paraben 0.58 0.45 0.44 0.49 0.48 0.48 0.26 
Propyl paraben 0.51 0.43 0.64 0.37 0.38 0.62 0.56 
Butyl paraben 0.75 0.55 0.58 0.4 0.61 0.69 0.29 
B) Creatinine standardized concentrationsa 
Nb of sample pairs  28 25 29 29 21 22 26 
2,4-dichlorophenol 0.88 0.65 0.63 0.69 0.41 0.41 0.22 
2,5-dichlorophenol 0.77 0.89 0.71 0.66 0.44 0.81 0.38 
Bisphenol A 0.22 0.05 0.07 0.19 0.38 0.53 -0.08 
Benzophenone-3 0.85 0.85 0.71 0.73 0.82 0.65 0.47 
Triclosan 0.64 0.68 0.54 0.48 0.74 0.56 0.49 
Methyl paraben 0.60 0.61 0.57 0.51 0.58 0.65 0.58 
Ethyl paraben 0.48 0.46 0.40 0.30 0.27 0.58 0.42 
Propyl paraben 0.52 0.45 0.52 0.36 0.37 0.78 0.58 
Butyl paraben 0.75 0.60 0.64 0.41 0.62 0.76 0.41 
C) Crude concentrations 
Nb of sample pairs  32 32 30 36 24 29 30 
2,4-dichlorophenol 0.67 0.75 0.40 0.58 0.43 0.29 0.16 
2,5-dichlorophenol 0.84 0.64 0.52 0.57 0.49 0.40 0.32 
Bisphenol A 0.43 0.14 0.48 0.41 0.36 0.22 0.06 
Benzophenone-3 0.71 0.76 0.53 0.64 0.56 0.58 0.32 
Triclosan 0.67 0.67 0.51 0.51 0.69 0.31 0.49 
Methyl paraben 0.50 0.50 0.53 0.56 0.6 0.44 0.63 
Ethyl paraben 0.46 0.54 0.41 0.44 0.57 0.51 0.35 
Propyl paraben 0.57 0.32 0.64 0.45 0.55 0.49 0.51 
Butyl paraben 0.72   0.63   0.63   0.49   0.49   0.64   0.28 
a Creatinine concentrations were missing for 11 samples 
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Table 21: Spearman correlation coefficients between pairs of ln-transformed phenol concentrations from the first, second and third samplings 
(specific gravity corrected (A), creatinine corrected (B) and uncorrected for urine dilution (C)), SARAEH study, 2005 to 2008. 
  
2,4-
dichlorophenol  
2,5-
dichlorophenol  
Bisphenol A 
 
Benzophenone-
3  
Triclosan 
 
Methylparaben 
 
Ethylparaben 
 
Propylparaben 
 
Butylparaben 
Sampling 1st 2nd 1st 2nd 1st 2nd 1st 2nd 1st 2nd 1st 2nd 1st 2nd   1st 2nd 1st 2nd 
A) Specific gravity corrected concentrations (n = 71 women, 213 samples) 
2nd 0.70 0.75 0.10 0.77 0.57 0.53 0.51 0.48 0.59 
3rd 0.54 0.62 0.56 0.63 0.26 0.18 0.53 0.64 0.49 0.61 0.63 0.73 0.41 0.53 0.53 0.54 0.49 0.61 
B) Creatinine corrected concentrations (n = 60 women, 180 samples) a 
2nd 0.74 0.84 0.15 0.86 0.6 0.55 0.42 0.47 0.61 
3rd 0.41 0.56 0.58 0.63 0.39 0.07 0.65 0.70 0.57 0.57 0.64 0.68 0.40 0.44 0.57 0.55 0.61 0.71 
C) Crude concentrations (n = 71 women, 213 samples)  
2nd 0.59 0.70 0.25 0.68 0.59 0.47 0.48 0.45 0.59 
3rd 0.35 0.56   0.43 0.59   0.42 0.28   0.47 0.60   0.53 0.58   0.58 0.58   0.48 0.47   0.56 0.50   0.52 0.62 
a Creatinine concentrations were missing for 11 samples. 
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d) Influence of collection conditions on phenol urinary concentrations 
 Regarding the associations between collection conditions and phenol urinary 
concentrations; specific gravity was positively associated with all urinary phenol biomarker 
concentrations; association was weaker for ethylparaben (p-value of 0.1) compared to the 
other phenols (p-values < 0.001, Table 22). Similar associations were observed using 
creatinine concentration (data not shown). We observed heterogeneity in 2,4-dichlorophenol, 
benzophenone-3, triclosan and butylparaben concentrations according to hour of sampling 
(Table 22). Benzophenone-3 concentrations were higher in samples collected in spring and 
summer (adjusted geometric mean: 110 µg/L) than in those collected in fall and winter 
(adjusted geometric mean: 69 µg /L).  
 Correlation coefficients between urinary concentrations standardized for collection 
conditions (Mortamais et al. 2012) and urinary concentrations corrected for specific gravity 
were high (Spearman correlation coefficients > 0.96). The use of concentrations standardized 
for collection conditions did not notably improve ICCs between spot urine collections      
(Table 19). 
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Table 22: Adjusteda geometric mean of urinary phenol concentrations according to collection conditions among 213 urine samples from the 71 
women of Study of Advanced Reproductive Age and Environmental Health, 2005 to 2008. 
Collection 
conditions n 
2,4-DCP   2,5-DCP   BPA   BP3   TCS   MP   EP   PP   BP 
GM p b   GM p b   GM p b   GM p b   GM p b   GM p b   GM p b   GM p b   GM p b 
Gestational age (weeks) 0.39  0.49 0.01  0.49 0.3 0.44 0.87 0.25 0.64 
≤ 18 c 54 0.7 12.2 1.0 105 15.8 159 4.1 38.3 1.8 
18.01 to 22 54 0.8 11.6 1.4 85.4 17.0 162 4.8 31.1 1.8 
22.01 to 32 58 0.9 13.8 1.3 71.5 15.6 123 3.9 22.8 1.4 
> 32  47 0.9 15.5 1.0 85.3 25.5 143 4.0 31.1 2.1 
Sampling season  0.87 0.33 0.3 0.02 0.98 0.17 0.30 0.1 0.31 
Oct-March  c 112 0.8 12.2 1.1 68.7 17.8 161 4.7 35.6 1.9 
April-Sep 101 0.8 14.2 1.3 110 17.9 130 3.7 25.1 1.5 
Hour of sampling  0.04 0.6 0.12 0.02 0.01 0.17 0.91 0.47 0.01 
8.00 to 11.00  c 67 1.0 14.0 1.2 116 20.6 182 4.1 33.4 2.6 
11.01 to 13.00 56 0.9 13.2 1.0 56.8 25.0 136 4.7 35.1 1.9 
13.01 to 15.00 56 0.8 13.7 1.4 100 16.4 126 3.8 24.6 1.2 
15.01 to 18.00 34 0.6 10.5 1.2 71.8 8.8 132 4.2 26.8 1.2 
Day of sampling 0.69 0.45 0.28 0.81 0.95 0.56 0.20 0.75 0.38 
Tuesday to Friday c 176 0.8 13.5 1.2 86.6 17.9 148 4.4 29.7 1.8 
Monday 37 0.8 11.6 1.0 81.8 17.6 133 3.1 32.2 1.4 
Specific gravity  <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.11 <0.001 <0.001 
1.002 to 1.009 c 74 0.4 5.4 0.6 54.5 10.1 69.7 3.3 13.5 1.0 
1.01 to 1.017 75 1.0 15.3 1.4 86.5 23.1 166 3.8 38.3 1.8 
1.018 to 1.036 64 1.8 30.5 2.2 143 25.3 293 6.0 57.8 3.1 
a Linear mixed models were simultaneously adjusted for the collection conditions and also for BMI, maternal age, year of sampling, maternal education and maternal race. 
b p-values of heterogeneity test. 
c Reference category. 
Abbreviations: BP: butlyparaben, BPA: bisphenol A, BP3: benzophenone-3, DCP: dichlorophenol, EP: ethylparaben, MP: methylparaben, PP, propylparaben, TCS: triclosan 
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4. Discussion  
 In our population of pregnant women referred for amniocentesis, the detection 
frequencies of phenol biomarkers in amniotic fluid were low, with only two phenols detected 
in 50% or more of the samples. With the exception of bisphenol A, the reproducibility of 
urine phenol biomarker concentrations in urine collected at three times during pregnancy was 
fairly good (ICCs of 0.48 – 0.62).  
a) Phenol concentrations in maternal urine  
 Urine collected on the day of the amniocentesis tended to be more dilute than those 
collected later; however no specific instructions (with respect to hydration) or procedures 
(e.g., use of intravenous therapy) which could impact urinary dilution was given before or 
during the amniocentesis. Methyl- and propyl- parabens are the most commonly used 
parabens in food and cosmetics (Soni et al. 2005), and as expected, urine concentrations of 
these phenols were higher than those observed for ethyl- and butyl- parabens. Triclosan and 
bisphenol A concentrations were similar; 2,5-dichlorophenol concentrations were lower than 
those reported in a previous mother-child cohort study conducted earlier at the Mount Sinai 
Medical Center (1998 to 2002), and which included predominantly Hispanic and African 
American participants (medians were 11 µg/L for triclosan, 1.3 µg/L for bisphenol A and 53 
µg/L for 2,5-dichlorophenol (Wolff et al. 2008)). Urinary concentrations of parabens were not 
reported in the study published by Wolff et al. Benzophenone-3 urine concentrations observed 
in our study population (medians ranged between 53 and 77 µg/L) were considerably higher 
than those reported in the aforementioned study (median of 7.5 µg/L). It is likely that this is at 
least in part reflective of the different racial/ethnic composition of these two Mount Sinai 
studies, since benzophenone-3 is found in sunscreens.  
b) Phenol concentrations in amniotic fluid  
 While the presence of phenol biomarkers in amniotic fluid highlights the potential for 
direct fetal exposure, the low detection frequency observed for the majority of these 
compounds may be suggestive of low transfer and/or rapid clearance of the phenols in 
amniotic fluid. That being said, we cannot exclude the possibility that the low detection of 
phenol biomarkers in amniotic fluid was the result of processing and/or storage of samples in 
the clinical laboratory prior to being released for research purposes. Ye et al. reported good 
stability of total phenol concentrations in urine stored at -70°C (Ye et al. 2007), but no 
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published data regarding the impact of storage at -20°C, nor data examining the stability of 
biomarker concentrations in amniotic fluid, exist.  
 We detected bisphenol A in only one amniotic fluid sample. Low concentrations of 
bisphenol A in amniotic fluid collected during pregnancy and at birth have been previously 
reported (medians ranged from 0.26 to 1.1 µg/L (Edlow et al. 2012; Engel et al. 2006; Ikezuki 
et al. 2002; Yamada et al. 2002)). In an ex-vivo experimental system, where 7 human 
placentas were in contact with a perfusate enriched in bisphenol A (10 µg/L), authors 
observed rapid transfer of this phenol across the placenta (Balakrishnan et al. 2010); however, 
this concentration was higher than those typically observed in the urine of pregnant women 
from the general population (Woodruff et al. 2011). Regarding the other phenols, in a study of 
20 second trimester amniotic fluid samples from women referred for amniocentesis at a 
Children’s Hospital Central California in Madera (California), Bradman et al. (2003) reported 
lower geometric mean of 2,5-dichlorophenol concentrations (0.39 µg/L) than in our 
population (geometric mean = 0.29 µg/L). To our knowledge, no previous study has examined 
amniotic fluid concentrations of benzophenone-3, triclosan or parabens in humans. 
c) Predictors of amniotic fluid concentrations  
 Women with the highest concentrations of phenols in urine were more likely to have 
detectable concentrations of environmental phenols in amniotic fluid. Because of the high 
percentage of undetectable concentrations, we were only able to evaluate predictors of 
amniotic fluid concentrations for benzophenone-3 and propylparaben, and for these 
substances, maternal urine concentration was found to be a strong predictor of amniotic fluid 
concentration. There have been few comparisons of maternal and fetal exposure for phenolic 
compounds (Ikezuki et al. 2002; Yamada et al. 2002). Ikezuki et al. (2002) compared 
bisphenol A concentration in maternal serum and amniotic fluid, and reported amniotic fluid 
biomarker concentrations (arithmetic mean 8.3 µg/L) about 5 times higher than in maternal 
serum (arithmetic mean 1.5 µg/L). However, a bisphenol A amniotic fluid mean concentration 
of 8.3 µg/L is extraordinarily high relative to values observed in other studies (medians in 
amniotic fluid ranged from 0.26 to 1.1 µg/L (Edlow et al. 2012; Engel et al. 2006; Yamada et 
al. 2002)), raising concerns regarding potential external contamination from environmental 
sources of free bisphenol A. 
 We found no association between gestational age at collection and benzophenone-3 or 
propylparaben amniotic fluid concentrations. However, we were limited in evaluating this 
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relationship by a lack of substantial variability in gestational age at amniocentesis                
(range: 15 to 23 gestational weeks). Two previous studies have reported higher bisphenol A 
concentrations in amniotic fluid collected in the second trimester as compared to later 
pregnancy. However, in these studies, the samples collected in the second and third trimesters 
were from different women who may have had different levels of exposure (Edlow et al. 
2012; Ikezuki et al. 2002). We observed that amniotic fluid concentration of propylparaben 
was lower for  female fetuses compared to male fetuses. This difference may have been due to 
chance, or might suggest sex differences in fetal metabolism or excretion. For example, a 
study of 55 fetuses showed sex-differences in the levels of several mRNA transcripts 
encoding hepatic enzymes (O'Shaughnessy et al. 2011) suggesting that fetal hepatic function 
may differ by sex.  
d) Variability in urinary concentrations 
 The poor reproducibility in bisphenol A concentration measured in serial spot urine 
samples collected during pregnancy is consistent with previous reports (Braun et al. 2012; 
Braun et al. 2011b) and taken together, these findings suggest that substantial exposure 
misclassification might occur in epidemiological studies assessing prenatal bisphenol A 
exposure using a single, or even a few spot urine samples. Exposures to the eight other 
phenols or their precursors appear to be more consistent throughout pregnancy (e.g., use of 
sunscreen, cosmetics, indoor deodorizers); for these we indeed observed a higher degree of 
temporal reproducibility in urinary concentrations, with ICC ranging between 0.5 and 0.6. A 
correlation of 0.6 between several measurements indicates that on average the correlation 
between the concentration from a spot sample and the biologically relevant exposure will be 
moderate. Although a correlation of this magnitude is superior to many rapidly metabolized 
compounds, it may still result in bias due to exposure misclassification. In order to limit the 
effects of this, studies aiming to assess the effects of phenol prenatal exposure on health 
should try to collect repeated urine samples during pregnancy (White et al. 2008). 
  Two previous studies among pregnant women have shown lower ICCs for methyl-, 
propyl- and butyl-parabens (ICCs < 0.5) relative to our population; the authors did not report 
results for ethylparaben (Meeker et al. 2013; Smith et al. 2012). In the study published by 
Meeker et al. (2013), ICCs for the other phenols were also lower than we reported here (0.47, 
0.38 and 0.49 for triclosan, 2,4- and 2,5-dichlorophenol), except for benzophenone-3 for 
which an ICC of 0.62 has been reported. The difference may be attributable to differences in 
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the exposure patterns between study populations or to differences in time elapsed between 
consecutive urinary collections. For example, the first, second and third urine samples were 
collected at gestational weeks 5.8, 20.6 and 33.5 in average in the Smith et al. study compared 
to weeks 17.6, 22.8 and 32.8 in our study.  
 Correction for urine dilution improved the temporal reproducibility in urinary 
concentration for most phenols evaluated in this study. We observed similar patterns of 
urinary creatinine and specific gravity measures throughout pregnancy, and the estimates of 
urinary concentration reliability (correlations, ICCs) were similar using both methods. These 
findings suggested that either could be used to correct for urine dilution in pregnant women.  
e) Influence of collection conditions on phenol urinary concentrations 
 Because benzophenone-3 is commonly used in sunscreen for its sun-blocking 
properties (Calafat et al. 2008), exposure is more likely to be high during the summer months 
as compared to the rest of the year, and we indeed observed this seasonal variability in 
benzophenone-3 concentrations in our population. The associations observed between hour of 
collection and benzophenone-3, triclosan, butylparaben and 2,4-dichlorophenol urinary 
concentrations suggested that exposures changed considerably throughout the day. We sought 
to remove the variability in phenol urinary concentrations due to heterogeneity in collection 
conditions by implementing the 2-step standardization method proposed by Mortamais et al. 
(2012). Our results suggest that study related variability in sample collection conditions did 
not strongly influence intra-subject comparability of biomarkers’ levels, because overall the 
ICCs obtained with the standardized concentrations were close to those obtained from the 
unstandardized concentrations. 
f) Study strengths and limitations 
 Our study is the first to report phenol concentrations in amniotic fluid and maternal 
urine collected on the same day. In addition, we examined variability in phenol biomarker 
concentrations over time during the prenatal period, for a diverse set of environmental 
phenols including some that have not been widely studied (triclosan, benzophenone-3 and 
dichlorophenols). Limitations include the relatively small sample size, and the low detection 
frequency of phenols in amniotic fluid. Additionally, although we made no exclusions on the 
basis of race/ethnicity, most of our study population was white. Since there is some 
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racial/ethnic variability in exposure patterns, our results may not fully represent any 
underlying variability in the general population. 
 To better understand the link between maternal and fetal exposures further studies 
with more diverse populations, having time-matched amniotic fluid and maternal samples 
may be required. Collecting more urine samples or having larger time intervals between 
sample collection may improve the characterization of the urine concentration variability 
during pregnancy.  
5. Conclusion 
 The degree of reproducibility in benzophenone-3, triclosan, 2,4- and                          
2,5-dichlorophenols, methyl-, ethyl-, propyl- and butyl-parabens urinary concentrations over 
the course of the pregnancy suggest that a small number of urine samples (more than one) 
may reasonably represent the individual exposure across pregnancy to these compounds or 
their precursors. As previously reported, we observed low reproducibility in bisphenol A 
urinary concentration among pregnant women with little evidence of secondary fetal exposure 
to bisphenol A via amniotic fluid. Given the infrequent detection and much lower 
concentrations of most biomarkers in amniotic fluid than in urine, our results suggest that 
amniotic fluid may not be a suitable matrix for assessing fetal exposure to non-persistent 
phenols using the currently available detection techniques.  
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II. Impact of exposure misclassification and of number of urine samples 
collected on bias and power in biomarkers based epidemiological 
studies; a simulation study applied to short half-life endocrine disruptors 
1. Background  
 Measurement error occurs whenever we cannot exactly observe one or more of the 
variables that enter into a model of interest (Buonaccorsi 2010). In this we focus on 
measurement error in exposure. There are several ways to describe and classify measurement 
error. Measurement error can be differential or not (a concept that will not be detailed here); it 
can have a Berkson or classical component and be of additive or multiplicative structure 
(Armstrong 1998; Heid et al. 2004; Rothman et al. 2008). Classical measurement error arises 
when the estimator of the true exposure (e.g., phenol concentrations measured in one urine 
sample) varies around the true value (e.g., the average pregnancy exposure) in such way that 
the average of many replicate measurements, conditional on the true value, will equal the true 
individual exposure. Classical error is statistically independent of the true value (Armstrong 
1998; Carroll et al. 1995; Heid et al. 2004). This type of error usually results in effect 
estimates that are smaller than the true effect, a phenomenon commonly called attenuation 
bias (Bateson and Wright 2010). Berkson error is independent of the surrogate measure of 
exposure and typically occurs when the same surrogate is used for many subjects (e.g., use of 
a central monitoring site to estimate the individual exposures of people living around this site) 
(Armstrong 1998; Bateson and Wright 2010; Zeger et al. 2000). Berkson error usually does 
not induce notable bias on the effect estimates but rather increases standard errors of the effect 
estimate and so weakens their precisions (Bateson and Wright 2010; Heid et al. 2004). 
 A recognized limitation of the studies aiming at exploring effects of prenatal exposure 
to short half-life endocrine disruptors is exposure estimation, generally based on biomarker 
measurements in maternal urine samples collected one to three times during pregnancy 
(Braun et al. 2011a; Philippat et al. 2012; Wolff et al. 2008). Because of the short half-life of 
these chemicals and the episodic nature of the exposures, concentrations are likely to be 
variable during pregnancy. Depending of the chemicals, the ICCs described in the previous 
chapter and in other studies ranged between 0.1 and 0.6 (Adibi et al. 2008a; Braun et al. 
2011b; Meeker et al. 2013; Philippat et al. In revision), suggesting that using a small number 
of measures during pregnancy may imperfectly reflect the global exposure throughout the 
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whole fetal life or during a specific time window and lead to measurement error in exposure 
estimation, which may in turn bias dose-response relationship.  
 Increasing the number of urine samples during pregnancy and pooling them could be a 
solution to improve exposure assessment to short half-life chemicals without increasing 
analytical cost (White et al. 2008). Conversely, increasing study sample size will lead to 
increased analytical cost without decreasing bias if error is of classical nature . 
 In this chapter, using simulated data, we characterized the bias associated with the use 
of one urine sample to estimate exposure to non persistent chemicals, and the impact of 
increasing the number of measurements on bias and statistical power of epidemiological 
studies aiming at describing associations between pregnancy exposure to non persistent 
chemicals and a birth outcome. We here assume that one considers birth weight, analyzed as a 
continuous variable as an outcome. 
2. Methods 
 We considered two chemicals A and B with intraclass correlation coefficients (ICC) of 
0.6 (A) and 0.15 (B), corresponding to the ICCs observed between ln transformed urine 
concentrations of benzophenone-3 and bisphenol A measured in three urine samples collected 
during pregnancy (see section I of this chapter, (Philippat et al. In revision)). For 500 subjects 
i(i = 1 - 500), we generated T = 294 variables Eit (t = 1 - 294) with standard normal distribution 
and a coefficient of correlation between any two of the within subject Eit(t = 1 - 294) variables of 
0.6; these variables represent the daily concentrations of A measured in spot urine samples 
collected in subject i during each day of pregnancy. Eit was standardized by the standard 
deviation of Ei3, which represents the average pregnancy concentration of A in subject i. We 
supposed that the real effect of A on birth weight (Yi) corresponded to a decrease of 80 g in 
mean birth weight for each increase by one in ln-transformed concentration of A. That is: 
 
Yi = α0 - 80xEi3+ εi 
 
α0: constant (3300g) 
Ei3 : Prenatal exposure to A for subject i (pregnancy average); Ei3 = ∑ Eit	/	294
294
61 	 
εi: Random error: variable normally distributed, centered on 0, with standard deviation (SD) of 456, 
corresponding to the observed SD of birth weight in EDEN cohort. 
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 We randomly selected j days during pregnancy and assumed that urine samples were 
collected on each of these days, so that exposure was assessed as the mean concentration of A 
during these j days. We tested values of j = 1, 2, 3, 4, 5, 10, 25, 50, 75 and 100. We estimated 
the association between the mean of the j concentrations and birth weight using linear 
regression. 
 For each value of j we performed 1000 simulations and computed the mean of the 
1000 estimated β parameters. In order to estimate the impact on statistical power we counted 
how many times the association was significant (p < 0.05 and β < 0).  
 A similar approach was used for chemical B, assuming that correlation between any 
two concentrations on two different days was 0.15 instead of 0.6.
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3. Results 
 For chemical A, as expected the empirical average correlation between two random 
samples from a given woman was 0.6. When only one urine sample was used, the average 
effect estimate was β1sample = - 49 g compared to βref, - 80 g (an attenuation by 40%). The 
statistical power was 83 %, compared to 97 % if all daily samples are used to estimate 
exposure. Using 5 samples led to an effect estimate of - 72 g (attenuation by around 10%) and 
a statistical power of 95% (Table 23, Figure 20).  
Figure 20: Distribution of the β parameter characterizing the association between exposure 
and birth weight using the average pregnancy exposure Ei3  or only one urine sample to assess 
exposure to chemicals with ICC of 0.6 (A) and to chemicals with ICC of 0.15 (B) (1000 
simulations were performed). 
Chemical A (ICC of 0.6) 
 
Chemical B (ICC of 0.15) 
 
 
 For chemical B, the empirical average correlation between two random samples from a 
given woman was 0.15. Using only one sample to estimate exposure led to an effect estimate 
biased toward the null (β1sample , -13 g compared to βref, - 80 g) and to low statistical power 
(33%). In addition, we observed a positive but not significant association (p-values > 0.2) for 
61 of the 1000 simulations. Our results suggest that more than 25 urine samples would be 
needed to correctly estimate the pregnancy average exposure and to obtain an effect estimate 
close to the expected β (less than 10% variation compared to βref) for chemicals B (Table 23). 
A statistical power of 87% is reached with 10 samples per subject.  
  
A B 
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Table 23: Statistical power and effect estimate (β) characterizing the association between 
birth weight and exposure assessed during pregnancy (simulation study, n = 500 women, 
1000 simulations)  
 Chemical A (ICC, 0.6)   Chemical B (ICC, 0.15) 
Number of urine 
samples used 
Β Statistical 
power (%)  
Β Statistical 
power (%) mean (SD) mean (SD) 
Reference a -81 20 97 
 
-81 21 98 
1  -49 16 83 
 
-13 8 33 
2  -61 18 91 
 
-22 11 52 
3  -66 19 95 
 
-28 12 62 
4  -70 19 95 
 
-34 14 71 
5  -72 19 95 
 
-39 15 76 
10  -76 20 96 
 
-53 17 87 
25  -79 20 97 
 
-67 19 94 
50  -80 20 97 
 
-75 20 96 
75  -81 20 97 
 
-77 20 97 
100  -81 20 97 
 
-78 20 98 
a corresponds to using the 294 pregnancy urine samples to assess exposure 
 
4. Discussion  
 Our results suggest that studies relying on one urine sample to assess exposure to short 
half-life endocrine disruptors in human are likely to be biased; the bias is very high for 
chemicals showing high intra-individual variability such as bisphenol A. The type of bias 
observed in our study is commonly referred to as attenuation bias. Attenuation bias has been 
previously described in situations of classical measurement errors and is not expected if error 
is only of Berkson nature (Bateson and Wright 2010; Heid et al. 2004; Whitehead et al. 2012). 
Such results was expected with regards to the way we simulated our data (the true exposure 
(pregnancy average) was considered to be the average of the values of the surrogate measures, 
which is typical of classical error).  
 One of the limitation of our study was the hypothesis regarding ICCs. The dataset 
simulation was based on correlation coefficients observed in the SARAEH study (Philippat et 
al. In revision) in which only three measurements per women during pregnancy have been 
collected. In addition, correlation was assumed to be the same between any two samples at 
whatever day of pregnancy, which may not be realistic. Having more precise information on 
phenol concentration variability within-day, -week and between-trimesters would be useful to 
make more realistic simulations. Our research team aims at collecting such information in the 
framework of a feasibility study (SEPAGES-Feasibility cohort) taking place at Grenoble and 
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including about 30 women with intensive urine collection (around 180 samples per woman). 
Also, we assumed that the biologically relevant exposure windows was the whole pregnancy, 
although for specific outcomes narrower time windows may be relevant. Finally, we did not 
take into account additional sources of error such as sampling and storage conditions; nor we 
have considered potential confounders, which might also be measured with error.  
 Our results showed that increasing the number of samples per participant and pooling 
them could be an efficient method to decrease measurement error in epidemiological studies. 
For chemicals with ICC of 0.6, using 4 or 5 samples gave an estimate close to the expected β 
(attenuation < 10 %). For chemicals with ICC of 0.15, around 25 samples were needed to 
reach an estimate close to the expected β. Collecting 25 samples per woman during pregnancy 
in the framework of an epidemiological study would imply a high observance of the 
participants and a complex organization for the research team in charge of the collection and 
processing of the urine samples. This would also be cumbersome for the participants and 
therefore might induce selection bias and low participation rate. In addition, decreasing 
measurement error by increasing the number of urine samples per participant is doable for 
further cohort studies but is not applicable to existing cohorts. For these reasons, statistical 
methods aiming at estimating an effect estimate (β) and 95% CI "corrected" for the 
measurement error have been developed (e.g., regression calibration, simulation 
extrapolation, (Buonaccorsi 2010; Carroll et al. 1995; White et al. 2008). To our knowledge, 
these methods have not been used in studies aiming at assessing the effects of phenols and 
phthalates on human health. They have been used in other settings (Bateson and Wright 2010; 
Spiegelman et al. 1997). We recently began working on the application of these methods in 
the framework of the study of the effects of short half-life chemicals. I am currently 
supervising a master 2 internship aiming at testing different measurement error models (based 
on simulated data and on the ICCs observed in the SARAEH study, chapter III, paragraph 
II.2) in order to identify a measurement error model that could be used to correct the β 
estimated in the previous studies using a small number of urine samples to assess exposure to 
phenols and phthalates. 
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I. Prenatal exposure to phthalates and phenols and pre- and post-natal 
growth  
1. Associations with birth outcomes 
 When this PhD was initiated in 2010, only two studies in Humans had explored the 
associations between prenatal exposure to phenols and prenatal growth (Padmanabhan et al. 
2008; Wolff et al. 2008); none had considered postnatal growth. The study by Wolff et al. 
(2008) had suggested possible sex-specific effects of some phenols on birth weight. Effects of 
prenatal exposure to phthalates on fetal growth were a little bit more documented                   
(n = 4 studies published before 2010 (Huang et al. 2009; Latini et al. 2003; Wolff et al. 2008; 
Zhang et al. 2009)), but that was not enough to allow to conclude about their effects on fetal 
growth. Limitation of these previous studies were the use of birth outcomes (weight, length 
and head circumference) as proxies of fetal growth (none of these had repeated measurements 
of fetal growth during pregnancy) and their relatively low sample size; only the study 
published by Wolff et al. (2008) had more than 150 subjects of each sex. In addition, because 
of the high number of comparisons performed, a part of their findings might have been due to 
chance and had to be replicated in another population before drawing any conclusion. For this 
reason, in the first part of my PhD, we aimed at reproducing previous published results, 
regarding the associations between these chemicals and birth outcomes. 
 Our study population consisted in a case–control study of male malformations of the 
genitalia nested in the EDEN and PELAGIE cohorts (Gona_PE study). This particular design 
has been taken into account in our analyses by using a weighting approach specifically 
developed to re-use of case–control data for analysis of new outcome variables (Reilly et al. 
2005; Richardson et al. 2007). A part of our findings on phenols and birth weight was in 
relatively good agreement with those reported by Wolff et al. (2008). An inverse association 
of 2,5-dichlorophenol and a positive association of benzophenone-3 with male birth weight 
were indeed observed in both studies, even if urine concentrations were lower in our 
population. Regarding phthalates, we observed non-monotonic associations with birth weight 
which had never been reported previously in rodents or in Humans and that we therefore 
considered cautiously.  
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2. Associations with fetal biometry and early postnatal growth 
 In 2011, a new funding allowed us to extend the measurements of phenol and 
phthalate urinary concentrations to all women of the EDEN cohort delivering boys with 
complete data on fetal biometry assessed during pregnancy by repeated ultrasound 
measurements and postnatal growth until 3 years of age (n=410); 110 women previously 
included in the case-control study matched these inclusion criteria and were also considered in 
our analyses (PEnDevE study). The objectives of this study were to replicate our previous 
findings on birth outcomes, to study the associations with the repeated ultrasound 
measurements of fetal biometry (which could allow highlighting potential susceptibility 
windows) and to study the association with child growth until 3 years of age. These three 
points contributed to the project originality since, when it was initiated, none of the authors of 
the previous studies had to our knowledge tried to reproduce their published findings and no 
study using ultrasound measurements or early postnatal growth measurements in relation of 
exposure to short half-life endocrine disruptors had been published. Because of limited 
funding and of our choice to try to replicate our previous findings rather than generating new 
ones, we did not assess phenols and phthalates in urine from mother delivering girls. Women 
of the PELAGIE cohort were not included because data from ultrasound examinations had not 
been collected in this cohort. The phthalates were studied by Jérémie Botton                          
(Inserm U1018 - Villejuif) and only the results regarding phenols have been reported in this 
thesis.  
 We were not able to replicate the negative associations previously observed between 
dichlorophenols and weight and head circumference at birth among the subsample of 191 
women from the EDEN cohort. Several possible explanations can be considered. These 
include chance findings and bias induced by exposure misclassification related to the short 
half-life of the studied chemicals; our simulation study has indeed shown that results of 
studies using one urine sample to assess exposure could be highly biased, even for chemicals 
showing relatively good ICC, such as dichlorophenols. We observed consistency across our 
studies regarding the positive association between benzophenone-3 and birth weight             
(ICC = 0.6). 
 Within the larger subpopulation of 520 male newborns, we observed a negative 
association between triclosan concentration and all of the third ultrasound measurements, 
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head circumference at birth and at 36 months. Parabens, especially the methyl, were 
positively associated with postnatal weight and weight at birth. 
3. Methodological issues  
a) Confounding 
 A confounding factor can be defined as being associated with both the exposure and 
the studied outcome without being affected by them (Rothman et al. 2008). In our study, we 
adjusted for many potential confounders, but residual confounding cannot be discarded. In our 
study, the association of maternal pregnancy bisphenol A level with child weight at 12 months 
was weakened by adjustment for the child caloric intake at 8 months, which is suggestive of 
confounding by child diet (this was detailed Chapter II, page 88). 
 A consideration when associating urinary biomarkers with health effects is that a part 
of the between-subject differences in the measured concentrations are due to variations in 
metabolism and xenobiotic excretion across participants. Specific metabolic disorders 
associated with both fetal growth and xenobiotic metabolism thus constitute potential 
confounders in our study. We considered this issue in Gona_PE study and excluding women 
with pregnancy-induced hypertension or gestational diabetes did not alter our findings. 
 We did not adjust our analyses for exposures which may co-exist with phenols and 
phthalates. This leaves room for residual confounding by unmeasured co-exposures.  
b) Selection bias and finding generalization 
 Selection bias arises when the relationship between exposure and disease is different 
for those who participate and for all of those who are eligible for the study, including those 
who do not participate (Rothman et al. 2008). The fact that we did not observe strong 
differences between the characteristics of the women selected to study the associations 
between phenols and pre- and post-natal growth and those of the whole EDEN women 
delivering boys, is not in favor of such bias in our study.  
 Comparison between the EDEN cohort population and a representative sample of 
women who delivered in 2003 throughout France (Blondel et al. 2006) has shown no 
difference in term of length of gestation and weight at birth of the newborns. Women included 
in EDEN were more highly educated and more often worked during pregnancy than women 
from the general population (Slama et al. 2009). These characteristics might be associated 
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with exposure to several of the studied chemicals; as an example, in the EDEN cohort we 
observed an inverse association between maternal education and the urinary bisphenol A 
concentrations during pregnancy (data not shown); this was also reported in a population of 
American pregnant women (Braun et al. 2011b). We therefore cannot discard that the urinary 
concentration of phthalates and phenols differ between women included in EDEN and the 
whole pregnant women of the general population.  
 Studying male newborns only prevents the generalization of our results to female 
newborns, but is not a source of bias. In term of public health, observing an effect of phenols 
on fetal growth in male newborns may be enough to call for more stringent regulations of the 
substances. Our choice to focus on males was that sex-specific associations had been reported, 
in particular between some phenol concentrations and male birth weight (Wolff et al. 2008); 
in this context warranting for analyses stratified on sex, we opted for a study of male 
newborns only, which had in expectancy a higher statistical power than two sex-specific 
analyses on populations samples with half our sample size. 
II. Variability in urine concentration and correspondence between urine 
and amniotic fluid concentration 
 A few papers have reported high between and within day variability of bisphenol A 
concentrations (Ye et al. 2011a) and in a study where three spot urine samples have been 
collected during pregnancy (n = 389 pregnant women from Cincinnati, Ohio), low intraclass 
correlation coefficient (0.11) had been reported for this phenol (Braun et al. 2011b). This 
suggests that single spot urine sample, as we had in our study, will not be representative of the 
whole pregnancy exposure and will strongly misclassify bisphenol A exposure. Even if this 
seems essential for the understanding of published epidemiological studies relating their 
urinary biomarkers to health endpoints, no data on urinary concentration variability during 
pregnancy was published for the other phenols. We aimed at filling this gap, by publishing the 
first study presenting data on urinary concentration reproducibility during pregnancy of 
triclosan, benzophenone-3 and dichlorophenol. Bisphenol A and parabens were also reported 
in our study and our results for these chemicals were generally in agreement with the few 
papers published before ours (Braun et al. 2012; Smith et al. 2012). For bisphenol A, our 
results were consistent with previous reports (Braun et al. 2012; Braun et al. 2011b) and we 
observed poor reproducibility along pregnancy (Philippat et al. In revision). For the other 
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phenols we observed a higher degree of reproducibility in urinary concentrations                
(ICCs ~ 0.5-0.6), suggesting that fewer samples would be needed to efficiently estimate 
pregnancy exposure for these phenols compared to bisphenol A. However, even in this range 
there might be exposure misclassification leading to bias in epidemiological studies using a 
single spot urine sample. In order to estimate the bias associated with such ICCs, we 
performed a simulation study and illustrated that using one urine sample to assess exposure to 
short half-life phenols will lead to bias in the estimated relationship between exposure and a 
health outcome and that; bias will be stronger for phenols showing high variability during 
pregnancy (e.g., ICC < 0.2). We provide the first estimate of the optimal number of samples 
required to characterize average pregnancy exposure; around 5 for chemicals such as 
benzophenone-3 with an ICC of 0.6, and above 20 for chemicals with an ICC of 0.15. These 
estimations could be made more accurate by using more precise data on phenols urine 
concentrations variability during pregnancy (e.g., variability within-day, -week and between-
trimesters). In the framework of the SARAEH study we indeed had only three measurements 
per woman, which had been collected in a narrow time window (the first, second and third 
urine samples were collected in average at gestational weeks 18, 23 and 33) . 
 Another originality of this work is that an amniotic fluid sample collected the same 
day of one of the urine sample was available for 69 women of the SARAEH study. Although 
previous studies have measured environmental phenols in this fluid, none of them had 
simultaneously collected urine and amniotic fluid samples (Edlow et al. 2012; Engel et al. 
2006; Yamada et al. 2002). This was particularly interesting since most of the epidemiological 
studies used maternal urine samples to assess fetal exposure while it is not well known to 
what extent maternal urine reflects it. We hypothesized that, because the fetus swallows 
amniotic fluid and because fetal urine is one of the main sources of this fluid in the second 
half of pregnancy (Modena and Fieni 2004; Underwood et al. 2005), concentrations measured 
in this matrix might be a relevant dosimeter of fetal exposure. Only two of the nine phenols 
assessed in amniotic fluid were detected in more than 50 % of the samples, and for these 
chemicals we observed a positive correlation with their concentrations measured in urine 
collected the same day. The low frequencies of detection suggest that amniotic fluid may not 
be a suitable matrix for assessing fetal exposure to non-persistent phenols using the currently 
available detection techniques.  
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III. Conclusion and research perspectives  
 The work performed in the EDEN and PELAGIE cohorts lends support to a potential 
effect of prenatal exposures to some phenols and phthalates on pre- and early post-natal 
growth. However our study had several limitations, especially regarding exposure assessment. 
Our findings need to be replicated in other Human studies with improved exposure 
assessment. This is also true for the other published studies, since repeated urine 
measurements of biomarkers in maternal urine have only been used in one study of fetal 
growth, with a sample size of 80 male and female newborns (Snijder et al. 2013).   
1. Improving exposure assessment during fetal life  
 Increasing the number of urine samples collected per participants during pregnancy is 
an obvious way to improve exposure assessment in cohort of pregnant women. This seems 
feasible in practice for phenols with relatively good reproducibility during pregnancy (ICCs ≈ 
0.6), for which our simulation study showed that about 5 random samples could reasonably 
well represent the whole pregnancy exposure (although it must be noted that most previous 
studies collected first morning voids and that collecting urine samples at random hours during 
the day may be cumbersome for some study participants). However for chemicals showing 
high variability during pregnancy, such as bisphenol A, we estimated that around 25 urine 
samples during pregnancy would be needed. Such a sampling scheme implies a strong 
implication of the enrolled women and results in an important workload for the research team 
to collect and process all the samples. Our ongoing experience from SEPAGES-feasibility 
cohort with 30 women from Grenoble urban area shows that this is feasible. An efficient 
alternative or complement could be the use of statistical methods specifically aiming at 
correcting the effect estimates for measurement errors. This includes approaches such as 
regression calibration and simulation extrapolation (Buonaccorsi 2010; Carroll et al. 1995).  
 Maternal urine concentrations are commonly used in epidemiological studies as a 
proxy of fetal exposure. This can be discussed in terms of relevance of using urinary 
metabolites as a marker of exposure as well as in terms of matrix used. Alternative matrices 
might be indeed useful in estimating direct fetal exposure. We showed low frequencies of 
detection for most phenols in amniotic fluid. In addition, with regards to the risks for the 
mother and fetus (e.g. amniotic fluid leakage, chorioamnionitis...), it would be unethical to 
subject women to amniocentesis purely for research purposes. Other matrices allowing to 
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avoid invasive collection exit (e.g., meconium). Meconium starts accumulating in the fetal 
bowel as early as the 13th week of gestation and measuring chemicals in this matrix might 
reflect fetal exposure during the second and third trimesters of pregnancy. Meconium has 
been already used to evaluate fetal exposure to alcohol, tobacco and cocaine (Joya et al. 2012; 
Ryan et al. 1994; Spanier et al. 2011); analytical techniques to assess non persistent chemicals 
also exist (Zhang et al. 2009) but have not been widely used yet. 
 In our study, we focused on the effects of prenatal exposure to phenols and phthalates 
on prenatal growth. Exposure during childhood might also have an effect on postnatal growth. 
Use of the child urine to assess his exposure to phenols and phthalates suffers of the same 
limitations than maternal urine; high variability has been reported in concentrations of these 
chemicals measured in repeated urine samples collected during childhood (Teitelbaum et al. 
2008).  
2. Link between the toxicological and epidemiological studies 
 In Human studies exposure to phthalates and phenols during pregnancy is usually 
estimated by measuring their biomarker concentrations in urine. These concentrations are 
wrongly called "exposure" and basically differ from the exposure available in toxicological 
studies (e.g. when animals are exposed through gavage). Urine concentrations indeed depend 
on exposure but are also determined by the metabolism and excretion capacity of each subject 
(Longnecker 2006). Physiologically Based Pharmacokinetic (PBPK) models are mathematical 
modeling techniques allowing prediction of the absorption, distribution, metabolism and 
excretion of chemicals in the organism and could be used to estimate exposure on the basis of 
urinary levels of metabolites (reverse dosimetry). Such models have been developed for 
several of the chemicals studied in the thesis (Fisher et al. 2011; Kawamoto et al. 2007), but 
they have been very little used in epidemiological studies and generally outside of the context 
of pregnancy. Using these models would make easier comparisons between exposures 
encountered in human populations with exposures used in animal experimentation. 
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RESUME DE LA THESE 
Contexte : Les phtalates et les phénols sont des perturbateurs endocriniens à courte demi-vie. L'exposition à ces composés 
chimiques est ubiquitaire en population générale, y compris pour les femmes enceintes. Certains sont capables de traverser le 
placenta et le fœtus est également exposé. Les données concernant les effets de l'exposition prénatale à ces composés sur la 
croissance fœtale et durant l'enfance sont limitées et suggèrent un effet dépendant du sexe de certains phénols sur le poids de 
naissance.  
Une des limites des études visant à évaluer les effets des expositions prénatales aux phénols et phtalates chez l'Homme est 
l'estimation de l'exposition, généralement basée sur la mesure de leurs concentrations dans un petit nombre d'échantillons 
d'urine maternelle. En raison de la faible persistance de ces composés chimiques dans l'organisme et de la nature épisodique 
probable de l'exposition, les concentrations urinaires varient dans le temps. Un petit nombre d'échantillons urinaires prélevés 
pendant la grossesse sont susceptibles de refléter de façon imparfaite l'exposition globale sur l'ensemble de la vie fœtale. Les 
concentrations dosées dans d'autres matrices, comme le liquide amniotique, pourraient être pertinentes pour estimer 
l'exposition fœtale. 
 
Objectifs : Les objectifs de la thèse étaient : 1) d'étudier les impacts potentiels de l'exposition prénatale aux phénols et aux 
phtalates sur la croissance du fœtus et de l'enfant ; 2) de caractériser la variabilité des concentrations urinaires de composés 
non persistants (phénols) au long de la grossesse et de comparer les concentrations de phénols dosées dans le liquide 
amniotique et l'urine maternelle recueillis le même jour ; 3) de caractériser le biais et l'impact sur la puissance statistique de 
l'utilisation d'un faible nombre d'échantillons urinaires pour estimer les expositions.  
 
Méthodes : Les associations entre les phénols, les phtalates et la croissance pré- et post-natale précoce ont été étudiées parmi 
les femmes de la cohorte mère-enfant EDEN ayant accouché de garçons. La croissance fœtale a été estimée à l'aide 
d'échographies, réalisées à trois reprises pendant la grossesse et de mesures à la naissance. La croissance postnatale à été 
modélisée à partir de mesures répétées normalisées, réalisées entre la naissance et 3 ans. Les biomarqueurs d'exposition aux 
phtalates et phénols ont été dosés dans les urines maternelles collectées une fois pendant la grossesse. Ces dosages ont été 
réalisés en 2008 pour 191 femmes et en 2012 pour 410 autres femmes (ntot = 601). Parmi elles, 520 avaient des enfants ayant 
des données complètes sur la croissance pré- et post-natale. 
La variabilité des concentrations urinaires de phénols et la correspondance avec les concentrations mesurées dans le liquide 
amniotique collecté le même jour ont été étudiées chez 71 femmes enceintes recevant une amniocentèse au centre médical 
Mount Sinaï (étude SARAEH, NY, États-Unis). Un échantillon d'urine maternelle a été recueilli le jour de l'amniocentèse, et 
à deux autres reprises pendant la grossesse. Neuf phénols ont été dosés dans l'urine et le liquide amniotique. 
L' étude concernant les biais est basée sur des données simulées.  
 
Résultats : Parmi le sous-échantillon de 191 femmes de la cohorte EDEN ayant eu des dosages en 2008, nous avons mis en 
évidence une association négative entre les dichlorophénols et le poids de naissance ainsi qu'une association positive entre la 
benzophénone-3 et le poids à la naissance (Philippat et al. 2012). Les associations avec les dichlorophénols n'ont pas été 
observées lorsque la taille de l'échantillon de population a été augmentée (n = 520). Les concentrations de triclosan étaient 
négativement associées à tout les paramètres de croissance mesurés au troisième examen échographique (p-valeurs comprises 
entre 0,01 et 0,16) et avec la périmètre crânien mesuré à la naissance (β = - 1,4 mm, IC 95%; -2.8; 0.0) et à 36 mois               
(β = - 1,0 mm, IC 95%; -2.8; 0.8). Les parabènes étaient associés positivement avec le poids à la naissance (p < 0,05). Ces 
associations se maintenaient dans l'enfance pour le méthyle et propyle parabènes, qui étaient positivement associés au poids à 
6, 12, 24 et 36 mois et la circonférence abdominale à 36 mois (p-valeurs comprises entre 0,02 et 0,14). 
En ce qui concerne la variabilité des concentrations urinaires de phénols pendant la grossesse, les coefficients de corrélation 
intra-classe (ICC) variaient entre 0,48 et 0,62 pour l'ensemble des phénols sauf le bisphénol A (ICC = 0,11). Seuls la 
benzophénone-3 et le propyle parabène ont été détectés dans au moins 50 % des échantillons de liquide amniotique ; les 
autres phénols n'étant détectés que très rarement (par exemple, le bisphénol A a été détecté dans seulement deux 
échantillons). Les concentrations de benzophénone-3 et de propyle parabène dosées dans l'urine maternelle et le liquide 
amniotique, recueillis le même jour, étaient positivement associés (Philippat et al. en révision). 
Dans le cadre d'une simulation, nous avons estimé que pour les produits chimiques avec un ICC de 0,6, utiliser 5 échantillons 
donnait un β proche du β obtenu lorsque que tout les échantillons d'urine (n = 294 par femme) étaient utilisés                 
(atténuation < 10 %), mais que pour des produits chimiques avec un ICC de 0,15, environ 25 échantillons étaient nécessaires 
pour atteindre une estimation proche de ce β. 
 
Discussion / Conclusion : La variabilité importante des concentrations de bisphénol A suggère que des erreurs de 
classification de l'exposition sont très susceptibles de se produire dans les études épidémiologiques basées sur un faible 
nombre d'échantillons urinaires pour estimer l'exposition. Une assez bonne reproductibilité a été observée pour les autres 
phénols (ICC ~ 0.5-0.6); néanmoins, même dans cette gamme d'ICCs, une mauvaise classification de l'exposition pouvant 
entrainer des biais est susceptible de se produire dans les études épidémiologiques utilisant un seul échantillon d'urine pour 
estimer l'exposition. 
Un seul échantillon d'urine était disponible pour évaluer les expositions des femmes de la cohorte EDEN et nos résultats 
peuvent être affectés d'un biais résultant d'erreurs de classification des expositions. Néanmoins, notre étude suggérait un effet 
de l'exposition prénatale à certains phénols sur la croissance pré- et post-natale. 
 
 
 
 
 
THESIS ABSTRACT 
Background: Phthalates and phenols belong to the family of short half-life endocrine disruptors. Exposure to 
these chemicals is ubiquitous in the general population including pregnant women. Some of these can cross the 
placental barrier and fetuses are also exposed. Data concerning the effects of prenatal exposure on fetal and early 
post-natal growth in Human are limited and suggest a sex-specific effect of some phenols on birth weight.  
One of the limitations of the studies aiming at assessing effects of prenatal exposure to phenols and phthalates in 
Human is exposure assessment usually based on the measurement of their concentrations in a small number of 
maternal urine samples. Because of their low persistence in the organisms and the likely episodic nature of the 
exposures, urinary concentrations of these chemicals are likely to vary. A small number of urine samples 
collected during pregnancy may imperfectly reflect the global exposure throughout the whole fetal life. Chemical 
concentrations measured in alternative matrix, such as amniotic fluid, might be a relevant dosimeter of fetal 
exposure. 
 
Objectives: Objectives of the thesis were 1) to study the potential effects of prenatal exposures to phenols and 
phthalates on pre- and early post-natal growth; 2) to characterize variability in maternal urine concentrations of 
non persistent chemicals (phenols) throughout pregnancy and to compare phenol concentrations in amniotic fluid 
to those measured in maternal urine collected same day; 3) to characterize the impact of increasing the number 
of measurements to estimate exposure on bias and statistical power of epidemiological studies. 
 
Methods: Associations between phenols, phthalates and pre- and early post-natal growth were studied among 
pregnant women of the French EDEN cohort, delivered boys. Pregnant women have been recruited before 24th 
gestational week and followed up until the child is 5 years old. We measured fetal growth with ultrasound (three 
times during pregnancy) and birth measurements. We used standardized measures acquired between birth and 3 
years of age to model postnatal growth. We measured biomarkers of phthalates and phenols in maternal urines 
collected once during pregnancy: 191 women were assessed in 2008 and 410 other women in 2012 (ntot = 601). 
Among them, 520 had complete data on pre- and post-natal growth of the offspring. 
Variability in phenol urine concentrations and relationship between concentrations measured in amniotic fluid 
and maternal urine collected on the same day were studied among 71 pregnant women presenting for an 
amniocentesis at the Mount Sinai Medical Center (SARAEH study, NY, USA). Maternal urine was collected at 
the time of the amniocentesis appointment, and on two subsequent occasions. Urine and amniotic fluid were 
analyzed for nine phenols. 
The study aiming at characterizing bias was based on simulated data.  
 
Results: Among the subsamples of 191 pregnant women from the EDEN cohort, we observed a negative 
association between dichlorophenols and birth weight and a positive association between benzophenone-3 and 
birth weight (Philippat et al. 2012). The associations with dichlorophenols were not replicated in the larger 
subsample of the EDEN cohort (n = 520). Triclosan concentration was negatively associated with all of the 
growth parameters measured at the third ultrasound examination (p-values ranged between 0.01 and 0.16) and 
with head circumference measured at birth (β = - 1.4 mm, 95% CI; -2.8; 0.0) and at 36 months (β = - 1.0 mm, 
95% CI; -2.8; 0.8). All of the parabens were positively associated with weight at birth (p < 0.05). These 
associations remained in childhood for methyl- and propyl-parabens. 
Regarding the variability in phenol urinary concentrations during pregnancy, the intraclass correlation 
coefficients (ICC) ranged between 0.48 and 0.62 for all phenols except bisphenol A (ICC = 0.11). Only 
benzophenone-3 and propylparaben were detectable in at least half of the amniotic fluid samples; other phenols 
were detected infrequently (e.g., bisphenol A was detected in only two samples). Concentrations of 
benzophenone-3 and propylparaben in maternal urine and amniotic fluid, collected on the same day, were 
positively associated (Philippat et al. In revision).  
In a simulation study, we estimated that for chemicals with ICC of 0.6, using 4 or 5 samples gave a β close to the 
β obtained when all of the urine samples collected during pregnancy (n= 294 per women) were used to estimate 
exposure (attenuation < 10 %); however for chemicals with ICC of 0.15 around 25 samples would be needed to 
reach an estimate close to this β. 
 
Discussion / Conclusion: The poor reproducibility in bisphenol A concentration suggests that substantial 
exposure misclassification occurs in epidemiological studies using a single spot urine sample to assess prenatal 
exposure to this phenol. Higher degree of reproducibility in urinary concentrations was observed for the other 
phenols (ICCs ~ 0.5-0.6). However, even in this range there might be exposure misclassification leading to 
substantial bias in epidemiological studies using a single spot urine sample.  
We only had spot urine sample to assess exposure in the EDEN cohort and findings may be affected by exposure 
misclassification. Nevertheless, our study lends support to a potential effect of prenatal exposure to some 
phenols on pre- and early post-natal growth. 
